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Abstract 
 
 Fruits have been increasingly studied for health-promoting properties and recent studies 
suggest that fruit compounds may provide protection against diabetes and its complications.  
Wild fruit species, Amelanchier alnifolia, Viburnum trilobum, Prunus virginiana, Shepherdia 
argentea, Vaccinium angustifolium, and Aristotelia chilensis, which have all been utilized by 
traditional cultures for sustenance and health, were evaluated for ability to protect against the 
development of diabetes and its complications.  Fruits of these species were extracted and 
separated into fractions rich in different phytochemical classes.  Fruits of V. trilobum 
demonstrated significant ability to improve energy expenditure by increasing fatty acid oxidation 
and glycogen accumulation in vitro.  The role of gene expression on these changes was explored 
and high-molecular weight proanthocyanidins (PAC-h) inhibited expression of glucose-6-
phosphatase in a dose dependent manner.  In addition, anthocyanins from V. trilobum interacted 
with the PAC-h in an additive manner to inhibit expression of glucose-6-phosphatase in vitro.  
Flavonoid-rich, anthocyanin-rich (ANC), and proanthocyanidin-rich (PAC) fractions from P. 
virginiana and V. angustifolium fruits were tested to determine potential to inhibit LPS-induced 
production of inflammatory mediators (IL-6, TNFα, and NO) in murine microglial cells.  Dose-
dependent inhibition of IL-6 was observed by the flavonoid-rich and ANC fractions from both 
species (maximum inhibition by V. angustifolium ANC fraction with IC50 = 111 µg/mL), 
inhibition of TNFα was seen by flavonoid-rich fractions of both species (greatest inhibition by P. 
virginiana with IC50 = 248 µg/mL), and inhibition of NO was demonstrated by flavonoid-rich 
and PAC fractions of both species (highest inhibition by V. angustifolium PAC fraction with IC50 
= 204 µg/mL).  Interactions between flavonoid-rich and PAC fractions of V. angustifolium 
showed a greater than additive type of interaction whereas interactions between PAC and ANC 
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were of an interference type.  Fruit extract of A. chilensis and P. virginiana were explored for 
aldose reductase inhibitory activity.  Overall, fractions from A. chilensis were more active than 
those from P. virginiana with maximum IC50 activity of 0.7 µg/mL.  Fractions with the most 
activity were positively associated with proanthocyanidin and flavonol content. 
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Chapter 1 
Background and Significance 
 
Fruits and Human Health 
In recent years, an increasing number of scientific and popular articles have demonstrated 
and popularized the potential of foods to improve health.  These health benefits are often linked 
to several mechanisms such as antioxidant capacity, anti-inflammation, enzyme 
inhibition/activation, and anti-adhesion.  Fruits have been closely examined for their ability to 
reduce risk of chronic diseases, alleviate complications associated with diseases, and slow age-
related degeneration. 
Fruits, mainly from the genus Vaccinium, have demonstrated bacterial anti-adhesion 
potential (prevention of urinary tract infection, UTI).  Howell et al. (1) found that 
proanthocyanidins from cranberry extract prevented the adherence of P-fimbriated Escherichia 
coli to uroepithelial-cells.  Later, Howell and Foxman (2) showed that the same 
proanthocyanidins were effective against antibiotic-resistant E. coli strains.  Additionally, wild 
blueberry fruit extracts have demonstrated similar anti-adhesion activity (3).  These effects have 
also been seen clinically.  Bailey et al. (4) showed that twelve women with a history of at least 
six UTIs per year had no reoccurrence for two years while taking a concentrated cranberry 
preparation, and Jepson and Craig (5) conducted a meta-analysis and found that in four 
randomized controlled trials of good quality, cranberry preparations significantly reduced re-
occurring UTIs in twelve months. 
Fruits have also shown potential to ameliorate several cognitive, neurological and 
behavioral problems that are often associated with aging.  Joseph et al. (6) showed that 
blueberries have the ability to prevent behavioral problems associated with Alzheimer’s disease 
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and that a diet rich in blueberries may help overcome a genetic predisposition to the disease.  A 
blueberry-supplemented diet also improved object recognition memory in an aged rat model 
which was correlated with decreased nuclear factor-kappa B levels in brain regions (7).  
Furthermore, Galli et al. (8) showed that a short term dietary intervention with blueberries 
improved heat shock protein generation capacity in the aged rat, which helps protect neuronal 
cells from toxins, reactive oxygen species, and necrosis.  Additionally, fruit components from 
Schizandra chinesis (a fruit-producing vine traditionally used in Chinese medicine) reversed 
induced spatial memory impairment in rats possibly by enhancing cholinergic function (9).  
Strawberry- and blueberry-supplemented diets also conferred protection from spatial and 
behavioral deficiencies in an aged rat model by improving hippocampal and striatal function 
(10), and blueberry- and bilberry-fed adult rats showed enhanced short-term and working 
memory compared to controls (11).  Shukitt-Hale et al. (12) demonstrated that Concord grape 
juice maintained cognitive function (improved working memory) and motor function in an aged 
rat model.  Although it is uncertain which berry compounds are neuroprotective, fruit 
anthocyanins have been shown to cross the blood-brain barrier in rats and concentrate in areas 
important for learning and memory (13). 
Fruit compounds have also been implicated in anti-inflammation ability.  Youdim et al. 
(14) found that both anthocyanins and hydroxycinnamic acids from blueberries reduced 
inflammatory mediator release in human microvascular endothelial cells after they were exposed 
to pro-inflammatory agents, and proanthocyanidins, especially oligomers, decreased production 
of inflammatory proteins such as inducible nitric oxide synthase (iNOS), cyclooxygenase-2 
(COX-2), and nuclear factor kappa-B (NF-κB) in a diabetic rat model (15).  Kelley et al. (16) 
showed that consumption of Bing sweet cherries lowered plasma inflammation markers, such as 
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C-reactive protein (CRP) and nitric oxide (NO), and that levels of these markers remained 
depressed for over a month post-consumption in healthy subjects.  A decrease in CRP was also 
observed in patients with peripheral arterial disease who were given a blackcurrant and orange 
juice mixture for 28 d (17).  Castilla et al. (18) found that consumption of concentrated red grape 
juice led to decreased levels of plasma monocyte chemoattractant protein 1 (MCP-1), an 
inflammatory biomarker of cardiovascular disease, in hemodialysis patients.  In addition, the 
lipopolysaccharide (LPS) -induced production of NO and COX-2 was attenuated in a murine 
macrophage cell line by an ethyl acetate soluble fraction of Lindera erythrocarpa berries (19), 
and Lau et al. (20) showed that a blueberry extract decreased the LPS-induced production of IL-
1β, TNFα, NO, and COX-2 in a murine microglial cell model.  Cornuside, a bisiridoid glucoside 
isolated from Cornus officinalis berries, reduced TNFα-induced expression of NF-κB, 
intercellular adhesion molecule-1 (ICAM), vascular cell adhesion moledule-1 (VCAM), and 
MCP-1 in a human endothelial cell system (21).  Furthermore, production of TNFα and IL-1β 
was reduced by a blueberry diet fed to rats with induced acute liver injury (22). 
Fruits have also shown potential to protect against the development of cardiovascular 
disease.  Kalea et al. (23) demonstrated that rats fed a blueberry-supplemented diet had increased 
glycosaminoglycan levels in the aorta which affects cellular signaling pathways, and Rhyu et al. 
(24) showed that rats given Schizandra chinensis fruit extract had more relaxed aortas due to 
increased NO production and inhibition of extracellular calcium flux into vascular smooth 
muscles.  Extracts from chokeberry and bilberry also had a relaxing effect on pig coronary 
arteries (25), and rats fed a blueberry (Vaccinium angustifolium) diet had reduced blood vessel 
contraction due to suppression of α1-adrenergic receptors (22).  Resveratrol, a common stilbene 
compound found in grapes and fruits, has demonstrated strong antioxidant and anti-inflammatory 
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properties which may reverse or delay the onset of cardiovascular complications (26).  Zhang et 
al. (27) found that resveratrol can also prevent arrhythmia in rat and guinea pig animal models.  
Quercetin and chlorogenic acid, other compounds commonly found in many berries, have 
demonstrated the ability to lower blood pressure and reduce cardiac hypertrophy (28, 29).  In 
men, cranberry juice consumption has increased HDL cholesterol (30) and reduced oxidized-
LDL cholesterol (31), both related to a decrease risk of atherosclerotic progression.  Sour cherry 
(Prunus cerasus) extracts have shown ability to reduce ischemic reperfusion injury by reducing 
cardiac cell death and inhibiting the development of ventricular fibrillation and ventricular 
tachycardia in a rat model (32).  Similarly, anthocyanins from Vaccinium myrtillus maintained 
capillary perfusion and thus reduced ischemic reperfusion injury in a hamster model (33).   
Several fruit extracts and fruit compounds have demonstrated the capacity to inhibit 
carcinogenesis.  Kraft et al. (34) found that fractions of lowbush blueberry (Vaccinium 
angustifolium) extract modulated enzyme (quinone reductase, cyclooxygenase, and ornithine 
decarboxylase) activity to slow the progression of different stages of carcinogenesis.  
Furthermore, Schmidt et al. (3) showed that proanthocyanidins from lowbush blueberries 
inhibited growth of mouse liver and human prostate cancerous cell lines.  Tart cherries and 
anthocyanins from cherries have demonstrated ability to reduce mouse cecal tumor size and 
number, and anthocyanin-rich extracts decreased growth of human colon cancer cells in vitro 
(35).  In rats, a diet supplemented with pterostilbene, a stilbene found in blueberries, reduced 
formation of induced-colorectal aberrant crypt foci (36).  Also, black raspberry (Rubus 
occidentalis) fractions that were high in gallic acid demonstrated potent anti-angiogenesis 
activity, which is important for inhibiting tumor growth and limiting metastasis (37), and 
cranberry juice consumption was shown to limit Helicobacter pylori infections, a bacterial 
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infection strongly correlated with gastric cancer, in an endemically infected population in China 
(38).  Yi et al. (39) assayed the activity of phenolic compounds from grape and blueberry 
cultivars against cancerous human hepatocytes in vitro and found that anthocyanin-rich fractions 
had the greatest activity compared to flavonol-, tannin-, and phenolic acid-rich fractions.  
However, McDougall et al. (40) demonstrated that proanthocyanidins had greater anti-
proliferative activity against human cervical cancer cells than anthocyanins.  Yeh and Yen (41) 
suggested that anthocyanins induce apoptosis and reduce cancer cell growth by activating 
caspase-3 proteases, inducing c-Jun N-terminal kinases (JNKs), and altering the Bax/Bcl-2 ratio 
in favor of apoptosis.  Apoptosis was also induced by anthocyanin-rich fractions of highbush 
blueberries (Vaccinium corymbosum) by increasing caspase-3 activity and DNA fragmentation 
(42).  Lowbush blueberry flavonoids have demonstrated the ability to reduce matrix 
metalloproteinases (MMP) in human prostate cells, thus indicating a mechanism for reducing 
metastasis (43).  Several studies have shown that fruit compounds can modulate cell cycle 
control to limit carcinogenesis by arresting cancer cells in G1 (44-47).  
Fruits also contain compounds that can reduce diabetic hyperglycemia and ameliorate 
microvascular complications associated with diabetes mellitus (DM).  The anthocyanins of 
bilberry (Vaccinium myrtillus) have been shown to maintain normal capillary structure and 
permeability in vascular smooth muscles, which has a hypoglycemic effect (48, 49).  Fermented 
juice of V. angustifolium (lowbush blueberry) increased glucose uptake in myocytes and 
adipocytes in vitro (50).  Similarly, the juice of the Asian plum and Viburnum dilatatum berries 
demonstrated ability to reduce blood glucose in diabetic rat models (51, 52).  Additionally, 
chokeberry (Aronia melanocarpa) juice and water extract of black plum (Eugenia jambolana) 
have shown potential to lower blood glucose in diabetic patients and in a diabetic rabbit model, 
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respectively (53, 54).  Insulin-resistant rats fed tart cherries for 90 d had reduced fasting blood 
glucose levels, decreased blood lipids, lowered blood insulin, and improved fatty liver (55).  
Fruits of cornelian cherry dogwood (Cornus mas) are high in anthocyanins and ursolic acid; both 
of these compounds maintained glucose tolerance in mice fed a high-fat diet that typically 
induces glucose intolerance (56).  Furthermore, grape seed proanthocyanidins increased 
pancreatic glutathione levels, decreased lipid peroxidation, decreased hyperglycemia, and 
increased serum insulin levels in alloxan-induced diabetic rats (57), and ethanol extracts of 
lowbush blueberries increased pancreatic β-cell proliferation in vitro (58).  Du et al. (59) also 
found that phenolic compounds from turmeric had potent inhibitory activity against aldose 
reductase.  Xie et al. (60) found similar results using an aqueous acetone extract of Saussurea 
medusa, a plant used in traditional Chinese medicine and Tibetan folk medicine.  In addition, de 
la Fuente and Manzanaro (61) extensively reviewed natural aldose reductase inhibitors and 
grouped them into terrestrial, marine, and microorganism sources. 
The mechanism of action for reducing hyperglycemia and diabetic complications by 
these fruit extracts is not well characterized.  Vijayakumar et al. (62) demonstrated that 
fenugreek seed extract attenuated hyperglycemia by inducing the translocation of glucose 
transporter 4 (GLUT 4) to the plasma membrane and activating enzymes in the insulin signaling 
pathway in a manner similar to that of insulin.  Several studies also indicate that berry 
compounds alter mRNA expression to induce protective factors, such as adiponectin and 
peroxisome proliferator-activated receptor gamma (PPARγ), and decrease inflammatory 
mediators, such as iNOS, COX-2, and NF-κB (15, 51, 63).  Additionally, flavonoids, which are 
common in many fruits are potent inhibitors of aldose reductase (61, 64, 65).  Phenolic acids and 
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anthocyanins have demonstrated ability to reduce dietary glucose uptake by inhibiting sucrase 
and maltase digestive enzymes (52). 
 
Traditional Use of Fruits in Health Maintenance 
Ethnobotanically important fruits have a historical basis in disease prevention.  Native 
Americans used a wide variety of wild berries year round for food and as medicines, including 
serviceberry (Amelanchier alnifolia), buffaloberry (Shepherdia sp.), chokecherry (Prunus 
virginiana), and wild raspberry (Rubus sp.).  Wild fruits were picked when ripe and stored for 
use throughout the year by drying them and/or incorporating the fruits into dried meat and 
animal fat, thus enabling tribal peoples to use them even when the berry was not in season (66, 
67). 
In South American tribal communities, the maqui berry (Aristotelia chilensis), an 
anthocyanin-rich berry native to the Aysén region of southern Chile, has been traditionally used 
as a tea to treat diarrhea and/or is applied directly to wounds to improve healing; it has been 
recently shown to also inhibit low-density lipoprotein oxidation in human endothelial cultures 
thus potentially providing protection from atherosclerosis (68).  Additionally, leaves, flowers and 
berries of the American elderberry (Sambucus canadensis) have been used in Brazilian folk 
medicine to treat respiratory and pulmonary disorders.  Extracts from the plant provide moderate 
antibacterial and antifungal activity in vitro (69), and fractions of elderberry fruit extract have 
demonstrated activity against both the initiation and promotion stages of cancer (70).  Members 
of the genus Vaccinium, such as bilberry (V. myrtillus) and cranberry (V. macrocarpon), were 
used traditionally for treatment of diabetic symptoms (71).  In addition, the noni berry (Morinda 
citrifolia) from southeast Asia has been used in folk medicine to treat colds, flu, diabetes, 
anxiety, hypertension, and caner; recent studies show that it contains compounds with GABAa 
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receptor agonistic activity leading to its sedative properties (72, 73).   Lastly, barberry (Berberis 
vulgaris) berries have been traditionally used to treat gastrointestinal problems, hepatic 
malfunction, menstrual pain, whooping cough, and fever.  New investigations suggest that 
extracts from the barberry berry have hypotensive activity, anticholinergic activity in the 
gastrointestinal tract, and sedative effects on the central nervous system (74). 
Wild fruits provide an ideal resource for investigating natural phytochemical interactions 
that influence human health because they contain natural levels of compounds which have not 
been influenced by commercial breeding and selection.  Several studies and reviews have found 
lower levels of bioactive plant secondary metabolites in conventionally grown crops compared to 
their non-cultivated counterparts (75, 76).  In addition, several crops grown using modern 
agribusiness technology have a lower nutrient content now then they did three decades ago (77). 
 
Fruit Compounds Implicated in Biological Activity 
Numerous flavonoid and non-flavonoid compounds from fruits have been associated with 
potent health benefits.  Proanthocyanidins, for example, are colorless oligomers and polymers of 
flavan-3-ol units (Figure 1.1) that have demonstrated anti-adhesion, anti-cancer, and antioxidant 
properties (78).  The degree of polymerization of proanthocyanidins has been shown to effect 
their activity.  For example, Schmidt et al. (3) found that after wild blueberry extract was 
chromatographically separated, fractions that contained proanthocyanidins with a high degree of 
polymerization were associated with increased anti-proliferation and anti-adhesion activities, 
compared to fractions composed of proanthocyanidins with a lower degree of polymerization.  
Anthocyanins (Figure 1.1), the second largest class of plant pigments, are strong antioxidants 
that have been associated with induction of apoptosis and prevention of cancer cell proliferation 
(79), protection from cardiovascular disease via decreasing endothelial oxidative stress (80) and 
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inducing nitric oxide release (81), and improvement of neurological function and protection from 
neurodegeneration (14, 82).  Terpenes, polymers of hydrocarbon isoprene units, are often 
associated with plant oils, including berries.  Terpene-based compounds have been linked with 
hypotensive and bradycardia effects (83) and with the capability to inhibit tumor growth (84). 
The broad spectrum health-protective properties of fruits are attributed not to any single 
compound, but to the distinctive and multifaceted mixture of phytochemical components that 
naturally accumulate in fruits.  The compounds in this mixture can interact to enhance biological 
activity.  Types of interactions include additive effects (active compounds do not affect the 
activity of each other), synergistic effects (active compounds have more activity together than 
the sum of individual activities), concomitant effects (the combination of active and non-active 
compounds results in a more active mixture), and interferences (compounds interact and activity 
is attenuated).  Lila and Raskin (85) reviewed interactions among phytochemical components 
and broadly divided them into endointeractions (interactions between compounds from the same 
plant) and exointeractions (interactions between compounds from different plants or between 
plant and synthetic compounds). 
Several examples of the health benefits associated with phytochemical interactions have 
been noted (85, 86).  Seeram et al. (87) demonstrated that a fraction of cranberry fruit extract 
containing a complete polyphenolic profile was more active in antiproliferation assays than 
fractions that contained just individual polyphenolic components, which suggests the presence of 
additive or synergistic interactions.  In addition, Eberhardt et al. (88) found that apple extracts 
had significantly more anti-proliferative capacity when the peel of the apple was included in the 
extract, indicating that compounds from the peel and remainder of the fruit interact to decrease 
cell proliferation.  As another example, leaf extract of Ginkgo biloba increases peripheral 
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circulation and slows age-related mental degradation via an interplay between flavonoids (mostly 
proanthocyanidins and rutins) and terpene lactones (ginkgolides and bilobalide).  The terpene 
lactones are platelet-activating factors, and the flavonoids promote the action of the terpenes, as 
well as serving as antioxidants and blood flow enhancers (89).  Additionally, Campbell et al. (90) 
showed that flavonoid aglycones reduced mouse liver and human prostate cancer cell 
proliferation in a synergistic manner, and Mertens-Talcott et al. (91) demonstrated that ellagic 
acid synergistically potentiated the anti-proliferative and apoptosis-inducing effects of quercetin 
in MOLT-4 human leukemia cells.  Jo et al. (92) illustrated that procyanidin B2 interacted 
synergistically with myricetin, resveratrol, and epicatechin gallate (all polyphenols) to provide 
catalytic inhibition of topoisomerase II, an enzyme important for cancer cell proliferation, and 
Chan et al. (93) showed that ethanol promoted the ability for resveratrol and quercetin, two 
bioactive polyphenols from red wine, to suppress iNOS expression and NO production.  
Kirakosyan et al. (94) suggested that rutin and other flavonoids interact with hyperforin to 
potentiate the antidepressant action of Hypericum perforatum (St. John’s Wort) extracts.  
Additionally, a crude methanol extract of black Jamapa beans (Phaseolus vulgaris) demonstrated 
greater cytotoxicity against human adenocarcinoma cells than silica gel fractions of the crude 
extract, suggesting an additive or synergistic interaction amongst compounds in the crude extract 
to afford the activity (95). 
 
Pathophysiology of Diabetes and Diabetic Complications 
 Diabetes mellitus (DM) is a chronic disorder of macronutrient metabolism with 
hyperglycemia and a relative or absolute insulin insufficiency as primary characteristics. It 
affects over 35 million people in the United States and is the seventh most prevalent cause of 
death.  DM is typically divided into two types:  type 1 and type 2 (96).   
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Type 1 DM is characterized by higher prevalence in children compared to adults, 
decreased levels of blood insulin, presence of autoimmune antibodies against pancreatic islet 
cells, β-cell destruction, and increased incidence of ketoacidosis.  The pathophysiology of type 1 
DM is centered around the destruction of pancreatic β-cells, which is thought to occur via the 
interaction between genetic susceptibility, autoimmunity, and environmental factors (96).  
Genetic factors most strongly associated with the development of type 1 DM are related to the 
major histocompatibility complex (MHC) class II coding region, and more specifically, for a set 
of human leukocyte antigen (HLA) genes that code for an amino acid other than aspartate at a  
point important for peptide binding specificity on the HLA molecule (97).  In terms of 
autoimmunity, CD8+ T lymphocytes are thought to play a primary role in the destruction of 
pancreatic islet β cells.  Finally, the major trigger for initiating the autoimmune reaction is 
suggested to be an environmental stimulus, such as a viral infection (98). 
On the other hand, type 2 DM is characterized by higher prevalence in adults compared 
to children, increased levels of blood insulin, presence of insulin resistance in cells normally 
responsive to insulin, and low occurrence of ketoacidosis.  In contrast to type I DM, autoimmune 
mechanisms do not play a prominent role in the development of type 2 DM.  Instead, multiple 
genetic defects and obesity are thought to be at the core of type 2 DM pathogenesis (96).  One 
genetic defect may be in the ability of pancreatic β cells to react to glucose levels, possibly due 
to an increased presence of the electron transport chain uncoupling protein (UCP2) that 
moderates the insulin response to glucose.  Another defect may lie in the increased accumulation 
of amyloid in islet cells that dampens the response of islet cells to glucose (99).  The insulin 
resistance typified by type 2 DM develops via mechanisms that are not entirely clear but obesity 
is thought to play a prominent role.  Obesity, regardless of the presence or absence of diabetes, 
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leads to insulin resistance and increased production of insulin.  Fat tissue secretes several factors 
that may be partially responsible for this phenomenon.  TNFα released by fat cells can modulate 
post-receptor insulin signaling and thus lead to insulin resistance.  In addition, resistin, a 
hormone involved in the development of insulin resistance, is secreted by fat cells and is found 
in greater amounts in obese patients (100). 
Many complications are associated with both types of DM including retinopathy, 
nephropathy, neuropathy, accelerated atherosclerosis, and microangiopathy (96).  Two 
mechanisms that explain the development of these pathologies have been heavily studied.  
Nonenzymatic glycosulation occurs when blood glucose levels increase and available amino 
acids on proteins become glycosylated, forming advanced glycation end products (AGEs).  Many 
of these AGEs form on proteins associated with vessel walls (leading to the development of 
atherosclerosis) and bind to receptors on endothelial and macrophage cells (effecting vessel 
permeability and inflammatory responses) (101).  Additionally, hyperglycemia causes increased 
activity of aldose reductase leading to the formation of sorbitol.  The increased production of 
sorbitol can cause osmotic damage to small vessels and nerves and also impair the action of 
cellular ion pumps (101). 
 
Inflammation and Diabetes 
Inflammation is the body’s reaction to infection or injury and is classically comprised of 
pain, swelling, erythema (redness), and warmth.  In the acute setting, inflammation plays an 
important role in protecting the body against invasion and promoting return to normal health 
(102, 103).  In some cases the immune response becomes excessive or persistent and leads to a 
state of chronic inflammation.  In addition, age is often associated with increased levels of 
inflammation (104).  Such a state has been associated with several disease conditions including 
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type 2 diabetes (105), age-related neurodegenerative diseases (106), inflammatory bowel disease, 
and rheumatoid arthritis (107). 
Inflammation is typified by production of cytokines, such as interleukin-6 (IL-6) and 
tumor necrosis factor α (TNFα), and reactive oxygen species, such as nitric oxide (NO).  
Cytokines are proteins released by immune cells that organize and direct inflammation (102) and 
reactive oxygen species have several roles, including the promotion of pro-inflammatory 
signaling (108).   
IL-6 mediates its effects by activation of two signaling pathways, the janus kinase/signal 
transducer and activator or transcription (Jak/STAT) and the mitogen-activated protein kinase 
(MAPK) pathways, when it binds to the IL-6 receptor (IL-6R) (109).  The correlation between 
elevated IL-6 levels and insulin resistance has been demonstrated in a number of studies.  Kocak 
et al. (110) found that IL-6 levels were significantly higher in diabetic women when compared to 
their prediabetic counterparts.  Interestingly, obese, diabetic patients that lost weight via gastric 
surgery showed decreased levels of IL-6 and reversal of insulin resistance after surgery (111).  In 
the liver, increased levels of IL-6 leads to hepatic insulin resistance which is reversed with when 
IL-6 levels decline (112, 113).  The effect of IL-6 on hepatic insulin resistance is partially due to 
suppression of tyrosine phosphorylation of insulin receptor substrate -1 (IRS-1) (114). 
The expression of TNFα mRNA increases with obesity and diabetes and has been 
correlated with decreased insulin-induced peripheral uptake of glucose.  Obese rats with 
depressed rates of peripheral glucose uptake show improved glucose uptake with TNF receptor-
immunoglobulin G, which effectively neutralizes the effects of TNFα (115, 116).  TNFα disturbs 
the insulin signaling pathway thus yielding its effects on insulin sensitivity (116).  One 
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mechanism by which TNFα disturbs insulin signaling is by stimulating serine phosphorylation of 
IRS-1 via binding to the p55 TNF receptor (117, 118). 
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Hypotheses 
Primary Hypothesis:  It is hypothesized that fruits contain phytochemical 
constituents that contribute to protection against diabetes and its complications. 
   
The primary hypothesis is overviewed in Chapter 2, which is titled “Phytochemical 
composition and metabolic performance-enhancing activity of dietary berries 
traditionally used by native North Americans.” 
 
Secondary Hypothesis #1:  It is hypothesized that the ability of V. trilobum fruit 
compounds to enhance glucose utilization (63) is due to their ability to activate 
and/or inhibit the expression of specific genes involved in glucose metabolism. 
 
Secondary hypothesis #1 is investigated in Chapter 3, which is titled “Effects of 
Viburnum trilobum fruit extract on expression of genes important in glucose regulation.” 
 
Secondary Hypothesis #2:  Prunus virginiana fruit compounds demonstrated ability to 
inhibit production of pro-inflammatory cytokines (63).  The heavily researched and 
broadly bioactive Vaccinium angustifolium fruit has also demonstrated anti-inflammatory 
ability (20).  Both P. virginiana and V. angustifolium fruits are rich in anthocyanins, 
however, only the latter contains prominent amounts of proanthocyanidins.  Both 
anthocyanins and proanthocyanidins have individually demonstrated anti-inflammatory 
activity via decreasing expression of pro-inflammatory cytokines.  It is hypothesized 
that the anti-inflammatory capacity of P. virginiana fruits will be less than the anti-
inflammatory capacity of V. angustifolium fruits due to interactions between 
anthocyanins and proanthocyanidins in V. angustifolium fruits. 
 
Secondary hypothesis #2 is tested in Chapter 4, which is titled “Interactions of 
compounds from Prunus virginiana and Vaccinium angustifolium fruits on in vitro IL-6, 
TNFα, and nitric oxide production.” 
 
Secondary Hypothesis #3:  P. virginiana fruit compounds have demonstrated the ability 
to inhibit aldose reductase (63).  Fruits of A. chilensis have demonstrated greater aldose 
reductase inhibitory activity than compounds from P. virginiana fruits. Fruits of A. 
chilensis also contain a unique array of flavonoids not found in P. virginiana.  It is 
hypothesized that the greater aldose reductase inhibitory activity of A. chilensis is 
due to the unique flavonoids found in this fruit. 
 
Secondary hypothesis #3 is explored in Chapter 5, which is titled “Comparative 
phytochemical composition and aldose reductase inhibitory activity of Aristotelia 
chilensis (maqui) and Prunus virginiana (chokecherry) fruits.” 
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Figures 
 
Figure 1.1 Structures of classes of flavonoid compounds 
Flavonols
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Chapter 2 
 
Phytochemical Composition and Metabolic Performance Enhancing Activity of 
 Dietary Berries Traditionally Used by Native North Americans 1 
 
Abstract 
 Four wild berry species, Amelanchier alnifolia, Viburnum trilobum, Prunus virginiana, 
and Shepherdia argentea, all integral to the traditional subsistence diet of Native American tribal 
communities, were evaluated to elucidate phytochemical composition and bioactive properties 
related to performance and human health.  Biological activity was screened using a range of 
bioassays that assessed the potential for these little-known dietary berries to affect diabetic 
microvascular complications, hyperglycemia, pro-inflammatory gene expression, and metabolic 
syndrome symptoms.  Non-polar constituents from berries, including carotenoids, were potent 
inhibitors of aldose reductase (an enzyme involved in the etiology of diabetic microvascular 
complications) whereas the polar constituents, mainly phenolic acids, anthocyanins, and 
proanthocyanidins, were hypoglycemic agents and strong inhibitors of IL-1β and COX-2 gene 
expression.  Berry samples also showed the ability to modulate lipid metabolism and energy 
expenditure in a manner consistent with improving metabolic syndrome.  The results 
demonstrate that these berries traditionally consumed by tribal cultures contain a rich array of 
phytochemicals that have the capacity to promote health and protect against chronic diseases, 
such as diabetes. 
 
 
1 Reproduced with permission from Kraft TFB, Dey M, Roger RB, Ribnicky DM, Gipp DM, 
Cefalu WT, Raskin I, Lila MA. 2008. Phytochemical composition and metabolic performance 
enhancing activity of dietary berries traditionally used by native North Americans. Journal of 
Agriculture and Food Chemistry 56: 654-660.  Copyright 2008 American Chemical Society. 
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Introduction 
Native Americans historically used a wide variety of wild berries, including serviceberry 
(Amelanchier alnifolia), highbush cranberry (Viburnum trilobum), chokecherry (Prunus 
virginiana), and silver buffaloberry (Shepherdia argentea) year round for food and medicine.  
Wild berries were picked when ripe and stored for use throughout the year by drying them and/or 
incorporating the berries into dried meat and animal fat, thus enabling tribal peoples to use them 
even when the fruits were not in season (1, 2).   
Wild berries provide an ideal resource for investigating phytochemicals that influence 
human health because they contain natural levels of compounds which have not been influenced 
by commercial breeding and selection (3).  Previous reports cited lower levels of bioactive plant 
secondary metabolites in conventionally grown crops compared to their organically grown 
counterparts (crops grown with fewer inputs) (4, 5).  In addition, many crops grown using 
modern agribusiness technology may have a lower nutrient content now than they did three 
decades ago (6).  Furthermore, several studies have demonstrated increased antioxidant activity 
and phenolic composition of wild berries compared to their domesticated (and genetically 
distinct) relatives (7-10). 
Amelanchier alnifolia (Saskatoon berry, Juneberry, or serviceberry) is a deciduous shrub 
that is native to western United States and Canada.  It was extensively used by native cultures 
both medicinally (as a disinfectant and to prevent miscarriages) and as a food source, often in 
forms such as pemmican (a mixture of dried meat, dried berries, and fat) (11).  More recently, 
Wang and Mazza (12) found that concentrated crude extract of A. alnifolia berries inhibited 
nitric oxide production in activated macrophages indicating a potential protective role against 
cardiovascular disease and chronic inflammation.   Hu et al. (13) found the berries of A. alnifolia 
to be strong scavengers of free radicals without reducing cell viability.  Fruit from the related 
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species, A. canadensis and A. arborea, inhibit cyclooxygenase-1 and -2 in vitro, indicating a role 
in moderating inflammation (14).  Previous cursory investigations of anthocyanin, phenolic acid, 
and flavonoid content of A. alnifolia fruit revealed an anthocyanin content of 86-125 mg 
anthocyanins / 100 g fresh berries with the 3-galactoside and 3-glucoside conjugates of cyanidin 
predominating (15).  Other anthocyanins include cyanidin 3-xyloside, pelargonin 3-glucoside, 
and malvidin derivatives (16).  Berries of A. alnifolia contain phenolic acids including 3-
feruloylquinic, chlorogenic, and 5-feruloylquinic acids (17).  Flavonoid compounds from the 
fruit include rutin, hyperoside, avicularin, and quercetin (18). 
Viburnum trilobum (highbush cranberry) is native to northern United States and southern 
Canada from New York to Oregon (19).  Native Americans ate the berries fresh, in jelly, and in 
pemmican (20).  Few studies have investigated the chemical composition of the berries.  
Cyanidin 3-arabinosylsambubioside and cyanidin 3-arabinoglucoside are two anthocyanins that 
have been previously identified in the fruit (21, 22). 
Prunus virginiana (chokecherry) is native to North America and commonly found in 
most of the United States and southern Canada.  It was widely used by Native Americans both as 
a food, such as wine, juice, and wasna (a mixture of dried berries and dried meat) (23) and as a 
medicine (11).  Recently, Acuña et al. (24) showed that methanol extracts of the fruit had 
antioxidant capacity.  No studies to date have studied the chemical composition of the fruits or 
other parts of the plant. 
Shepherdia argentea (silver buffaloberry) berries were traditionally used by Native 
Americans to treat stomach troubles and ceremonially to honor females entering puberty (11, 
23).  They were typically eaten fresh, dried, or in jelly (11).  The berries contain β-carotene, 
vitamin C, leucoanthocyanins, catechols, and flavonols (25, 26).  Tannins from the leaves of  S. 
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argentea have demonstrated the capacity to inhibit HIV-1 reverse transcriptase (27).  Recently, 
Ritch-Krc et al. (28) found that extracts of S. canadensis (Canadian buffaloberry), a closely 
related species, inhibited the growth of mouse mastocytoma cells. 
The objectives of this study were to characterize the major phytochemical constituents of 
four tribal wild berry genotypes (A. alnifolia, V. trilobum, P. virginiana, and S. argentea) and to 
evaluate their ability to protect against diabetes (by improving glucose utilization and inhibiting 
aldose reductase), suppress the expression of pro-inflammatory genes (cyclooxygenase-2 and 
interleukin-6), and improve other conditions associated with metabolic syndrome (by measuring 
changes in lipid metabolism and energy expenditure).  These attributes were likely to have 
contributed to the health protective value of berry fruits in the traditional tribal diets. 
 
Materials and Methods 
Berry sources.   Viburnum trilobum (highbush cranberry), Prunus virginiana (chokecherry), and 
Shepherdia argentea (silver buffaloberry) berries were all collected in late summer and fall 
harvest seasons 2005 and 2006 on tribal lands in North Dakota by members of the five tribes 
served by United Tribes Technical College (Bismarck, ND).  Due to drought conditions and 
consequent poor serviceberry yield on tribal lands during these collection seasons, Amelanchier 
alnifolia fruits were purchased from Room 2 Grow (Pincher Creek, Alberta, Canada) and were a 
mixture of ‘Smoky’, ‘Theissen’, and ‘Northline’ cultivars.  All berries were frozen after harvest 
and stored at -80 °C. 
 
Extraction and fractionation of berries.  Frozen berries were slightly thawed, mashed, refrozen, 
and then lyophilized until completely dry.  The dried berry mass ranged from 37% (Shepherdia 
argentea) to 18% (Amelanchier alnifolia) of the fresh mass.  Freeze-dried berries of all species 
were extracted in 80% aqueous ethanol (1:10, g berries / mL solvent) by stirring for 1 hr and then 
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filtered using several layers of cheese cloth.  This process was repeated 3 additional times.  The 
filtrate (crude extract) was filtered through #4 Whatman filter paper and then concentrated under 
vacuum in a 40 °C water bath to a thick, aqueous slurry.  The percent recovery of crude extract 
from fresh mass ranged from 11% (V. trilobum) to 25% (S. argentea). 
A liquid-liquid extraction of the crude extract was made by adding equal portions of 
water and ethyl acetate to the concentrated crude extract followed by shaking the mixture and 
then separating the ethyl acetate phase (top) from the water phase (bottom).  The water phase 
was mixed with fresh ethyl acetate 4 times.  Both phases were concentrated under vacuum in a 
40 °C water bath and lyophilized until dry.   
 For each species, a portion of the concentrated water phase from the liquid-liquid 
extraction was separated into 6 fractions using vacuum liquid chromatography (VLC) to 
facilitate the identification of compounds in the water phase.  A HW-40F Toyopearl (TP; Tosoh, 
Bioscience LLC, Montgomeryville, PA) column (7 x 5 cm, w x l) was used and supported by a 
medium-pore-size fritted glass filter.  Fractions were eluted using water (850 mL), 50% aqueous 
methanol (MeOH, 1 L), 100% MeOH (1 L), 100% acetone (1 L), 50% aqueous acetone (1 L), 
and 35% aqueous ethanol (500 mL) yielding fractions TP1-TP6, respectively.  These fractions 
were concentrated under vacuum in a 40 °C water bath and then lyophilized until dry. 
 
Mass spectrometry.  Electrospray ionization (ESI) mass spectral analysis was used to determine 
the phytochemical content of berry extracts and fractions in a manner similar to Kraft et al. (29).  
Spectra were recorded over the range m/z 100 to 2000. All samples were run in positive mode 
and dissolved in MeOH. 
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Bioactivity assays. 
Aldose Reductase Assay:  Aldose reductase (alditol : NADP+ 1-oxidoreductase, EC 
1.1.1.21) catalyzes the first reaction in the polyol pathway, which is the reduction of glucose to 
sorbitol.  Even though aldose reductase has a low affinity for hexoses, such as glucose, there is 
increased sorbitol production in a diabetic hyperglycemic state because the substrate level is 
elevated.  This increased formation of sorbitol has been linked to diabetic microvascular 
complications such as retinopathy, neuropathy, and nephropathy.  Therefore, inhibition of aldose 
reductase is a recognized anti-diabetic mechanism of plant extracts (30).  Aldose reductase 
(Wako Chemicals, Richmond, VA) activity was measured by monitoring the change in β-
nicotinamide adenine dinucleotide phosphate (NADPH; Sigma, St. Louis, MO) absorbance at 
340 nm over a 5 min interval (30).  Berry samples were dissolved in dimethyl sulfoxide (DMSO) 
and tested at a concentration of 5 μg/mL.  3,3-Tetramethyleneglutaric acid was used as a positive 
control.  Inhibition of 70% and greater was considered strong activity and inhibition between 
40% and 70% was considered moderate activity.  Berry samples were run in quadruplicate and 
expressed as average % inhibition ± standard error. 
Quantitative Real-Time RT-PCR:  Inflammation is associated with obesity, problems 
with lipid metabolism, and development of diabetes (31).  Inhibition of pro-inflammatory gene 
expression was measured using methods similar to Ma et al. (32).  Briefly, mouse 
monocyte/macrophage cell line RAW 264.7 (American Type Culture Collection, Manassas, VA) 
was plated at a density of 0.4 X 106 in 24 well plates 12 h before treatment.  Cells were treated 
with the berry samples (100 μg/mL, dissolved in 95% aqueous EtOH) two h before elicitation 
with 1 μg/mL lipopolysaccharide (LPS; Sigma, St. Louis, MO).  RNA was harvested from cells 
using TRIzol® reagent (Invitrogen, Carlsbad, CA) 6 h after LPS elicitation.  Expression of COX-
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2, IL-1β, and β-actin (control) genes were quantified using Stratagene Mx 3000pTM  RT-PCR 
System (Stratagene, La Jolla, CA) and a Brilliant® SYBR® Green PCR master mix kit 
(Stratagene).  The amplification program was the same as that used by Ma et al. (32).  Samples 
were run in duplicate. Greater or equal to 75% inhibition was considered high activity, 50-75% 
inhibition was moderate activity, and less that 50% inhibition was low activity. 
Culture Systems:  L6 cells, which are widely used as a cell model for studying insulin 
action (33), were purchased from American Type Culture Collection (Manassas, VA).  L6 
culture was performed as described by Mandel and Pearson (34).  Specifically, the cells were 
seeded at the density of 10,000/cm2 in Dulbecco’s Modified Eagle’s Medium (DMEM), 
supplemented with 100 U/mL penicillin, 100 μg/mL streptomycin, and 10% heat-inactivated 
fetal bovine serum (FBS).  When the cells reached 70% confluence, serum-free medium 
consisting of DMEM supplemented with 1% (wt/vol) fatty acid-free bovine serum albumin 
(BSA; Sigma; St. Louis, MO) or 1% FBS-containing DMEM (differentiation medium) was 
added for 5 d.  After differentiation, the botanical extracts were added and, after overnight 
incubation, were processed. 
Basal and Insulin Stimulated Glycogen Accumulation:  Decreasing hyperglycemia, 
the cornerstone of diabetes treatment, is primarily accomplished by enhancing the uptake of 
glucose from the blood into muscle tissue, the primary site of glucose uptake.  Muscle cells use 
blood glucose to produce glycogen.  Changes in glycogen accumulation in muscle cells are 
therefore a means of measuring potential hypoglycemic activity.  Glycogen contents of L6 cells 
were measured as described by Gomez-Lechon et al. (35) with some modifications.  Briefly, 
berry sample-treated L6 myotubes were deprived of serum for 2 h.  Cells were incubated with or 
without insulin for 2 h (100 nM insulin plus 30 mM glucose) and were then washed 3 times with 
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phosphate buffer solution (PBS)  pH 7.4.  200 uL of 0.2 M sodium acetate buffer (pH 4.8) was 
added to each well and the plate was sonicated.  50 uL aliquots of these berry samples were 
taken for protein assay.  Amyloglucosidase was added and plates were shaken for 2 h at 40 °C.  
After centrifugation, 50 uL of supernatant was transferred to a 96-well plate and 150 μL of assay 
solution [(0.4 U/mL glucose oxidase, 0.8 U/mL peroxidase and 1 mg/mL ABST (2,2’-
azinobis(3-ethylbenzothialine-6-sulfonic acid) in 100 mM phosphate buffer (pH 6)] was added.  
The berry samples were incubated at room temperature in the dark for 30 min. The intensity of 
the color reaction was measured at 405 nm using a microplate reader.  A blank of the reaction 
was performed using incubated cell homogenate without adding amyloglucosidate; this value 
represents the free glucose and was subtracted from the total glucose obtained after enzymatic 
hydrolysis.  A standard curve was constructed with a known amount of rabbit liver glycogen and 
processed as test samples.  The glycogen content was expressed as nM glucose equivalent/well 
after correction for protein concentration. 
Fatty Acid Oxidation:   A common manifestation of metabolic syndrome is defective fat 
metabolism leading to enhanced levels of circulating free fatty acids and fat accumulation.  
Marker assays for fat metabolism were used to detect berry samples that influence the 
metabolism of fat in vitro as a model for how fat is metabolized in vivo.  Fatty acid oxidation was 
measured as described by Muoio et al. (36).  Briefly, L6 myotubes were incubated with 20 μg/ml 
compounds as indicated overnight without 10% FBS.  Then, cells were incubated at 37 °C in 
sealed 12-well plates containing 1 mL of media plus 12.5 mmol/L HEPES, 0.2% BSA, 1.0 
mmol/L  carnitine, 100 μmol oleate, 50 μg/mL gentamicin, and 1.0 μCi/mL [14C]-palmitic acid 
(PerkinElmer Life Science, Boston, MA).  After 3 h, the incubation media was assayed for 
labeled CO2 and acid soluble metabolites as previously reported (37, 38).  The cells were placed 
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on ice, washed twice with PBS, scraped into a 1.5-mL Eppendorf tube in two additions of  0.30 
mL 0.05% SDS lysis buffer.  Cell lysates were assayed for protein and results are expressed as 
percent change relative to controls.  Assays were performed in triplicate. 
Mitochondrial Number:  Mitochondria are the cellular organelles responsible for the 
energy status of the cell and are the site of fatty acid oxidation.  Mitochondria are impaired in 
function and number as a result of insulin resistance and metabolic syndrome especially in 
diabetic patients.  Therefore measurement of mitochondrial number provides a means of 
evaluating the effect of berry samples on the energy status of animal cells.  The effect of berry 
samples on mitochondrial quantity was determined by washing L6 cells with PBS followed by 
staining them with the mitochondrial stains MitoTracker Green FM (MTG, 100 nM, Invitrogen, 
Carlsbad, CA).  MTG stains lipids characteristic of mitochondrial membranes (39) and the assay 
was performed according manufacturer’s protocol.  Samples were measured in triplicate.  Data 
were expressed as percent change compared to control cells. 
 
Results 
Phytochemical content.  Amelanchier alnifolia extract and fractions revealed the presence of 
phenolic acids, anthocyanins, and a series of proanthocyanidin polymers (Table 2.1).  
Chlorogenic acid (m/z 355.3), caffeic acid (m/z 181.1), and hydroxybenzoic acid (m/z 139.2) 
were indicated in the ESI-mass spectra.  The anthocyanin compounds 3-glucosides and/or 3-
galactosides of cyanidin (m/z 449) and petunidin (m/z 479), cyanidin 3-xyloside (m/z 419), and 
cyanidin 3,5-diglucoside (m/z 611) were detected.  Additionally, flavanols, such as 
catechin/epicatechin (m/z 291) and epicatechin gallate (m/z 443), and a series of 
proanthocyanidin polymers ranging from dimers to hexamers (m/z 579 to m/z 1731) were 
consistent with the mass spectra.  This analysis provides the first documentation of caffeic acid, 
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hydroxybenzoic acid, petunidin 3-glucoside/galactoside, cyanidin 3,5-diglucoside, 
catechin/epicatechin, epicatechin gallate, and the proanthocyanidin series in this species. 
Spectra of Viburnum trilobum berry samples revealed phenolic acids, anthocyanins, 
flavanols, a series of proanthocyanidin polymers, and carotenoids (Table 2.1).  Caffeic acid (m/z 
180), chlorogenic acid (m/z 355), and hydroxybenzoic acid (m/z 139) were phenolic acids 
consistent with the mass spectra of V. trilobum berry samples.  Cyanidin 3,5-diglucoside (m/z 
610), petunidin 3-glucoside/galactoside (m/z 479), and cyanidin 3-glucoside (m/z 449) were 
anthocyanins consistent with the mass spectra and the latter appeared to be the dominant 
anthocyanin in the berry.  In addition, the flavanols catechin and/or epicatechin (m/z 291) and a 
proanthocyanidin series of polymers ranging from dimers to hexamers (m/z 579 to m/z 1731) 
were prominent (Figure 2.1).  β-Carotene / lycopene (m/z 536) was also identified.  Other than 
cyanidin 3-glucoside, this is the first time these compounds have been reported for V. trilobum. 
Prunus virginiana berry samples were found to contain phenolic acids, a diverse range of 
anthocyanins, and carotenoids (Table 2.1).  Chlorogenic acid (m/z 355), ferulic acid (m/z 194), 
caffeic acid (m/z 181), and sinapic acid (m/z 225) were phenolic acids consistent with the mass 
spectra of P. virginiana berries.  The anthocyanins that afford most of the color associated with 
the berry included 3-glucosides and/or 3-galactosides of cyanidin (m/z 449) and delphinidin (m/z 
464), petunidin 3-acetylglucoside (m/z 520), delphinidin 3,5-diglucoside (m/z 668), cyanidin 3-p-
coumaroylglucoside (m/z 595), and cyanidin 3,5-diglucoside (m/z 611).  In addition, the berries 
contain the carotenoids β-carotene / lycopene (m/z 536 and β-cryptoxanthin (m/z 553).  The 
chemical composition of this species has not been previously studied, hence this chemical 
analysis represents the first time any compounds have been identified in its fruit. 
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Shepherdia argentea berries contained several carotenoids, no detectable anthocyanins, 
and few phenolic acids (Table 2.1).  Mass spectral analysis revealed the presence of β-carotene / 
lycopene (m/z 536), β-cryptoxanthin (m/z 553), and zeaxanthin (m/z 571), which are responsible 
for the yellow-orange pigmentation associated with the berries.  Chlorogenic acid (m/z 355) was 
found in small quantities.  With the exception of β-carotene, this is the first time the above 
compounds have been reported in the berry. 
 
Bioactivity.  Amelanchier alnifolia samples demonstrated the ability to inhibit aldose reductase, 
improve glucose uptake, and reduce expression of IL-1β (one of the anti-inflammatory markers).  
The non-polar fraction of A. alnifolia strongly inhibited aldose reductase (82% inhibition; Table 
2.2).  The crude extract and polar fraction, on the other hand, exhibited significant capacity to 
improve glycogen accumulation at a basal state (Table 2.3).  The crude extract and the non-polar 
fraction but not the polar fraction minimally inhibited IL-1β gene expression (36% and 32%, 
respectively; Table 2.4).  These results indicate that non-polar compounds from A. alnifolia may 
provide protection from diabetic microvascular complications and may help mediate 
inflammation, whereas polar compounds may help reduce inflammation as well, but also 
improve glucose uptake via an insulin-like effect.  
Viburnum trilobum berries showed the capacity to inhibit aldose reductase, improve 
glucose uptake, reduce IL-1β expression, and modulate energy expenditure.  The non-polar 
fraction of V. trilobum strongly inhibited aldose reductase (76% inhibition; Table 2.2).   The 
crude extract also showed very significant ability to improve glycogen accumulation at a basal 
state (Table 2.3).  Both the crude extract and the polar fraction moderately inhibited IL-1β (56% 
and 45%, respectively; Table 2.4), and all three preparations of V. trilobum modulated energy 
expenditure via several mechanisms (Table 2.5).  These results suggest that although not a 
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powerful mediator of inflammation, compounds from V. trilobum can not only provide 
protection from diabetic microvascular complications but can also improve glucose uptake via an 
insulin-like effect as well as change energy expenditure.  Taken together, these indicate potential 
to partially modulate mechanisms that may play a role in development of insulin resistance and 
metabolic syndrome. 
Prunus virginiana samples exhibited potential to inhibit aldose reductase, reduce the 
expression of both IL-1β and COX-2, and alter energy expenditure.  The non-polar fraction of P. 
virginiana strongly inhibited aldose reductase (73% inhibition) and the other two samples 
showed only moderate inhibition (Table 2.2).  Both the crude extract and polar fractions strongly 
inhibited IL-1β expression (78% and 74%, respectively; Table 2.4), and these two samples and 
the ethyl acetate fraction minimally inhibited COX-2 expression (47%, 43%, and 24%,  
respectively; Table 2.4).  Additionally, both the polar and non-polar fractions demonstrated some 
capacity to modulate energy expenditure (Table 2.5).  These results indicate that compounds 
from P. virginiana have the potential to reduce the development of diabetic microvascular 
complications and are strong inhibitors of inflammation. 
Shepherdia argentea samples showed the capacity to inhibit aldose reductase, improve 
glycogen accumulation, reduce the expression of both IL-1β and COX-2, and alter energy 
expenditure.  All samples from S. argentea moderately inhibited aldose reductase; inhibition 
ranged from 27% (polar fraction) to 64% (non-polar fraction) (Table 2.2).  In addition, the crude 
extract demonstrated the ability to improve glycogen accumulation at a basal state (Table 2.3), 
and the polar fraction showed significant capacity to modulate energy expenditure via different 
mechanisms (Table 2.5).  The crude extract strongly inhibited expression of IL-1β  (76% 
inhibition) but only minimally reduced expression of COX-2 (45% inhibition).  The water 
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fraction only minimally inhibited expression of IL-1β and moderately inhibited expression of 
COX-2 (70%) (Table 2.4).  These results indicate that compounds from S. argentea can 
moderately provide protection from diabetic microvascular complications and can also reduce 
inflammation.  Furthermore, compounds from this species have the potential to counter the 
symptoms of metabolic syndrome via improving glucose uptake and energy expenditure. 
 
Discussion 
These four berry species, each components in the traditional tribal diets, differ greatly in 
content.  This range of phytochemicals amongst the different species implies that the traditional 
tribal diet consisted of a rich array of bioactive compounds that may have promoted health and 
provided protection from chronic diseases via a range of potential mechanisms.  A. alnifolia and 
V. trilobum berries contained very few carotenoids but were rich in phenolic acids, anthocyanins, 
and proanthocyanidins.  S. argentea, on the other hand, was rich in carotenoids but not phenolic 
acids nor flavonoids.  P. virginiana had a high content of phenolic acids, anthocyanins, and 
carotenoids but lacked proanthocyanidins.  All of the four tribal berry species examined in this 
study contained biologically-active chlorogenic acid.  
Non-polar botanical compounds, such as terpenes, have been shown by others to be 
strong aldose reductase inhibitors.  Compounds in the ethyl acetate fraction of these tribal 
berries, such as carotenoids, inhibited aldose reductase whereas polar constituents and crude 
extract did not inhibit enzymatic activity (Table 2.4), which indicates the potential of these non-
polar compounds to protect against diabetic complications as aldose reductase inhibitors.   
Flavonoids and phenolic acids (polar phytochemicals) have previously demonstrated aldose 
reductase inhibitory activity (40), but our flavonoid-rich water fractions did not demonstrate such 
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activity at the tested concentration.  This apparent lack of activity from the flavonoid-rich 
fractions may be due to interference or a dilution effect from other compounds. 
The anti-inflammatory effects of the berries on in vitro gene expression were mostly 
observed in crude or polar fractions, except in the case of A. alnifolia (Table 2.2).  The variation 
among different berries in terms of the activity levels (moderate to high) could be due to the 
differences in the nature of their bioactive constituents and/or due to the variation in the amount 
of those constituents present in the samples.  The anti-inflammatory properties of these wild 
berries augment the health beneficial attributes observed in the other assays.  For example, the 
associations between obesity, impaired skeletal muscle fatty acid metabolism, and type 2 
diabetes is well established (31).  Inflammation due to obesity acts as a precursor to defects in 
skeletal muscle fatty acid oxidation and generates a vicious cycle exacerbating the development 
of insulin resistance.  In the obese state, elevated circulating fatty acids initiate a pro-
inflammatory cascade by macrophage activation (31).  
Both V. trilobum and A. alnifolia crude extracts and water fractions may provide benefit 
with regard to diabetes by improving blood glucose utilization.  Samples from both of these 
berries improved glycogen accumulation at a basal state, whereas insulin-stimulated glycogen 
accumulation was not enhanced for any of the berries.  Tabular data indicates only basal state 
glycogen accumulation.  These were also the two berry species with a series of proanthocyanidin 
polymers, suggesting that higher molecular weigh proanthocyanidins may be integral to the 
improved glycogen accumulation.  Proanthocyanidins have previously been reported to 
ameliorate hyperglycemia (41) in vivo, in a rat model. 
Lipid metabolism and energy expenditure are other important parameters associated with 
metabolic syndrome and related disorders.  Acid soluble metabolites and fatty acid oxidation 
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were used to investigate possible activities of the berry samples in regard to lipid metabolism. 
The water soluble fractions from V. trilobum and S. argentea as well as the crude extract of P. 
virginiana had notable activity for enhancing lipid metabolism.  The positive enhancement of 
both biomarkers by V. trilobum and S. argentea suggest a robust effect, especially when coupled 
with the CO2 production enhancement from the V. trilobum samples.   Each of the V. trilobum 
extracts enhanced CO2 production to a similar extent suggesting multiple active compounds with 
different polarities.  Since only the crude extract of S. argentea increased CO2 production, the 
fractionation procedure must have somehow eliminated the activity.  Changes in mitochondrial 
number associated with the berry extracts were used as an indicator for change in energy 
expenditure potential.  High numbers of mitochondria are noted in tissues with high levels of 
energy expenditure.  Only 2 of the extracts increased mitochondrial number but they did not 
correlate with CO2 production.   
Spring drought conditions during the two seasons of this research precluded harvest of 
sufficient Amelanchier fruits in the wild; juneberry has an earlier berry maturation and harvest 
season than the other berries in this study, which bear later in the season.  Because of the 
importance of juneberry in traditional tribal diets, we obtained fruit from a commercial grower 
with generally similar climatic conditions to North Dakota.  The deposition of the key 
phytochemical metabolites important to bioactivity are likely to be less intense in a cultivated 
environment (characterized by irrigation, higher fertility, and pest control), and the berries larger, 
than expected in wildcrafted harvests.  Thus it is possible that the level of bioactivity gauged for 
Juneberry in this study will underestimate the potential for a wild berry sample. 
Specific modes of action for the berries, which may have contributed to their value as 
medicinal and subsistence foods in traditional diets, cannot be conclusively determined from a 
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screening study based solely on in vitro bioassays.  In vitro bioassays can help to identify cellular 
mechanisms, but the results can not be directly extrapolated to formulate health claims.  Further 
experimentation in animal models is required to confirm in vivo efficacy of ingested berry 
compounds.   The ability of these extracts to affect specific cellular targets has been 
demonstrated, however, which suggests that further activity-guided fractionation and 
characterization will lead to validation of the basis for their biological activity after consumption.   
There is a growing interest within tribal communities for fostering a return to more 
traditional dietary choices, as well as an increasing interest in the broader U.S. population for 
discovery of new food choices which offer a proactive means of health maintenance.  An 
opportunity for small-scale production on tribal lands to serve this niche market is emerging, 
however, given the impact of cultivation practices on phytochemical composition and bioactive 
potency of berries, it is critical that cultivated berry plots be designed to mimic, to the extent 
possible, conditions that are inherent in the wild.   
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Tables and Figures 
 
Table 2.1 Partial composition of Amelanchier alnifolia, Viburnum trilobum, Prunus virginiana, 
and Shepherdia argentea berries as determined by ESI-MS 
 A. alnifolia V. trilobum P. virginiana S. argentea 
Phenolic Acids: chlorogenic acid chlorogenic acid* chlorogenic acid* chlorogenic acid 
 caffeic acid* caffeic acid* caffeic acid*  
 hydroxybenzoic 
acid* 
hydroxybenzoic 
acid* 
ferulic acid*  
   sinapic acid*  
     
Anthocyanins: cyanidin 3-glu/gla cyanidin 3-glu/gal cyanidin 3-glu/gal*  
 petunidin 3-
glu/gla* 
petunidin 3-glu/gal* delphinidin 3-glu/gal*  
 cyanidin 3,5-diglu* cyanidin 3,5-diglu* cyanidin 3,5-diglu*  
 cyanidin 3-xyloside  delphinidin 3,5-diglu*  
   petunidin 3-acetylglu*  
   cyanidin  3-p-
coumarolylglu* 
 
Proanthocyanidins: dimer* dimer*   
 trimer* trimer*   
 tetramer* tetramer*   
 pentamer* pentamer*   
 hexamer* hexamer*   
Flavanols: catechin/ 
epicatechin* 
catechin/epicatechin
* 
  
 epicatechin gallate*    
Carotenoids:  β-carotene/ 
lycopene* 
β-carotene/lycopene* β-carotene/ 
lycopene 
   β-cryptoxanthin* β-cryptoxanthin* 
    zeaxanthin* 
* Indicates first time compound reported in the tribal berry. 
The listed compounds have molecular weights consistent with ESI-mass spectral (positive mode) 
analysis.  Anthocyanins may be glucosides (glu), galactosides (gal), or both unless otherwise 
indicated. 
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Table 2.2 Percent inhibition of aldose reductase 
by tribal berry samples 
Berry Extract % Inhibition 
Amelanchier alnifolia  
Crude Extract NA 
Water NA 
Ethyl Acetate 82 ± 0.73 
Viburnum trilobum  
Crude Extract 24 ± 2.31 
Water NA 
Ethyl Acetate 76 ± 1.57 
Prunus virginiana  
Crude Extract 42 ± 0.76 
Water 43 ± 1.56 
Ethyl Acetate 73 ± 0.98 
Shepherdia argentea  
Crude Extract 30 ± 0.87 
Water 27 ± 1.68 
Ethyl Acetate 64 ± 2.27 
NA = not active; Samples tested at 5 µg/mL in 
quadruplicate.  Expressed as % inhibition ± SE 
compared to DMSO control. 
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Table 2.3 Percent change in glycogen 
accumulation by tribal berry samples in non-
insulin stimulated rat myotubes (L6 cells) 
Berry Extract % Change in Glycogen 
Amelanchier alnifolia  
Crude Extract 76* 
Water 92* 
Ethyl Acetate 23 
Viburnum trilobum  
Crude Extract 168** 
Water 4 
Ethyl Acetate -12 
Prunus virginiana  
Crude Extract 8 
Water 12 
Ethyl Acetate -9 
Shepherdia argentea  
Crude Extract 54* 
Water 5 
Ethyl Acetate -29 
* denotes significant activity, p < 0.05;  **denotes 
very significant activity, p <0.001; Samples run in 
triplicate and expressed as % change of glycogen 
accumulation compared to 95% aqueous ethanol 
control. 
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Table 2.4 Percent inhibition of LPS-induced 
inflammatory gene expression in murine RAW 
macrophages by tribal berry samples 
 Inflammatory Markers 
Berry Extract IL-1b COX-2 
Amelanchier alnifolia   
Crude Extract 36 NA 
Water NA NA 
Ethyl Acetate 32 NA 
Viburnum trilobum   
Crude Extract 56 NA 
Water 45 NA 
Ethyl Acetate NA NA 
Prunus virginiana   
Crude Extract 78 47 
Water 74 43 
Ethyl Acetate NA 24 
Shepherdia argentea   
Crude Extract 76 45 
Water 38 70 
Ethyl Acetate NA NA 
NA = not active; IL-1b = interleukin 1b; COX-2 
= cyclooxygenase-2; Samples run in duplicate 
and tested at 100 μg/mL.  < 50% is low activity, 
50-75% is moderate activity, and >75% is high 
activity.   Expressed as % inhibition compared 
to 95% ethanol control. 
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Table 2.5  The ability of tribal berry samples to modulate lipid metabolism and energy 
expenditure in rat myotubes (L6 cells) 
 
Lipid Metabolism Markers 
Energy Expenditure 
Marker 
Berry Extracts 
Acid Soluble 
Metabolite 
Accumulation 
Fatty Acid 
Oxidation 
Rate CO2 Production Mitochondria Number 
Amelanchier alnifolia     
Crude Extract -1.5     -6.6 -13.0               20.2 * 
Water -11.6    - 13.1 -15.1         -4.5 
Ethyl Acetate 2.4    -5.5 -15.5               21.1 * 
Viburnum trilobum     
Crude Extract 14.6   17.2          20.5 *       -23.3 
Water       32.8 *      27.6 *          20.8 *          3.2 
Ethyl Acetate 6.8   17.4          31.3 *       -31.9 
Prunus virginiana     
Crude Extract       28.0 *     7.1 -4.7       -27.6 
Water -8.3  -10.4 -11.6       -33.7 
Ethyl Acetate 6.4    -1.6 -6.0               24.1 * 
Shepherdia argentea     
Crude Extract -11.8    12.2        29.5 *       -25.1 
Water       85.1 **       43.8 * 14.0       -26.4 
Ethyl Acetate -46.0    -15.9 5.8       -31.5 
* denotes significant activity, p < 0.05;  **denotes very significant activity,  p < 0.001; Samples 
run in triplicate and expressed as percent change compared to 95% aqueous ethanol control. 
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Figure 2.1 Representative ESI-MS of Toyopearl fraction 5 of Vaccinium trilobum showing a 
series of proanthocyanidin (PAC) oligomers and polymers 
 
 
 
 
 
 
 
 
 
 
 
 
Representative ESI-MS of Toyopearl fraction 5 of 
Vaccinium trilobum showing a series of 
proanthocyanidin (PAC) oligomers and polymers 
PAC 
C2 
PAC 
C3 
PAC 
C4 PAC 
C5 PAC 
C6 
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Chapter 3 
 
Effects of Viburnum trilobum Fruit Extract on Expression of 
Genes Important in Glucose Regulation 
 
 
Abstract 
 Recent studies of Viburnum trilobum (highbush cranberry) fruits have demonstrated its 
potential to provide protection against the development of diabetes and its complications.  The 
mechanism of this activity was explored by evaluating the effect of V. trilobum fruit crude 
extract and phytochemical (anthocyanin, low-molecular weight proanthocyanidin, and high-
molecular weight proanthocyanidin)-rich fractions on expression of genes related to the 
pathogenesis and complications of diabetes using gene arrays.  The activity of the fractions was 
compared to that of a dexamethasone-cAMP (Dex-cAMP) treatment, which mimics an insulin 
resistant state.  The crude extract inhibited the expression of the glucose-6-phosphatase catalytic 
unit (G6Pc) in a dose dependent manner.  The high molecular weight proanthocyanidin (PAC-h) 
fraction also inhibited G6Pc in a dose dependent manner, although to a lesser extent.  The 
inactive anthocyanin-rich fraction (ANC) and the active PAC-h fraction were combined together 
in manner that approximated their equivalent proportions found in the crude extract and this 
combined fraction demonstrated activity that was statistically the same as predicted (45% 
inhibition vs. 30% inhibition, respectively; p = 0.12) suggesting an additive type of interaction.  
LC-ESI-MS and HPLC-MS identified anthocyanins and proanthocyanidins that have not 
previously been reported in this fruit.   
 
Introduction 
 Viburnum trilobum (highbush cranberry) fruit (botanically a drupe) was recently 
screened, along with several other fruits traditionally consumed by Native Americans, for 
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metabolic performance-enhancing activity (1).  Fruit extracts of this northern United States and 
southern Canada native showed broad and significant improvement of energy expenditure via 
increasing the rate of fatty acid oxidation in rat L6 myotube cell culture, and demonstrated robust 
improvement of glycogen accumulation at a basal state indicating the potential to improve blood 
glucose levels in an insulin-like manner.  Pro-inflammatory gene expression analysis using a 
mouse macrophage cell line revealed moderate anti-inflammatory activity via reduced expression 
of interleukin 1 beta (IL-1β), a pro-inflammatory cytokine (1).  These activities suggest that V. 
trilobum fruits may be able to confer protection against diabetes mellitus (DM) and its 
complications. 
 Although the mechanisms are not completely understood, mammalian genetics affects the 
pathogenesis of DM and metabolic syndrome.  Many of the genes that influence the development 
of DM are instrumental to the regulation of glucose utilization, the efficiency of the insulin 
signaling pathway, macronutrient metabolism, the progression of diabetes, and inflammatory 
processes (2, 3).  The manner in which ingested plant-derived compounds effect the expression 
of these genes in a human is relevant since dietary interventions are often the first step in the 
management of DM. 
Candidate genes which may be influenced by plant (food) components include 
phosphoinositide 3-kinase (PI3K), glucose-6-phosphatase (G6P), and receptors for advanced 
glycation end products (RAGE).  Insulin signaling involves the insulin receptor substrate (IRS) 
proteins which are regulated by changes in expression and post-translational modification, such 
as via PI3K mediated phosphorylation (4).  G6P cleaves free glucose from glucose-6-phosphate 
in the final enzymatic step of gluconeogenesis and is controlled via both transcriptional and non-
transcription mechanisms (5).  Insulin acts to strongly inhibit the expression of G6P via PI3K in 
 60
a fed state (6).  The RAGE and their substrates (advanced glycation end products) are 
upregulated in hyperglycemic states and are partially responsible for the increased vessel 
permeability and inflammation associated with diabetes (7). 
 The direct influence of ingested plant compounds on expression of many of these key 
genes involved in DM pathogenesis has already been demonstrated in several recent 
investigations.  Prasad et al. (8) used a rat hepatoma cell model to demonstrate that a water 
soluble extract of Syzygium aromaticum (clove) seeds (2.5 mg ground seed equivalent in 15 µL 
water; 0.167 µg/mL) significantly reduced expression of phosphoenolpyruvate carboxykinase 
(PEPCK) and G6P potentially accounting for its observed hypoglycemic activity.  Metformin, a 
biguanide compound initially extracted from the plant Galega officinalis and now used clinically 
as a hypoglycemic agent (adult dosage range: 850 – 2550 mg/d), was shown to decrease the 
expression of G6P, at least partially accounting for its clinical effect (9).  Feeding diabetic rats a 
daily dosage of 250 mg/kg grape seed proanthocyanidins, a secondary metabolite commonly 
found in fruits, resulted in decreased expression of RAGE, which suggests possible amelioration 
of diabetic complications (10). 
The objective of this study was to determine if the demonstrated ability of V. trilobum 
fruit extracts to improve glucose utilization and slow the onset of diabetic complications involves 
a change in expression of genes related to insulin signaling and/or other events in diabetes 
pathogenesis.  Phytochemical constituents of the V. trilobum fruit extract (anthocyanins, low 
molecular weight proanthocyanidins, and high molecular weight proanthocyanidins) were 
compared with regard to their ability to effect G6P expression in rat hepatoma cells.  In addition, 
interactive effects between V. trilobum anthocyanin and high molecular weight 
proanthocyanidins on G6P gene expression were investigated. 
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Materials and Methods 
Fruit source.  Viburnum trilobum (highbush cranberry) fruits were collected in late summer and 
fall harvest seasons 2005 and 2006 on tribal lands in North Dakota by members of five tribes 
coordinated under the leadership of United Tribes Technical College, Bismarck, ND, frozen 
immediately after harvest, and stored at -80 °C. 
 
Fruit extraction.   Crude extract was made following the procedure detailed by Kraft et al. (1).  
Briefly, frozen fruits were mashed, lyophilized until completely dry, and then extracted 4 times 
in 80% (v/v) aqueous ethanol (1:10, grams of fruit:milliliter of solvent) by stirring for 1 hr 
followed by filtering through several layers of cheesecloth and Whatman no. 4 (Fisher Scientific; 
Pittsburg, PA) filter paper.  The filtrate (crude extract) was concentrated under vacuum in a 40 
°C water bath to an aqueous slurry. 
 
Fractionation of crude extract.  A liquid-liquid extraction of the crude extract (157 g equivalent) 
was made by mixing it with equal volumes of water and ethyl acetate, shaking the mixture, and 
then separating the aqueous phase from the ethyl acetate phase.  The aqueous portion was mixed 
with and then separated from ethyl acetate four times.  Both phases were concentrated under 
vacuum in a 40 °C water bath and dried via lyophilization. 
 Anthocyanin- and proanthocyanidin-rich fractions were made by first passing the crude 
extract over an Amberlite XAD7HP (Sigma, St. Louis MO) column and then separating the 
resulting fraction using Sephadex LH20 (Sigma).  A portion of the concentrated crude extract 
(139 g equivalent) was mixed with Amberlite and water:trifluoroacetic acid (100:0.3 v/v, 
acidified water) and poured onto a 70 mm diameter coarse-grade fritted glass filter.  Acidified 
water (2 L) was used to remove sugars (with vacuum) and the column was then rinsed with 1.25 
L methanol:trifluoroacetic acid (100:0.3 v/v, acidified methanol) without vacuum to elute 
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anthocyanins and proanthocyanidins.  The methanolic fraction was concentrated and dried as 
described above yielding 22.8 g.  A portion of the dried methanolic fraction (4.0 g) was 
dissolved in water:methanol:trifluoroacetic acid (80:20:0.3 v/v/v, acidified 20% aqueous 
methanol) and gently poured on top of a 75 cm x 3.5 cm (l x w) Sephadex LH20 column 
saturated in acidified 20% aqueous methanol.  Sixteen fractions (75 mL each) were eluted using 
acidified 20% aqueous methanol followed by the elution of one, 250 mL fraction using 
acetone:water (70:30 v/v).  These 17 fractions were concentrated individually and dried as 
described above.  Sephadex fractions 3-7 were combined and comprised an anthocyanin-rich 
fraction (ANC).  Sephadex fraction 16 was composed of low molecular weight 
proanthocyanidins (PAC-l), and Sephadex fraction 17 contained mostly high molecular weight 
proanthocyanidins (PAC-h). 
 
Culture system.  H4IIE rat hepatoma cells (American Type Cell Cultures, Manassas, VA; CRL-
1600 ) were maintained as described by Govorko et al. (11).  Briefly, H4IIE cells were cultured 
in Dulbecco’s Minimal Essential Medium (DMEM; Invitrogen, Carlsbad, CA) that was 
supplemented with 1.25% fetal bovine serum (FBS, Invitrogen), 1.25% horse serum (Invitrogen), 
and 100 U/mL penicillin and 100 µg/mL streptomyocin (Invitrogen) at 37 °C in 5% CO2.  Cells 
were grown until 95% confluent and then plated in array plates, 24-well tissue culture plates, or 
96-well plates.  Once cells were nearly 100% confluent, media was removed and replaced with 
DMEM supplemented with 500 nM dexamethasone (Sigma) and 0.1 mM 8-CTP-cAMP (Sigma) 
(Dex-cAMP) to mimic an insulin resistant state.  Various concentrations of V. trilobum fruit 
crude extract, ANC, PAC-l, PAC-h, or 10 nM insulin (positive control; Eli Lilly, Indianapolis, 
IN), were added at the same time.  Dimethylsulfoxide (DMSO; Sigma) was used to dissolve fruit 
extract and fractions and comprised 0.5% of the total volume. 
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Cell viability assay.  The effect of V. trilobum fruit extract and fractions on cell viability was 
determined using the CellTiter 96® Aqueous One Solution Cell Proliferation Assay (Promega; 
Madison, WI) following the recommendations of the manufacturer.  The assay reagent was 
added 5 hr after treatment of the cells with fruit extract and Dex-cAMP.  Absorbance was read at 
490 nm 3 hr later on a microplate reader spectrophotometer (Molecular Devices; Sunnyvale, 
CA).  All concentrations of fruit extract and fractions were tested in the assay and compared to a 
0.5% (v/v) DMSO control in Dex-cAMP treated media.  Samples were tested in quadruplicate. 
 
Gene array.  Genes involved in diabetes and the insulin signaling pathway were studied using 
two gene arrays obtained from SABiosciences (Frederick, MD).  Each array consisted of 84 
genes of interest; 13 genes overlapped in both arrays.  Three treatments (each with a total 
concentration of 0.5% (v/v) DMSO) were tested in each array: (1) untreated media (control), (2) 
Dex-cAMP treated media, and (3) Dex-cAMP treated media plus 100 µg/mL V. trilobum crude 
extract.  Treatments lasted 4 hr and were replicated three times.  Changes in gene expression 
were significant if the V. trilobum crude extract resulted in at least a two-fold change of gene 
expression compared to Dex-cAMP treated media. 
 
Array validation.  Cells were plated in 24-well plates and treated with (1) Dex-cAMP media and 
DMSO, (2) Dex-cAMP media and V. trilobum fruit crude extract in DMSO, (3) Dex-cAMP 
media containing 10 nM insulin and DMSO, (4) DMEM and crude extract in DMSO, or (5) 
DMEM and DMSO.  DMSO was 0.5% (v/v) concentration in all treatments.  The crude extract 
was tested at 75, 100, and 125 µg/mL to validate the array.  Treatment duration was 8 hr and 
each treatment was replicated three times. 
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Effect of ANC, PAC-l, and PAC-h on expression of G6Pc.  Cells were plated in 24-well plates 
and treated with (1) Dex-cAMP media and DMSO, (2) Dex-cAMP media and V. trilobum fruit 
fractions in DMSO, (3) Dex-cAMP media containing 10 nM insulin and DMSO, (4) DMEM and 
fruit fractions in DMSO, or (5) DMEM and DMSO.  DMSO was 0.5% (v/v) concentration in all 
treatments.  The three phytochemical-rich fractions (ANC, PAC-l, or PAC-h) were tested at three 
concentrations:  (1) the concentration of the fraction found in crude extract at the concentration 
tested in the gene array (equivalent concentration), (2) 10x the equivalent concentration, and (3) 
0.1x the equivalent concentration.  Treatment duration was 8 hr and each treatment was 
replicated three times. 
 
RNA extraction, purification, and cDNA synthesis.  Total RNA was extracted using TriZOL 
(Invitrogen).  RNA quality was determined after deoxyribonuclease I (Invitrogen) treatment 
using a NanoDrop 1000 spectrophotometer (Wilmington, DE) and measuring absorbance at 260 
and 280 nm.  cDNA from each treatment was synthesized from 3.0 µg of RNA using a high-
capacity cDNA reverse transcription kit (Applied Biosystems; Foster City, CA).  All reagents 
were used according to the manufacturer’s instructions. 
 
Quantification of mRNA levels by real-time PCR.  Products of the cDNA synthesis were diluted 
2.5 times with BPC (Biotechnology Performance Certified) grade water (Sigma), which 
comprised 2 µL of the 25 µL PCR reaction volume.  The remaining portion of the reaction 
volume was comprised of gene-specific, pre-validated primers (SA Biosciences) and SBYR-
Green Master Mix (SA Biosciences), both used according to the specifications of the 
manufacturer.  Pre-validated primers for five genes (G6pc, Akt3, Serpine1, Vegfa, and Pik3r1) 
whose expression was significantly effected by the Dex-cAMP treatment and then reversed by 
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addition of the crude extract in the arrays, were used to validate the array results and test the 
effect of V. trilobum fruit crude extract fractions on gene expression.  Rpl13A was used as a 
housekeeping gene.  Real-time PCR was run on a MX3000P machine (Stratagene; La Jolla, CA) 
using the following thermal profile: 2 min at 50 °C (1 cycle), 10 min at 95 °C (1 cycle), 15 sec at 
95 °C followed by 1 min at 60 °C (40 cycles).  The dissociation curve was generated by 1 cycle 
of 1 min at 95 °C followed by 30 sec at 55 °C and ending with 30 sec at 95 °C (11). 
 Analysis of gene mRNA expression was conducted following the method described in 
Govorko et al. (11) using the ΔΔCT method and normalizing with respect to the Rpl13a gene.   
The effect of V. trilobum fruit crude extract and fractions on gene expression was compared to 
the Dex-cAMP treatment.  Insulin was used as the positive control.  All samples were run in 
duplicate and replicated in three separate experiments. Results shown represent the mean percent 
inhibition of gene expression ± standard error.  Differences between treatments were analyzed 
via a one-way ANOVA and Tukey test (p < 0.05) using SigmaStat 3.5 (San Jose, CA). 
 
Analysis of PAC-h and ANC interaction.  Potential interactions between V. trilobum high 
molecular weight proanthocyanidins and anthocyanins was evaluated by combining PAC-h and 
ANC fractions in proportions that mimicked their equivalent concentrations in the crude extract, 
and testing the effects of PAC-h, ANC, or the combined fraction on the expression of G6Pc.  
Predicted (calculated) and empirically derived values of percent inhibition were compared to 
each other to determine the type of potentiating interactions.  Empirical values that were 
significantly greater than the predicted values were considered to have a “more than additive” 
effect on G6Pc expression and empirical values that were less than the predicted values were 
considered to have an “interfering” effect (12-14).  Concomitant effects were those where a non 
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active fraction combined with an active fraction resulted in activity significantly greater than that 
associated with the active fraction.  Differences were considered significant at p < 0.05 using an 
independent sample t-test and SigmaStat 3.5 (Systat Software, Inc.; San Jose, CA). 
 
Quantification of fruit components via HPLC.  An Agilent 1100 HPLC system (Agilent 
Technologies, Inc.; Wilmington, DE) with autosampler, photodiode array detector (PDA), and 
Supelcosil LC18 reverse-phase column (250 mm x 4.6 mm x 5 µm; Supelco; Bellefonte, PA) was 
used to quantify anthocyanins and proanthocyanidins in V. trilobum fruit extract and fractions.  
All samples were prepared by dissolving 5 mg in 1 ml methanol and filtering through 0.2 µm 
nylon filters (Fisher Scientific, Hanover Park, IL) before injecting 15 µL onto the HPLC column 
kept at a constant temperature of 20 °C.  All anthocyanin and proanthocyanidin standards were 
prepared at three concentrations (0.25, 0.5, and 1.0 mg/mL) using 100% methanol and had a 15 
µL injection volume.  For anthocyanin quantification, cyanidin-3-O-glucoside (C3G; 
Chromadex; Santa Ana, CA) was used as the standard.  The mobile phase consisted of 5% 
formic acid in water (v/v, solvent A) and 100% methanol (solvent B). The flow rate was constant 
during HPLC analysis at 1 ml/min with a step gradient of 10%, 15%, 20%, 25%, 30%, 60%, 
10%, and 10% of solvent B at 0, 5, 15, 20, 25, 45, 47, and 60 min, respectively.  Quantification 
of anthocyanins was performed from the peak areas recorded at 520 nm with reference to the 
calibration curve obtained with cyanidin-3-O-glycoside.  For proanthocyanidin quantification, 
epicatechin (EC; Sigma) was used as the standard.   The mobile phase consisted of 
water:acetonitrile:formic acid (95:5:0.1 v/v/v, solvent A) and acetonitrile:water:formic acid 
(95:5:0.1 v/v/v, solvent B). The flow rate was constant during HPLC analysis at 1 ml/min with a 
step gradient of 0%, 5%, 30%, 60%, 90%, 0%, and 0% of solvent B at 0, 5, 40, 45, 50, 55, and 
60 min, respectively.  Quantification of proanthocyanidins was performed from the peak areas 
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recorded at 280 nm with reference to the calibration curve obtained with epicatechin.  All data 
were processed using Chemstation Software for LC 3D systems (Rev. A.10.02; Agilent) and 
analyzed in triplicate. 
 
HPLC/MS analysis of fruit components.  High performance liquid chromatography-mass 
spectrometry (HPLC-MS) data were obtained for identification of flavonoids using an LCQ Deca 
XP mass spectrometer with an electrospray ionization attached to photodiode array (PDA) 
detector (UV: 262 mm; Thermo Scientific; San Jose, CA).  For identification of flavonoids, 
HPLC separations were carried out on a C18-reversed-phase column with 2.1 mm x 150 mm and 
particle size 5 µm, 90 A° (VYDAC; Western Analytical; Murrieta, CA).  The same solvents and 
gradient as described above for proanthocyanidin quantification were used with a m/z range of 
150-2000 in positive mode. 
The concentration of sugars (sucrose, glucose, and fructose) in V. trilobum fruit crude 
extract and fractions was determined to study the potential effects of these sugars on gene 
expression.  Sugar quantification was accomplished using HPLC-MS and the methodology 
utilized by Liu et al. (15).  Briefly, a Supelcosil LC-NH2 column (250 mm x 4.6 mm x 5 µm; 
Supelco), was used at room temperature.  The solvent (80:20 acetonitrile:water, v/v) was used in 
an isocratic manner for 20 min with a flow rate of 200 µL/min.  Sucrose, glucose, and fructose 
(Sigma) were used at three concentrations (25, 50, and 100 mg/mL) and prepared in 50% (v/v) 
aqueous methanol.  Samples were prepared as described above.  A m/z range of 150-800 was 
used and run in positive mode.  Data analysis for all HPLC-ESI/MS was accomplished using 
Xcalibur (Version 1.4 SR; Thermo Scientific). 
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LC-ESI-MS analysis of fruit components.  High performance liquid chromatography-electro 
spray ionization-mass spectrophotometer (HPLC-ESI-MS) data were obtained for identification 
of flavonoids.  The HPLC separations were carried out on Waters Alliance 2795 (Waters 
Corporation, Beverly, MA) using the same column and PDA detector described above.  A 15 µL 
injection volume was used.  The mobile phase consisted of water:acetonitrile:formic acid 
(95:5:0.1 v/v/v, solvent A) and acetonitrile:water:formic acid (95:5:0.1 v/v/v, solvent B). The 
flow rate was constant during HPLC analysis (200 µL/min) with a step gradient of 0%, 5%, 30%, 
60%, 90%, 0%, and 0% of solvent B at 0, 5, 40, 45, 50, 55, and 60 min, respectively.  The 
HPLC-PDA was connected to a LCQ Deca XP mass spectrometer (Thermo Finnigan Corp., San 
Jose, CA) run in positive mode with a scan range of 100-2000 m/z.  Xcalibur software (Version 
1.4 SR1; Termo Electron; San Jose, CA.) was used for data processing. 
 
Results 
Gene array results.  The effect of V. trilobum fruit crude extract on expression of genes 
associated with diabetes and insulin signaling was tested using two gene arrays and H4IIE rat 
hepatoma cells.  The effect of the crude extract (100 µg/mL) was determined by calculating the 
ability of the crude extract to reverse the gene expression changes caused by Dex-cAMP; 
changes greater than 2-fold were considered significant.  Of the 155 genes tested, 8 genes were 
found to be significantly affected by V. trilobum fruit crude extract (Table 3.1).  The expression 
of Snap23, the gene that encodes synpatosomal-associated protein 23 which is a component of 
the SNARE complex in adipocyctes and involved in GLUT4 translocation (16, 17), was most 
affected by the crude extract (-4.1 fold change in expression with respect to Dex-cAMP 
treatment).   
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The crude extract also significantly effected the expression of two genes, Pik3r1 and 
Atk3, whose protein products, phosphatidylinositol 3-kinase regulatory subunit polypeptide 1 
and thymoma viral proto-oncogene 3, are part of the phosphatidylinositol 3-kinase (PI3K) 
pathway that interacts with IRS (insulin receptor substrate) to mediate insulin signaling (18, 19).  
The crude extract downregulated Pik3r1 expression 3.8 fold and upregulated Akt3 2.8 fold 
compared to Dex-cAMP (Table 3.1).  The effect of the crude extract on both these genes 
promotes insulin signaling.   The expression of genes targeted by the PI3K pathway, such as 
G6Pc, Vegfa, and Serpine1, was significantly downregulated by the crude extract by 2.8, 2.4, 
and 2.2 fold, respectively (Table 3.1).  G6Pc codes for the catalytic subunit of glucose-6-
phosphatase, which is the final enzyme of gluconeogenesis, and thus the effect of the crude 
extract decreases endogenous production of glucose.  Vegfa encodes vascular endothelial growth 
factor A, which is an angiogenic and vascular permeability factor that plays a role in the 
development of microvascular diabetic complications (20), and Serpine1 codes for serine 
peptidase inhibitor clade E member 1, a negative regulator of fibrinolysis and typically increased 
in diabetics making them more susceptible to thrombus formation (21).  Tgfb1, a gene that codes 
for transforming growth factor beta 1, was downregulated 2.9 fold by the crude extract compared 
to the Dex-cAMP treatment (Table 3.1), and it is often upregulated in the diabetic state leading to 
organ fibrosis and diabetic nephropathy (22).  PPARα codes for peroxisome proliferator 
activated receptor α and it was also downregulated 2.7 fold by the crude extract compared to the 
Dex-cAMP treatment (Table 3.1).  PPARα is an important nuclear transcription factor that has 
been shown to improve diabetic hyperglycemia and dyslipidemia (23). 
 
Validation of gene array results.  The results of the gene array were validated by selecting five 
genes which were active in the array (G6pc, Pik3r1, Akt3, Vegfa, and Serpine1) and testing the 
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effect of V. trilobum fruit crude extract on their expression in a dose dependent manner using 
H4IIE rat hepatoma cells.  The crude extract was tested at 75 µg/mL, the same concentration 
used in the gene array (100 µg/mL), and 125 µg/mL.   The dose-dependent effect of the crude 
extract on gene expression was seen in only with the G6Pc gene.  The inhibition of G6Pc 
expression was 38%, 67%, and 74% at the three concentrations tested (from lowest to highest) 
relative to the Dex-cAMP treatment, and the highest and lowest concentrations were statistically 
different from each other (p < 0.05, Figure 3.1).  Therefore, G6Pc was the gene selected for 
further tests to determine which components in the crude extract were responsible for changes in 
gene expression.  The crude extract and its fractions were tested to determine their effect on cell 
viability and no significant effect was found (data not shown). 
 
Effect of ANC, PAC-l, and PAC-h on G6Pc expression.  Each fraction (ANC, PAC-l, and PAC-h) 
was tested at the concentration equivalent to its concentration in the crude extract at the level 
used in the gene array (equivalent concentration), 10x the equivalent concentration, and 0.1x the 
equivalent concentration.  Fractions that had a dose-dependent effect on G6Pc expression were 
deemed significant. 
The PAC-h fraction was the only fraction that significantly inhibited the expression of 
G6Pc (22%, 38%, and 77% inhibition at the three concentrations tested from lowest to highest), 
and the 10 x equivalent concentration was significantly more active than the lower two 
concentrations (Figure 3.2)  The ANC fraction did not show any consistent effect on G6Pc 
expression (data not shown).  The PAC-l fraction provided 27%, 44%, and 36% inhibition of 
G6Pc expression at the three concentrations (lowest to highest, respectively) and these were not 
dose-dependent (data not shown). 
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Interaction study.  The interactive effect between high molecular weight proanthocyanidins and 
anthocyanins from V. trilobum fruit on G6Pc expression was investigated since flavonoids are 
known to interact with each other to exert altered biological effects (14, 24-26).  This interaction 
was studied by evaluating the percent inhibition of G6Pc expression by PAC-h and ANC 
individually at their equivalent concentrations, calculating the predicted percent inhibition of 
G6Pc expression by a combined fraction if additive effects resulted, and empirically determining 
the percent inhibition of G6Pc expression by combining PAC-h and ANC together in manner 
that represents their equivalent masses found naturally in the crude extract (11:1, PAC-h:ANC).  
PAC-h had a 31% inhibition and ANC had a -1% inhibition of G6Pc expression at their 
equivalent concentrations, and the predicted (calculated) activity of a combined sample was 30% 
inhibition.  The empirically determined activity of this combined sample was 45% inhibition of 
G6Pc expression (Figure 3.3).  Because the empirically determined inhibitory activity is greater 
in the combined sample than predicted, this suggests a tendency towards a more than additive 
interaction.  More specifically, it suggests a concomitant effect because the ANC fraction had no 
activity.  However, this interaction was not statistically significant (p = 0.12) and therefore it is 
considered an additive effect between the PAC-h and ANC (Figure 3.3). 
 
Phytochemical composition.  The phytochemical content of V. trilobum fruit crude extract and 
fractions was analyzed using LC-MS (positive mode) with appropriate standards (epicatechin, 
catechin, procyanidin B1, procyanidin B2, and cyanidin-3-O-glucoside).  In addition, the 
composition of fractions was further investigated with LC-ESI-MS (positive mode), which 
allows the identification of compounds based upon their characteristic fragmentation pattern and 
works particularly well for flavonoids such as anthocyanins and proanthocyanidins (27-29). 
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A partial chemical composition of the crude extract of Viburnum trilobum fruit has been 
previously reported (1).  Due to the significant activity of the crude extract and the high 
molecular weight proanthocyanidin fraction in this study, a more complete characterization of 
the proanthocyanidins in the crude extract was warranted.  The LC-MS analysis of crude extract 
reveals the presence of the flavan-3-ols (catechin and epicatechin), proanthocyanidin oligomers 
(dimers and trimers), and proanthocyanidin polymers (tetramer and greater).  Catechin (retention 
time, RT, = 9.4 min, m/z 291) and epicatechin (RT = 13.3 min, m/z 291) were confirmed using 
standards (Sigma).  Additionally, the presence of procyanidin B1 dimer (RT = 7.2 min, m/z 579) 
and procyanidin B2 dimer (RT = 11.4, m/z 579) were verified using standards obtained from 
Chromadex (Irvine, CA).  In addition, the presence of the B-type procyanidin dimer was 
confirmed using LC-ESI-MS (Table 3.2).  The V. trilobum crude extract LC-MS spectra also 
revealed the presence of proanthocyanidin trimers as well as proanthocyanidin polymers.  A 
procyanidin trimer (m/z 867) was found at several RT (9.1, 11.4, 13.2, 14.9 min), a tetramer (m/z 
1155) was identified at 7.1, 11.4, 13.2, and 15.6 min, a pentamer (m/z 1443) was present at 9.1, 
13.2, and 14.9 min, and a hexamer (m/z 1731) was discovered at 11.4 and 14.9 min.  Although 
not confirmed with standards, the spectra are strongly suggestive of the presence of the above 
procyanidin oligomers and polymers given the strong correlation of the m/z on the spectra, their 
known molecular weight, and their absorbance at 280 nm (30-32).  Overall, quantitative analysis 
showed that the crude extract contains low levels of anthocyanins and proanthocyanidins (3 mg 
C3G equivalent / g sample and 41 mg EC equivalent / g sample, respectively, Table 3.3).  
The LC-MS spectra of high molecular weight proanthocyanidin fraction (PAC-h, Figure 
3.4) show the presence of flavan-3-ols (catechin and epicatechin), proanthocyanidin oligomers, 
and a broad range of proanthocyanidin polymers.  The flavan-3-ols, catechin (RT = 9.1 min, m/z 
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291) and epicatechin (RT = 12.9 min, m/z 291), procyanidin B1 dimer (RT = 7.0 min, m/z 579), 
and procyanidin B2 dimer (RT = 11.1 min, m/z 579) were identified with standards.  The spectra 
for PAC-h also revealed the presence of proanthocyanidins ranging from trimers-11mers.  
Proanthocyanidin trimers through hexamers were identified easily based on their calculated m/z 
whereas polymers with degrees of polymerization greater than 6 were identified based on the 
presence of their doubly charged ion form found 144 amu (atomic mass units) between singly 
charged ions (Figure 3.4) (31, 32).   These trimers-11mers were found at several retention times 
ranging from 8.7 – 20.0 min.  At most retention times in this range, proanthocyanidin trimers and 
tetramers were the dominant compounds.  LC-ESI-MS analysis of this fraction verified the 
presence of the procyanidin dimer and tetramer both with B-type interflavan linkages (Table 
3.2).  The UV absorption spectra (280 nm, Figure 3.4) shows a broad proanthocyanidin hump 
between 7-31 min, which is consistent with the reports of others studying proanthocyanidin-rich 
fractions (32).  This region also dominates the total ion current (TIC) indicating that 
proanthocyanidins are the major group of compounds found in the fraction.  Quantitative 
analysis confirms that this fraction contains a high amount of proanthocyanidins (470 mg EC 
equivalent / g sample) and no detectable anthocyanins (Table 3.3). 
The phytochemical composition of lower molecular weight proanthocyanidin V. trilobum 
fraction (PAC-l) was evaluated via LC-MS and LC-ESI-MS.  The LC-MS spectrum shows the 
presence of flavan-3-ols (catechin and epicatechin), proanthocyanidin dimers, and 
proanthocyanidin trimers.  Catechin, epicatechin, procyanidin B1, and procyanidin B2 were 
detected using standards at the same retention times as indicated above for PAC-h.  LC-ESI-MS 
analysis demonstrated the presence of three B-linked proanthocyanidin dimers: (epi)cat-(epi)cat, 
(epi)afz-(epi)cat (order of subunits tentatively assigned), and (epi)cat-(epi)gal.  In addition the B-
 74
linked trimer (epi)cat-(epi)gal-(epi)cat was identified (Table 3.2).  There were not any 
proanthocyanidin polymers with more than three degrees of polymerization found in PAC-l.  
Quantitative analysis of PAC-l confirms that it is rich in proanthocyanidins (517 mg EC 
equivalent / g sample) and contains few anthocyanins (1 mg C3G equivalent / g sample) (Table 
3.3).  To the best of our knowledge, this is the first time that (epi)cat-(epi)gal and (epi)cat-
(epi)gal-(epi)cat have been identified in the fruit of this species. 
The composition of the V. trilobum anthocyanin-rich fraction was determined by LC-ESI-
MS to be composed solely of cyanidin-based anthocyanins.  The detected anthocyanins were 
cyanidin-3-gal/glu, cyanidin-3,5-diglucoside, cyanidin-3-sambubioside, and cyanidin-3,5-
diarabinoside/dixyloside (Table 3.2).  Quantitative analysis of this fraction shows that it contains 
a respective anthocyanin and proanthocyanidin content of 345 mg C3G equivalent / g sample and 
124 mg EC equivalent / g sample (Table 3.3).  To our knowledge, this is the first time that 
cyanidin-3-sambubioside and cyanidin-3,5-diarabinoside/dixyloside have been identified in the 
fruit of this species. 
 
Sugar content of fractions and effect of sugar on G6Pc expression.  The sugar content of V. 
trilobum crude extract, ANC, PAC-l, and PAC-h was determined using HPLC-MS and 
appropriate standards (glucose, fructose, and sucrose).  Overall, the crude extract had the highest 
percentage of sugars by mass (10%, 8%, and 0.2% of glucose, fructose, and sucrose, 
respectively) and the anthocyanin-rich fraction had low levels of sugars (1%, 0.5%, and 0.1%, 
respectively) (Table 3.4).  There were no sugars detected in the two proanthocyanidin fractions. 
From these results, a sugar control was created that mimicked the sugar content in the 
crude extract (since it contained the highest sugar concentration) to control for the effect of 
sugars on gene expression.  This sugar control, a sample containing 10 x the sugar content of the 
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sugar control, and a sample containing 0.1 x the sugar content of the sugar control were tested 
for their effects on gene expression.  There was no significant dose-dependent effect of the sugar 
control on G6pc, Pik3r1, Akt3, Vegfa, and Serpine1 expression (data not shown). 
 
Discussion 
Data from the National Institute of Diabetes and Digestive and Kidney Diseases 
(NIDDK) shows that 7.8% of the United States population (23.6 million people) had diabetes in 
2007 and that those with diabetes had 2-4 times increased risk of stroke and/or heart disease 
compared to non-diabetics.  First line therapy for diabetes management depends on the type of 
diabetes (type 1 vs. type 2), but in both cases, diet plays a vital part in controlling the disease and 
lessening the onset of potential complications.  In this regard, food and dietary choices play an 
important and not completely understood role in diabetes care. 
In this study, the manner in which diet can effect gene expression related to diabetes 
pathogenesis was explored.  Several genes were screened that are involved in different aspects of 
diabetes, and G6Pc was found to be consistently effected in a dose-dependent manner by the V. 
trilobum crude extract.  The high-molecular weight proanthocyanidins in V. trilobum fruit were 
shown to provide a key role in this activity, although they did not fully account for the extent of 
activity found in the crude extract.  This indicates that either unstudied compounds or 
compounds found to be inactive must be contributing to the activity seen with the crude extract.  
When inactive V. trilobum anthocyanins were combined with the high-molecular weight 
proanthocyanidins, inhibition of G6Pc expression was greater than that observed in PAC-h alone, 
suggesting that these two groups of compounds interact with each other to potentiate the 
inhibition of G6Pc gene expression. 
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Interactive effects of flavonoids on biological activity have been demonstrated previously 
using both purified compounds (13, 14, 24, 26) and extracts of plant material (14, 33), although 
none of these have studied the effect of flavonoid interaction on gene expression.  Interaction 
between proanthocyanidins and anthocyanins in cranberries increased antiproliferative activity in 
human tumor cell lines compared to their additive individual activities (33).  This study of V. 
trilobum fruit extract and fractions shows the potential for proanthocyanidins and anthocyanins 
to interact together in a concomitant manner and in this case, to effect the expression of G6Pc, a 
gene important to diabetes pathogenesis.
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Tables and Figures 
Table 3.1 Effect of Dex-cAMP treatment and Viburnum  trilobum fruit crude extract on expression of 
genes related to diabetes and insulin signaling in H4IIE rat hepatoma cells 
Gene Gene Description Dex-cAMP V. trilobum CE 
Snap23 Synaptosomal-associated protein 23 2.1 -4.1 
Pik3r1 Phosphatidylinositol 3-kinase, 
regulatory subunit, polypeptide 1 
2.5 -3.8 
Tgfb1 Transforming growth factor, beta 1 2.1 -2.9 
Akt3 Thymoma viral proto-oncogene 3 -2.7 2.8 
G6Pc Glucose-6-phosphatase, catalytic 3.3 -2.8 
PPARα Peroxisome proliferator activated 
receptor alpha 
3.9 -2.7 
Vegfa Vascular endothelial growth factor A 2.1 -2.4 
Serpine1 Serine (or cysteine) peptidase inhibitor, 
clade E, member 1 
3.0 -2.2 
Data represents fold change in gene expression (negative value indicates decrease gene 
expression) after incubating H4IIE cells for 4 hrs with different treatments:  Dex-cAMP (500 nM 
dexamethason and 0.1 mM 8-CTP-cAMP) and V. trilobum CE (100 µg/mL crude extract). 
Changes in gene expression for the Dex-cAMP treatment are with respect to the control (cells 
grown only in media) and changes in gene expression for V. trilobum CE treatment are with 
respect to Dex-cAMP.  n=3 
 
Table 3.2  Identification of proanthocyanidins and anthocyanins in Viburnum trilobum fruit extract and fractions via 
LC-ESI-MS 
Extract / 
Fractions 
Compound [M+H]+ 
(m/z) 
Fragment ions (m/z) 
CE (epi)cat-(epi)cat 579 453, 427, 313, 301, 291, 
289 
    
ANC cyanidin-3-galactoside/glucoside 449 287 
 cyanidin-3-diarabinoside/dixyloside * 551 419, 287 
 cyandin-3-sambubioside * 581 287 
 cyanidin-3,5-diglucoside 611 449, 287 
    
PAC-l (epi)afz-(epi)cat  # 563 437, 411, 297, 285 
 (epi)cat-(epi)cat  579 427, 301, 289 
 (epi)cat-(epi)gal * 595 443, 287 
 (epi)cat-(epi)gal-(epi)cat * 883 595 
    
PAC-h (epi)cat-(epi)cat  579 453, 427, 301, 291, 289 
 (epi)cat-(epi)cat-(epi)cat-(epi)cat 1155 865 
Identification of proanthocyanidins and anthocyanins from Viburnum trilobum fruit extract and 
fractions using LC-ESI-MS.  * indicates first time compound indentified in V. trilobum fruit.  # 
indicates order of flavan units is tentatively assigned.  “/” indicates that either or both sugars 
could be present.  (epi)cat, (epi)gal, and (epi)afz are abbreviations for (epi)catechin, 
(epi)gallocatechin, and (epi) afzelechin, respectively.  
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Table 3.3 Anthocyanin and proanthocyanidin content of Viburnum trilobum fruit fractions 
Extract / Fraction Anthocyanin Content 
(mg C3G equivalent / g sample) 
Proanthocyanidin Content 
(mg EC equivalent / g sample) 
CE 3 41 
ANC 345 124 
PAC-h ND 470 
PAC-l 1 517 
Anthocyanin and proanthocyanidin content of Viburnum trilobum fruit crude extract and 
fractions was determined via HPLC using cyanidin-3-O-glycoside (C3G) and epicatechin (EC), 
respectively.  Values are expressed as C3G and EC equivalents by mass. ND = none detected 
 
 
 
Table 3.4  Percent sugars by mass of Viburnum trilobum crude extract and fractions 
Extract / Fractions % Glucose % Fructose % Sucrose 
CE 10 8 ND 
ANC 1 1 ND 
PAC-l ND ND ND 
PAC-h ND ND ND 
Percent glucose, fructose, and sucrose content of Viburnum trilobum fruit crude extract and 
fractions was determined via HPLC using appropriate standards.  Values are expressed as % 
sugars by mass. ND = none detected 
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Figure 3.1 Effect of Viburnum trilobum fruit crude extract on 
G6Pc gene expression in H4IIE rat hepatoma cells
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The effect of V. trilobum fruit crude extract on the expression of G6Pc (catalytic subunit of 
glucose-6-phosphatase) in H4IIE rat hepatoma cells after treatment with Dex-cAMP.  Values 
represent mean percent inhibition relative to a DMSO control as an average of 3 runs with 
standard error bars.  Letters indicate statistically significant differences using one-way ANOVA 
with Tukey test. p < 0.05. 
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Figure 3.2  Effect of Viburnum trilobum high MW proanthocyanidin 
fraction on G6Pc gene expression in H4IIE rat hepatoma cells
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The effect of V. trilobum fruit high molecular weight (MW) proanthocyanidin (PAC-h) fraction 
on the expression of G6Pc (catalytic subunit of glucose-6-phosphatase) in H4IIE rat hepatoma 
cells after treatment with Dex-cAMP.  The middle concentration (8.49 µg/mL) is the equivalent 
concentration of high MW proanthocyanidins found in the crude extract.  Values represent mean 
percent inhibition relative to a DMSO control as an average of 3 runs with standard error bars.  
Letters indicate statistically significant differences using one-way ANOVA with Tukey test. p < 
0.05.  
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Figure 3.3  Effect of interaction between an anthocyanin-rich and a high MW
proanthocyanidin-rich fraction of Viburnum trilobum fruit extract on 
expression of G6Pc in H4IIE rat hepatoma cells
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The interactive effect of V. trilobum fruit anthocyanins and high-molecular weight 
proanthocyanidins on G6Pc expression in H4IIE rat hepatoma cells was evaluated by testing an 
anthocyanin-rich fraction (ANC) and a high molecular weight proanthocyanidin-rich fraction 
(PAC-h) individually and in a combined manner (ANC & PAC-h).  The predicted (calculated) 
value of the combined fraction (dashed line) was determined based on the activity of the 
individual fractions and compared to the empirically determined value (bar).  Values represent 
percent inhibition relative to a DMSO control as an average of three runs with standard error 
bars; p = 0.12 (t-test). 
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Figure 3.4  Representative LC-MS spectra from the high molecular weight proanthocyanidin 
fraction from Viburnum trilobum fruit 
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LC-MS of the high molecular weight proanthocyanidin fraction from Viburnum trilobum fruit.  
“A” section is the total ion current, “B” section is the UV absorption chromatogram at 280 nm, 
and “C” is the mass spectrometry from 4-35 minutes in positive mode.  Compounds indentified 
on “B” were determined using standards.  Parenthetical numbers on “C” refer to degrees of 
polymerization of proanthocyanidins. 
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Chapter 4 
 
Interactions of Compounds from Prunus virginiana and Vaccinium angustifolium Fruits on In 
Vitro IL-6, TNFα, and Nitric Oxide Production 
 
 
Abstract 
 Fruit extracts are known to have anti-inflammatory properties and provide protection 
from age-related neurodegeneration.  In this study, a flavonoid-rich fraction, an anthocyanidin-
rich (ANC) fraction, and a proanthocyanidin-rich (PAC) fraction from the fruits of Vaccinium 
angustifolium and Prunus virginiana were evaluated for their potential to inhibit the LPS-
induced production of interleukin-6 (IL-6), tumor necrosis factor α (TNFα), and nitric oxide 
(NO) in BV-2 (murine microglial) cells.  Dose-dependent inhibition of IL-6 was observed by the 
flavonoid-rich and ANC fractions from both species (maximum inhibition by V. angustifolium 
ANC fraction with IC50 = 111 µg/mL), inhibition of TNFα was seen by flavonoid-rich fractions 
of both species (greatest inhibition by P. virginiana with IC50 = 248 µg/mL), and inhibition of 
NO was demonstrated by flavonoid-rich and PAC fractions of both species (highest inhibition by 
V. angustifolium PAC fraction with IC50 = 204 µg/mL).  Interactions between flavonoid-rich and 
PAC fractions of V. angustifolium showed a greater than additive type of interaction whereas 
interactions between PAC and ANC appeared to be interferences. 
 
 
Introduction 
Age-related central nervous system inflammation and diabetes are both factors in the 
pathophysiology of neurodegenerative diseases, such as Alzheimer’s disease (AD) (1-4).  
Inflammation typically increases with age (5) and in the central nervous system inflammation is 
mediated by microglial cells (6), macrophage-like cells of the central nervous system.  When 
activated, microglial cells produce inflammatory cytokines, such as interleukin-6 (IL-6) and 
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tumor necrosis factor α (TNFα), and reactive oxygen species, such as nitric oxide (NO) (3, 7, 8), 
which potentiate the inflammatory response.  
Diabetic individuals are more susceptible than non-diabetics to neurodegenerative 
diseases although the specific reasons for this predisposition have not been clearly elucidated (4).  
Luchsinger et al. (9) found that the risk of developing AD was 39% more likely in those with 
hyperinsulinemia and that overall, those with type 2 diabetes showed greater tendencies toward 
memory deficiencies.  Similarly, Arvanitakis et al. (10) conducted a longitudinal cohort study 
and demonstrated a 65% increased risk of developing dementia and a 44% decrease in perceptual 
speed associated with type 2 diabetes.  Interestingly, rats that were injected with streptozotocin 
(STZ), a diabetogenic agent that decreases both insulin receptor autophosphorylation and 
tyrosine kinase activity, exhibited lesions in their brains characteristic of AD and are used as an 
animal model for studying AD (4).  The mechanisms by which type 2 diabetes exacerbates the 
effects of age-related neurodegeneration is not completely understood, but may include changes 
of tau and Aβ protein expression and metabolism due to altered insulin receptor sensitivity in the 
central nervous system (11, 12). 
Compounds from fruits are known to have anti-inflammatory activities and provide 
protection against age-related neurodegeneration (13-18).  For example, proanthocyanidins, 
polymers of flavan-3-ols common in many fruits, have shown the ability to protect against 
neurodegeneration.  Deshane et al. (19) used proteomic analysis to demonstrate that adult rats fed 
proanthocyanidins from grape seed extract had changes in brain proteins consistent with 
resistance to development of several neurodegenerative diseases, suggesting a protective role 
from such diseases.  Anthocyanins, pigmented compounds associated with many health benefits 
and found in many fruits, have also shown potential to impede neurodegeneration (20, 21).  For 
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example, anthocyanins inhibited the induced production of reactive oxygen species in a human 
neural cell line indicating the capacity to protect neural cells from oxidative damage (20).  
Compounds from fruits, such as proanthocyanidins and anthocyanins, are known to interact with 
each other in ways that modify their individual activities.  These types of interactions can be 
simply additive (the combination of compounds results in activity equal to the summation of 
their individual activities), more than additive (the combination of compounds results in greater 
than expected activity), or interference (the combination results in less than expected activity) 
(22-24). 
The fruit of Vaccinium angustifolium, lowbush blueberry, has been intensely studied for 
its ability to protect and lessen the degree of age-related neurodegeneration.  Joseph et al. (25) 
showed that rats fed a V. angustifolium berry extract-enriched diet demonstrated improvement of 
age-related decreases in brain function, and an aged rat model fed a similar diet had reversals of 
learning deficits (26).  V. angustifolium berry extracts were also able to reduce 
lipopolysaccharide (LPS)-activated production of IL-1β, TNFα, NO, and cyclooxygenase-2 
(COX-2) and decrease expression of inducible nitric oxide synthase (iNOS) and COX-2 in 
murine microglial cells (8).  V. angustifolium berry-enriched diets also protected rats from 
induced-learning impairment in a model of Alzheimer’s disease (27), and a similar diet restored 
the production of heat shock protein 70 in aged-rats, which is indicative of increased 
neuroprotection to stress (28).  The berries of V. angustifolium are rich sources of phenolic acids, 
anthocyanins, and proanthocyanidins.  The prominent anthocyanins in these berries include the 
3-galactosides and 3-glucosides of malvidin, petunidin, and delphinidin (29) and the array of 
proanthocyanidins includes oligomers and polymers consisting mainly of B-type interflavan 
linkages (30-33). 
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  The fruit, botanically a drupe, of Prunus virginiana was recently screened along with 
the fruits of several other species for its effect on the expression of genes associated with 
inflammation, such as IL-1β and COX-2 (34).  Fruit extracts demonstrated the capacity to inhibit 
the expression of IL-1β and COX-2 by 78% and 47%, respectively.  Similarly, seed extracts from 
the related species P. armeniaca (apricot) inhibited the LPS-induced expression of pro-
inflammatory COX-2 and iNOS mRNA in microglial cell culture (35), and P. domestica 
(European plum) juice supplemented in the diet improved age-related deficits and cognitive 
function in aged rats (36).  The phytochemical content of P. virginiana fruits has not been 
extensively studied but is known to contain phenolic acids (chlorogenic acid, caffeic acid, ferulic 
acid, and sinapic acid), anthocyanins (3-glucosides and 3,5-diglucosides of cyanidin and 
delphinidin, petunidin 3-acetylglucoside, and cyanidin 3-p-coumarolylglucoside), and 
carotenoids (β-carotene, lycopene, and β-cryptoxanthin) (34). 
The objective of this study was to further evaluate the anti-inflammatory properties of V. 
angustifolium and P. virginiana fruit using murine microglial cells (BV-2 cells) to assess the 
effect of these fruits on inflammation in the central nervous system.  Both V. angustifolium and 
P. virginiana fruits are rich in anthocyanins; however, only the former contains significant 
amounts of proanthocyanidins.  Both anthocyanins and proanthocyanidins have individually 
demonstrated anti-inflammatory activity via decreasing production of pro-inflammatory 
cytokines.  It was hypothesized that the anti-inflammatory capacity of P. virginiana fruit would 
be less than the anti-inflammatory capacity of V. angustifolium berries due to interactions 
between anthocyanins and proanthocyanidins in V. angustifolium berries. 
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Materials and Methods 
Fruit source.  Vaccinium angustifolium (Ait.) berries provided by the Wild Blueberry 
Association of North America (Bar Harbor, ME) were freeze-dried  by Oregon Freeze Dry, Inc. 
(Albany, OR).  The blueberries were a composite of fruit from different growing regions 
including Prince Edward Island, New Brunswick, Nova Scotia, and Maine, and the composite 
sample was made in fall 2005.  Prunus virginiana (chokecherry) fruit was collected in late 
summer and fall harvest seasons 2005 and 2006 on tribal lands in North Dakota by members of 
five tribes coordinated under the leadership of United Tribes Technical College, Bismarck, ND 
and immediately frozen after harvest.  Both fruits were stored at -80 °C. 
 
Fruit extraction.   Crude extract was made following the procedure detailed by Kraft et al. (34).  
Briefly, frozen P. virginiana fruit was mashed, and then lyophilized until completely dry.  Then 
the freeze-dried fruits were extracted 4 times in 80% (v/v) aqueous ethanol (1:10, grams of 
fruit:milliliter of solvent) by stirring for 1 hr followed by filtering through several layers of 
cheesecloth and no. 4 Whatman (Fisher Scientific; Pittsburg, PA) filter paper.  The filtrate (crude 
extract) was concentrated to an aqueous slurry using a rotary evaporator and a 40 °C water bath. 
 
Fractionation of crude extract.  A liquid-liquid extraction of the crude extract from each fruit 
(190 g and 123 g equivalent for V. angustifolium and P. virginiana fruit, respectively) was made 
by mixing it with equal volumes of water and ethyl acetate, shaking the mixture, and then 
separating the aqueous phase (aqueous extract) from the ethyl acetate phase.  The aqueous 
extract was mixed with and then separated from ethyl acetate four times.  Both extracts were 
concentrated with a rotary evaporator using a 40 °C water bath and dried via lyophilization.  The 
extract obtained from the ethyl acetate phase was designated as the flavonoid-rich fraction. 
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 Anthocyanin- and proanthocyanidin-rich fractions for each fruit were made by first 
passing the aqueous extract over an Amberlite XAD7HP (Sigma, St. Louis MO) column and 
then separating the resulting fraction using Sephadex LH20 (Sigma).  A portion of the aqueous 
extract (52 g and 68 g for V. angustifolium and P. virginiana fruit, respectively) was mixed with 
Amberlite and water:trifluoroacetic acid (100:0.3 v/v, acidified water) and poured onto a 70 mm 
diameter coarse-grade fritted glass filter.  Acidified water (2 L) was used to remove sugars (with 
vacuum) and the column was then rinsed with 1.25 L methanol:trifluoroacetic acid (100:0.3 v/v, 
acidified methanol) without vacuum to elute anthocyanins and proanthocyanidins.  The 
methanolic fraction was concentrated and dried as described above yielding 3.8 g and 5.2 g for 
V. angustifolium and P. virginiana fruit, respectively.  A portion of the dried methanolic fraction 
(3.5 g and 4.0 g for V. angustifolium and P. virginiana fruit, respectively) was dissolved in 
water:methanol:trifluoroacetic acid (80:20:0.3 v/v/v, acidified 20% aqueous methanol) and 
gently poured over a 75 cm x 3.5 cm (l x w) Sephadex LH20 column saturated in acidified 20% 
aqueous methanol.  Twenty-one and 13 fractions (75 mL each) for V. angustifolium and P. 
virginiana fruit, respectively were eluted using acidified 20% aqueous methanol followed by the 
elution of one 250 mL fraction using acetone:water (70:30 v/v).  These fractions were 
concentrated and dried as described above.  The second Sephadex fraction comprised an 
anthocyanin-rich fraction (VA-ANC and PV-ANC for V. angustifolium and P. virginiana fruit, 
respectively), and the final Sephadex fraction was used as a proanthocyanidin-rich fraction (VA-
PAC and PV-PAC for V. angustifolium and P. virginiana fruit, respectively). 
 
Cell culture.  BV-2 (mouse microglial) cell line was maintained at 37 °C under 5% CO2 in 
DMEM (Dulbecco's Modified Eagle's Medium; 4.5 g/L glucose) with 10% (v/v) heat inactivated 
FBS (fetal bovine serum), supplemented with 100 U/mL penicillin, 0.1 mg/mL streptomycin, 
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0.25 µg/mL amphotericin B, and 2 mM glutamine.  For maintenance, confluent cultures were 
washed with HBSS (Hank’s Balanced Salt Solution) and passed via trypsinization.  All 
chemicals were obtained from Fisher Scientific (Pittsburg, PA) except for glutamine (Invitrogen, 
Carlsbad, CA). 
BV-2 cells were plated at 1 x 106 cells / well in 6-well plates (2 mL total volume) for 24 h 
and then samples dissolved in DMSO were added to wells (10 μL). After 1 h incubation with 
samples, LPS (lipopolysaccharide; dissolved in sterile water) was added (10 μL) to wells (10 
ng/mL LPS).  After 8 h of LPS exposure, cells were harvested.  Cell media from wells was 
collected (1.5 mL), centrifuged at 4 °C at 14,000 rpm for 3 min, and 1 mL of supernatant was 
saved. 
 
Quantification of IL-6 and TNFα via ELISA.  OptEIATM ELISA kits (BD Biosciences; San 
Diego, CA) were used to test for mouse IL-6 and TNFα in the collected supernatant.  Samples 
containing LPS were diluted 1:20 with cell media before assaying.   Kits were used as per the 
manufacturer’s instructions.  The concentration of IL-6 and TNFα in samples was calculated 
using a standard curve based on 8 concentrations of standards. Appropriate water and DMSO 
controls were used; all samples and controls were assayed in duplicate in at least 5 independent 
runs.  IC50 values were calculated using a nonlinear least squares equation of best fit and 
GraphPad Prism 5.00 (GraphPad Software; San Diego, CA); 95% confidence intervals were used 
to determine significance. 
 
Quantification of NO.  Griess reagents (Cayman Chemical; Ann Arbor, MI) were used to 
quantify the amount of nitric oxide in the collected supernatant and used as per the 
manufacturer’s instructions.  The concentration of NO in samples was calculated using a 
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standard curve based on 8 concentrations of standards.  Appropriate water and DMSO controls 
were used.  Cells treated with fruit samples but not with LPS were used to correct for color 
interference.  All samples and controls were assayed in duplicate in at least 5 independent runs.  
IC50 values were calculated using a nonlinear least squares equation of best fit and GraphPad 
Prism 5.00. 
 
Cell viability.  Cell viability was assayed using the CellTiter-Blue® Cell Viability Assay 
(Promega; Madision, WI) to monitor the effect of samples, DMSO, and LPS on BV-2 cell 
growth.  Cells were grown, plated, and exposed to samples and LPS as mentioned above and 
fluorescence (490 nm) was measured 8 h after LPS treatment.  The assay was conducted in 
triplicate and according to the manufacturer’s instructions. 
 
Analysis of interactions.  The effect of the interactions between fruit fractions was evaluated by 
combining fractions in a manner that replicated their relative masses found naturally in the crude 
extract and testing the effect of this combined fraction on the production of IL-6, TNFα, and NO 
in BV-2 cells.  Predicted (calculated) and empirically derived values of percent inhibition were 
compared to each other to determine the type of interactions.  Empirical values that differed 
significantly from the predicted values were considered to have a “more than additive” or 
“interference” effect on production of IL-6, TNFα, and NO (24, 37, 38).  Differences were 
considered significant at p < 0.05 using an independent sample t-test and SigmaStat 3.5 (Systat 
Software, Inc.; San Jose, CA). 
 
Quantification of fruit components via HPLC.  An Agilent 1100 HPLC system (Agilent 
Technologies, Inc.; Wilmington, DE) with autosampler, photodiode array detector (PDA), and 
Supelcosil LC18 reverse-phase column (250 mm x 4.6 mm x 5 µm; Supelco; Bellefonte, PA) was 
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used to quantify anthocyanins and proanthocyanidins in V. angustifolium and P. virginiana fruit 
extracts and fractions.  All samples were prepared at 5 mg/mL in 100% MeOH and filtered 
through 0.2 µm nylon filters (Fisher Scientific; Hanover Park, IL) before injecting 15 µL onto 
the HPLC column kept at a constant temperature of 20 °C.  All anthocyanin and 
proanthocyanidin standards were prepared at three concentrations (0.25, 0.5, and 1.0 mg/mL) 
using 100% methanol and an injection volume of 15 µL.  For anthocyanin quantification, 
cyanidin-3-O-glucoside was used as the standard.  The mobile phase consisted of 5% formic acid 
in water (solvent A) and 100% MeOH (solvent B). The flow rate was constant during HPLC 
analysis at 1 ml/min with a step gradient of 10%, 15%, 20%, 25%, 30%, 60%, 10%, and 10% of 
solvent B at 0, 5, 15, 20, 25, 45, 47, and 60 min, respectively.  Quantification of anthocyanins 
was performed from the peak areas recorded at 520 nm with reference to the calibration curve 
obtained with cyanidin-3-O-glycoside.  For proanthocyanidin quantification, epicatechin was 
used as the standard.  The mobile phase consisted of water:acetonitrile:formic acid (95:5:0.1 
v/v/v, solvent A) and acetonitrile:water:formic acid (95:5:0.1 v/v/v, solvent B).  The flow rate 
was constant during HPLC analysis at 1 ml/min with a step gradient of 0%, 5%, 30%, 60%, 90%, 
0%, and 0% of solvent B at 0, 5, 40, 45, 50, 55, and 60 min, respectively.  Quantification of 
proanthocyanidins was performed from the peak areas recorded at 280 nm with reference to the 
calibration curve obtained with epicatechin.  All data were processed using Chemstation 
Software for LC 3D systems (Rev. A.10.02; Agilent). 
 
LC-ESI-MS analysis of fruit components.  High performance liquid chromatography-electrospray 
ionization-mass spectrophotometer (HPLC-ESI-MS) data were obtained for identification of 
flavonoids.  The HPLC separations were carried out on Waters Alliance 2795 (Waters 
Corporation; Beverly, MA) on  a C18-reversed-phase column with 2.1 mm x 150 mm and particle 
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size 5 µm, 90 A° (VYDAC; Western Analytical; Murrieta, CA) connected to a photodiode array 
(PDA) detector (UV: 262 mm; Thermo Scientific; San Jose, CA; 280, 340, and 520 nm).  A 15 
µL injection volume was used.  The mobile phase consisted of water:acetonitrile:formic acid 
(95:5:0.1 v/v/v, solvent A) and acetonitrile:water:formic acid (95:5:0.1 v/v/v, solvent B). The 
flow rate was constant during HPLC analysis (200 µl/min) with a step gradient of 0%, 5%, 30%, 
60%, 90%, 0%, and 0% of solvent B at 0, 5, 40, 45, 50, 55, and 60 min, respectively.  The 
HPLC-PDA was connected to a LCQ Deca XP mass spectrometer (Thermo Finnigan Corp., San 
Jose, CA) run in positive mode with a scan range of 100-2000 m/z.  Xcalibur software (Version 
1.4 SR1; Thermo Electron; San Jose, CA.) was used for data processing. 
 
Results 
Inhibition of IL-6, TNFα, and NO production.  The ability of V. angustifolium and P. virginiana 
fruit flavonoid-rich fractions, anthocyanin-rich (ANC) fractions, and proanthocyanidin-rich 
(PAC) fractions to inhibit the LPS-induced production of IL-6, TNFα, and NO in BV-2 cells was 
evaluated using ELISA and Griess reagent assay.  Briefly, BV-2 cells were pretreated with 
various concentrations of fruit fractions for 1 hour and then exposed to 10 ng/mL LPS for 8 
hours before harvest.  Samples were considered active and an IC50 value was calculated when a 
dose-dependent trend was observed. 
IL-6 production was inhibited by the flavonoid-rich fraction and the anthocyanin-rich 
(ANC) fraction of both V. angustifolium and P. virginiana fruits but not by either 
proanthocyanidin-rich (PAC) fraction.  All four of the active fractions (flavonoid-rich and ANC 
fractions of both fruits) demonstrated a dose dependent trend of increased inhibition of IL-6 
production with increasing dose.  The flavonoid-rich fraction of V. angustifolium was 1.6 times 
more active than the flavonoid-rich fraction from P. virginiana (IC50 = 220 and 352 µg/mL, 
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respectively, Figure 4.1).  In addition, the ANC fraction of V. angustifolium berries was 4.5 times 
more active than the ANC fraction of P. virginiana fruit (IC50 = 111 and 499 µg/mL, 
respectively, Figure 4.1).   In both species, there was a significant difference in activity between 
the flavonoid-rich fraction and the ANC fraction as demonstrated by 95% confidence intervals.  
However, in V. angustifolium berries the ANC fraction was more active and in P. virginiana fruit 
the flavonoid-rich fraction was more active. 
Only the flavonoid-rich fraction from V. angustifolium and P. virginiana fruits inhibited 
the production of TNFα.  Both the ANC and PAC fractions were not active.  Both flavonoid-rich 
fractions demonstrated a positive dose-dependent trend with inhibition of TNFα production.  The 
flavonoid-rich fraction of P. virginiana was 1.5 times more active than the flavonoid-rich 
fraction of V. angustifolium at inhibiting the production of TNFα (IC50 = 248 and 374 µg/mL, 
respectively, Figure 4.2). 
The flavonoid-rich and PAC fractions of V. angustifolium and P. virginiana fruits 
inhibited the production of NO in BV-2 cells in a dose-dependent manner.  The flavonoid-rich 
fraction of V. angustifolium was a stronger inhibitor of NO production than the flavonoid-rich 
fraction of P. virginiana (IC50 = 219 and 259 µg/mL) and the PAC fraction of V. angustifolium 
was slightly more active at decreasing NO production than the PAC fraction of P. virginiana 
(IC50 = 204 and 251 µg/mL, respectively, Figure 4.3).  For both fruit species, the flavonoid-rich 
fraction and the PAC fractions had similar levels of inhibitory activity and were not statistically 
different.  All fruit fractions were tested to determine their effect on cell viability and no 
significant effect was found (data not shown). 
 
Effect of fruit fraction interactions on the production of IL-6, TNFα, and NO.    The manner in 
which fruit fractions interact with each other to inhibit the production of inflammatory markers 
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such as IL-6, TNFα, and NO was evaluated by combining the active flavonoid-rich, ANC, and 
PAC fractions together in a manner that mimicked their relative proportion to each other (by 
mass) in the crude extract.  For each fruit species, the fractions could be combined in four ways: 
flavonoid-rich + PAC, flavonoid-rich + ANC, PAC + ANC, and All (flavonoid-rich + PAC + 
ANC).  For each combination, a predicted percent inhibition was calculated based on each 
fraction’s empirically determined percent inhibition.  The interaction was termed additive if the 
empirical inhibition equaled the predicted inhibition, more than additive if the empirical 
inhibition was significantly greater than the predicted inhibition, and interference if the empirical 
inhibition was significantly less than the predicted inhibition. 
 The active fractions of V. angustifolium berries were combined together in all possible 
combinations in a manner that reflected their relative masses to each other in the crude extract 
(flavonoid-rich:PAC, 1.0:0.5; flavonoid-rich:ANC, 1.0:0.7; PAC:ANC, 1.0:0.7; and flavonoid-
rich:PAC:ANC 1.0:0.5:0.7).  Only the flavonoid-rich:ANC combined fraction inhibited the 
production of IL-6 and TNFα.  This combined fraction had an additive type of interaction effect 
on the inhibition of IL-6 production (71% empirically determined inhibition vs. 78% predicted 
inhibition; p > 0.05), and an additive effect on the inhibition of TNFα (30% empirically 
determined inhibition vs. 38% predicted inhibition; p > 0.05).  Flavonoid-rich:ANC also had an 
additive effect on the inhibition of NO production (49% empirically determined inhibition vs. 
41% predicted inhibition, p > 0.05).  However, the flavonoid-rich:PAC combination had a more 
than additive effect on NO production (65% empirically determined inhibition vs. 33% predicted 
inhibition; p = 0.03; Figure 4.4).  The PAC:ANC combination, on the other hand, had an 
interference effect on NO production (2.2% empirically determined inhibition vs. 10% predicted 
inhibition; p = 0.04; Figure 4.5) and the flavonoid-rich:PAC:ANC fraction (All) had an additive 
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effect on NO production (49% empirically determined inhibition vs. 42% predicted inhibition; p 
> 0.05). 
 The active fractions of P. virginiana fruit were also combined together in all possible 
combinations in a manner that reflected their relative masses to each other in the crude extract 
(flavonoid-rich:PAC, 1.0:1.3; flavonoid-rich:ANC, 1.9:1.0; PAC:ANC, 2.4:1; and flavonoid-
rich:PAC:ANC 1.0:1.3:2.4).  Only the flavonoid-rich:ANC combined fraction of P. virginiana 
fruit was active against the LPS-induced production of IL-6 and TNFα.  This combined fraction 
had an additive effect on IL-6 production (72% empirically determined inhibition vs. 68% 
predicted inhibition; p > 0.05) as well as an additive effect on TNFα production (20% 
empirically determined inhibition vs. 21% predicted inhibition; p > 0.05).  The only combined 
fraction that was active against NO production was flavonoid-rich:PAC and this interaction was 
also additive (31% empirically determined inhibition vs. 27% predicted inhibition; p > 0.05).  
The flavonoid-rich:PAC:ANC and the PAC:ANC combined fractions from P. virginiana fruit 
were not active against the production of any of the studied inflammatory markers. 
 
Phytochemical analysis.  Aqueous ethanol extracts of freeze-dried V. angustifolium and P. 
virginiana fruit were concentrated and then separated into ethyl acetate and water phases via 
liquid-liquid extraction.  An Amberlite column was used to remove sugars from the water phase, 
which would otherwise complicate further fractionation and testing (29).  Then, a Sephadex LH-
20 column was used to gently separate anthocyanins from proanthocyanidins in the water phase. 
 The total anthocyanin content and total proanthocyanidin content of V. angustifolium and 
P. virginiana fruit fractions was determined by comparing HPLC chromatograms of fruit 
fractions to a standard curve based on three concentrations of cyanidin-3-O-glycoside (C3G) and 
epicatechin (EC) standards, respectively.  The anthocyanin-rich fraction of V. angustifolium 
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berries had twice the concentration of anthocyanins found in the similar fraction of P. virginiana 
fruits (964 and 443 mg C3G equivalent / g sample, respectively; Table 4.1).  In addition, the 
ANC fraction of P. virginiana fruits contained 271 mg EC equivalent / g sample of 
proanthocyanidins whereas there were no proanthocyanidins detected in the ANC fraction of V. 
angustifolium berries (Table 4.1). 
 The PAC fraction of V. angustifolium and P. virginiana fruits contained similar levels of 
proanthocyanidins (931 and 1130 mg EC equivalents / g sample, respectively) and both 
contained low levels of anthocyanins (5.70 and 13.5 mg C3G equivalent / g sample, respectively; 
Table 4.1).   The flavonoid-rich fraction of V. angustifolium berries contained low amounts of 
anthocyanins (12.6 mg C3G equivalent / g sample) and no detectable amounts of 
proanthocyanidins (Table 4.1).  The flavonoid-rich fraction of P. virginiana fruit also contained 
few anthocyanins (53.5 mg C3G equivalent / g sample) but had a high concentration of 
proanthocyanidins (950 mg EC equivalent / g sample, Table 4.1). 
 
Compound identification using LC-ESI-MS and LC-MS.  The compounds in the flavonoid-rich 
fractions of both fruits were identified using LC-ESI-MS (positive mode).  For both fruits, this 
fraction was composed of chlorogenic acid, anthocyanins, and flavonols.  The flavonoid-rich 
fraction of V. angustifolium berries contained simple anthocyanins, such as peonidin-3-
galactoside/glucoside (gal/glu; / indicates that either or both hexosides could be present), 
malvidin-3-gal/glu, delphinidin-3-gal/glu, malvidin-3-arabinoside, and malvidin-6-acetyl-3-
glucoside.  In addition, it contained flavonols including the 3-gal/glu of quercetin and 
isorhamnetin and one B-type proanthocyanidin dimer (Table 4.2).  The flavonoid-rich fraction of 
P. virginiana berries included two identifiable anthocyanins (cyanidin-3-gal/glu and cyanidin-3-
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rutinoside) and two identifiable flavonols (quercetin-3-gal/glu and quercetin-3-rutinoside, Table 
4.3). 
Anthocyanins from fruit fractions were identified by analyzing ion fragments from LC-
ESI-MS (positive mode), and compound assignments were verified by comparison to appropriate 
literature (29, 39, 40).  The ANC fraction of V. angustifolium berries contained a broad array of 
anthocyanins, all of which have previously been identified in these berries and were expected to 
be found in this fraction (29, 41).  The identified anthocyanins include the 3-gal/glu of cyanidin, 
peonidin, delphinidin, petunidin, and malvidin; the 3-arabinosides of delphinidin, petunidin, and 
malvidin; the 6-acetyl-3-gal/glu of cyanidin, petunidin, and malvidin; delphinidin-3-(6-
coumaroyl)glucoside; and cyanidin-3,5-diglucoside (Table 4.2). 
A much narrower range of anthocyanins were identified in the ANC fraction of P. 
virginiana fruit, and these included cyanidin-3-gal/glu, cyanidin-3-rutinoside, and cyanidin-3,5-
diglucoside (Table 4.3).  The anthocyanins found in P. virginiana fruit, including the ones 
identified above, were recently reported by our lab (34, 42). 
 The composition of PAC fractions of V. angustifolium and P. virginiana fruits was 
analyzed using both LC-ESI-MS and LC-MS (both in positive mode).   The PAC fraction of V. 
angustifolium berries contained three identifiable anthocyanins (the 3-gal/glu of cyanidin, 
delphinidin, and petunidin), and one A-type proanthocyanidin dimer, (epi)catechin-A-
(epi)catechin (A represents an A-type interflavan linkage, Table 4.2).  In addition, a series of B-
type proanthocyanidins (those with B-type interflavan linkages) composed of (epi)catechin 
subunits and with degrees of polymerization ranging from 2-12 was identified using both LC-
ESI-MS and LC-MS.  The dimer and hexamer were verified using LC-ESI-MS by analysis of 
fragment ions.  The remaining proanthocyanidins in the series were indentified using LC-MS by 
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analyzing the singly charged peaks (for proanthocyanidins with degree of polymerization from 2-
6) and doubly charged peaks (for proanthocyanidins with degree of polymerization from 7-12) 
and then comparing them with known m/z for V. angustifolium berry proanthocyanidins (Table 
4.2). The proanthocyanidins of V. angustifolium berries have been intensely studied and the ones 
reported above have all been previously identified (32, 41, 43). 
The PAC fraction of P. virginiana fruit was found to contain two anthocyanins (cyanidin-
3-rutinoside and delphinidin-3-rutinoside) and several proanthocyanidins.  Two 
proanthocyanidin dimers were detected using LC-ESI-MS: the A-linked proanthocyanidin dimer, 
(epi)catechin-A-(epi)catechin and the B-linked dimer, (epi)gallocatechin-(epi)gallocatechin 
(Table 4.3).  
 
Discussion 
 Epidemiological evidence has shown that dietary intake of flavonoids is positively 
associated with protection from neurodegeneration, a condition that increases with age and with 
chronic health problems such as diabetes (44).  The protective effects of flavonoids are thought 
to be due to their radical scavenging effect and by their ability to modulate cellular signals.  
Many of the cellular signals that flavonoids affect are associated with changing cytokine 
expression and altering phosphoylation of inflammatory pathway intermediates.  Flavonoids 
have also been shown to induce activity of heme-oxygenase 1, an enzyme that protects against 
reactive oxygen species (45), and antioxidant response elements (46). 
For dietary compounds, such as flavonoids, to affect neurodegeneration, the compounds 
must be able to pass the blood brain barrier (BBB) and reach various parts of the brain.  
Anthocyanins from blueberry fruits fed to rats have been shown to pass the BBB and were found 
in the cerebellum, cortex, hippocampus, and striatum (47).  Epicatechin, a flavan-3-ol, fed to rats 
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was shown to be metabolized to epicatechin glucuronide and 3’-O-methyl epicatechin 
glucuronide, which were detected in low quantities in the rat brain (48).  Quercetin, a flavonol, 
fed to rats and pigs were detected in low quantities in the brains after being on a 1% quercetin 
diet for 11 wks (49).  For the most part, the extent to which flavonoids can pass the BBB is 
unknown and this is a topic of intense investigation (50). 
The data from this work further supports evidence of the protective effects of fruit 
compounds on the prevention and reduction of age related neurodegeneration via anti-
inflammatory properties.  In this study, the dose-dependent effect of compounds from V. 
angustifolium and P. virginiana fruit on inhibiting the production of IL-6, TNFα, and NO was 
demonstrated.  Compounds found in the flavonoid-rich fraction of both fruits, such as flavonols 
and simple anthocyanins and proanthocyanidins, inhibited the production of all three 
inflammatory mediators studied.  Anthocyanin-rich fractions from both fruits inhibited 
production of IL-6, whereas the PAC fractions were limited to only decreasing production of 
NO. 
The activity of V. angustifolium fractions was greater than the activity of the comparable 
P. virginiana fractions against each inflammatory marker except for TNFα.  In particular, the 
ANC fraction of V. angustifolium demonstrated much stronger inhibition of IL-6 production than 
the ANC fraction of P. virginiana suggesting that the more diverse anthocyanin content of the V. 
angustifolium berry is related to the increased activity.    The activity of the PAC fractions from 
the different fruit species against NO production was similar. 
The effect of V. angustifolium berries on inflammation has been similarly examined by 
Lau et al. (8) also using BV-2 cells, although only a crude extract was studied.  They found 
comparable inhibition of TNFα and NO production and in addition, demonstrated inhibition of 
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IL-1β and COX-2.  The comparable results from these two studies further strengthens the 
conclusion that V. angustifolium berries have anti-inflammatory properties, which may provide 
protection against age-related neurodegeneration. 
The interaction between fruit fractions and their anti-inflammatory activity was 
demonstrated by fractions of both V. angustifolium and P. virginiana.  The fractions of V. 
angustifolium, however, showed multiple types of interactions (more than additive, additive, and 
interference), whereas those of P. virginiana were only additive.  One possible explanation for 
this could be due to the complexity of the different V. angustifolium fruit fractions.  Both the 
ANC and PAC fractions of V. angustifolium berries are much more complex and contain a more 
diverse array of compounds than the respective fractions of P. virginiana.  This greater diversity 
of compounds may simply provide more opportunities for interaction.
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Tables and Figures 
 
 
Table 4.1 Anthocyanin and proanthocyanidin content  of V. angustifolium and P. virginiana 
fruit fractions 
 Anthocyanin Content 
(mg C3G equivalent / g sample)
Proanthocyanidin Content 
(mg EC equivalent / g sample) 
Vaccinium angustifolium   
FLV 12.6 ND 
PAC 5.70 931 
ANC 964 ND 
Prunus virginiana   
FLV 53.5 950 
PAC 13.5 1130 
ANC 443 271 
Values are expressed as cyanidin-3-O-glycoside (C3G) and epicatechin (EC) equivalents by 
mass. FLV = flavonoid-rich fraction, PAC = proanthocyanidin-rich fraction, ANC = 
anthocyanin-rich fraction 
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Table 4.2  Compounds indentified from fractions of Vaccinium angustifolium berries by LC-MS 
and LC-ESI-MS 
Compound [M + H]+ (m/z) Fragment ions (m/z) 
Flavonoid-rich fraction 
Chlorogenic acid 355  
Peonidin-3-galactoside/glucoside 463 301 
Malvidin-3-arabinoside 463 331 
Delphinidin-3-galactoside/glucoside 465 303 
Quercetin-3-galactoside/glucoside 465 303 
Isorhamnetin-3-glalactoside/glucoside 479 317 
Malvidin-3-glatactoside/glucoside 493 331 
Malvidin-6-acetyl-3-glucoside 535 331 
(epi)cat-(epi)cat 579 453, 427, 313, 
301, 291, 289 
Quercetin-3-rutinoside 611 465, 303 
Anthocyanin-rich fraction 
Delphinidin-3-arabinoside 435 303 
Cyanidin-3-galactoside/glucoside 449 287 
Petunidin-3-arabinoside 449 317 
Peonidin-3-galactoside/glucoside 463 301 
Malvidin-3-arabinoside 463 331 
Delphinidin-3-galactoside/glucoside 465 303 
Petunidin-3-galactoside/glucoside 479 317 
Cyanidin-6-acetyl-3-glucoside 491 287 
Malvidin-3-glatactoside/glucoside 493 331 
Petunidin-6-acetyl-3-glucoside 521 317 
Malvidin-6-acetyl-3-glucoside 535 331 
Delphinidin-3-(6-coumaroyl)glucoside 611 303 
Cyanidin-3,5-diglucoside 611 449, 287 
Proanthocyanidin-rich fraction 
Cyanidin-3-galactoside/glucoside 449 287 
Delphinidin-3-galactoside/glucoside 465 303 
Petunidin-3-galactoside/glucoside 479 317 
(epi)cat-A-(epi)cat 577 451, 437, 425, 
287 
(epi)cat-(epi)cat 579 453, 427, 301, 
291, 289 
(epi)cat-(epi)cat-(epi)cat-(epi)cat-(epi)cat 1443 1153, 579 
(epi)cat (x2 – x12) *   
-A- indicates an A-type interflavan linkage. All other interflavan linkages are B-type.  (epi)cat  = 
(epi)catechin.  * indicates indentified using LC-MS and x2 – x12 indicates degree of 
polymerization.  All other compounds indentified via LC-ESI-MS 
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Table 4.3  Compounds indentified from fractions of Prunus virginiana fruit by LC-ESI-MS 
Compound [M + H]+ (m/z) Fragment ions (m/z) 
Flavonoid-rich fraction 
Chlorogenic acid 355  
Cyanidin-3-galactoside/glucoside 449 287 
Quercetin-3-galactoside/glucoside 465 303 
Cyanidin-3-rutinoside 595 449, 287 
Quercetin-3-rutinoside 611 465, 303 
Anthocyanin-rich fraction 
   
Cyanidin-3-galactoside/glucoside 449 287 
Cyanidin-3-rutinoside 595 449, 287 
Cyanidin-3,5-diglucoside 611 449, 287 
Proanthocyanidin-rich fraction 
(epi)cat-A-(epi)cat 577 451, 437, 425, 311, 
287 
Cyanidin-3-rutinoside 595 449, 287 
Delphindin-3-rutinoside 611 465, 303 
(epi)gal-(epi)gal 611 443, 317 
-A- indicates an A-type interflavan linkage. All other interflavan linkages are B-type.  (epi)cat  = 
(epi)catechin, (epi)gal = (epi)gallocatechin 
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Figure 4.1 Inhibition of LPS-induced IL-6 production by fruit fractions of Vaccinium 
angustifolium and Prunus virginiana in BV-2 cells 
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Prunus virginiana - flavonoid-rich fraction
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The inhibition of LPS (10ng/mL) induced production of IL-6 by 4 concentrations of fruit 
fractions of V. angustifolium and P. virginiana in murine BV-2 cells.  Data is represented as 
mean percent inhibition ± standard error of n ≥ 5 relative to DMSO control.   Letters above bars 
indicate significant statistical differences, p ≤ 0.05.  IC50 values were calculated using a 
nonlinear least squares equation of best fit.  CI = Confidence Interval 
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Figure 4.2 Inhibition of LPS-induced TNFα production by fruit fractions of Vaccinium 
angustifolium and Prunus virginiana in BV-2 cells 
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The inhibition of LPS (10ng/mL) induced production of TNFα by 4 concentrations of fruit 
fractions of V. angustifolium and P. virginiana in murine BV-2 cells.  Data is represented as 
mean percent inhibition ± standard error of n ≥ 5 relative to DMSO control.   Letters above bars 
indicate significant statistical differences, p < 0.05.  IC50 values were calculated using a 
nonlinear least squares equation of best fit.  CI = Confidence Interval   
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Figure 4.3 Inhibition of LPS-induced nitric oxide production by fruit fractions of Vaccinium 
angustifolium and Prunus virginiana in BV-2 cells 
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The inhibition of LPS (10 ng/mL) induced production of nitric oxide by 4 concentrations of fruit 
fractions of V. angustifolium and P. virginiana in murine BV-2 cells.  Data is represented as 
mean percent inhibition ± standard error of n ≥ 5 relative to DMSO control.   Letters above bars 
indicate significant statistical differences, p ≤ 0.05.  IC50 values were calculated using a 
nonlinear least squares equation of best fit.  CI = Confidence Interval 
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Figure 4.4 Effect of interactions between a flavonoid-rich and a proanthocyanidin-rich fraction 
of Vaccinium angustifolium fruit extract on production of nitric oxide in LPS-induced BV-2 cells 
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The interactive effect of V. angustifolium fruit flavonoid-rich (FLV) and proanthocyanidin-rich 
(PAC) fractions on nitric oxide production in BV-2 microglial cells was evaluated by testing a 
FLV fraction and PAC fraction individually and in a combined manner (FLV and PAC).  The 
predicted (calculated) value of the combined fraction (dashed line) was determined based on the 
activity of the individual fractions and compared to the empirically determined value (bar).  Data 
is represented as mean percent inhibition ± standard error of n = 5 relative to DMSO control; p = 
0.03 (t-test). 
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Figure 4.5 Effect of interactions between a proanthocyanidin-rich and an anthocyanin-rich 
fraction of Vaccinium angustifolium fruit extract on production of nitric oxide in LPS-induced 
BV-2 cells 
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The interactive effect of V. angustifolium fruit a proanthocyanidin-rich (PAC) and an 
anthocyanin-rich (ANC) fraction on nitric oxide production in BV-2 microglial cells was 
evaluated by testing a PAC fraction and an ANC fraction individually and in a combined manner 
(PAC and ANC).  The predicted (calculated) value of the combined fraction (dashed line) was 
determined based on the activity of the individual fractions and compared to the empirically 
determined value (bar).  Data is represented as mean percent inhibition ± standard error of n = 5 
relative to DMSO control; p = 0.04 (t-test). 
 114
Literature Cited 
1. Stewart, R.; Liolitsa, D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. 
Med. 1999, 16, 93-112. 
2. Esch, T.; Stefano, G.B.; Fricchione, G.L.; Benson, H. Stress-related diseases -- a potential role 
for nitric oxide. Med. Sci. Monit. 2002, 8, RA103-18. 
3. McGeer, P.L.; McGeer, E.G. Inflammation and the degenerative diseases of aging. Ann. N. Y. 
Acad. Sci. 2004, 1035, 104-116. 
4. Li, L.; Holscher, C. Common pathological processes in Alzheimer disease and type 2 diabetes: 
A review. Brain Res. Rev. 2007, 56, 384-402. 
5. Stowe, R.P.; Peek, M.K.; Cutchin, M.P.; Goodwin, J.S. Plasma cytokine levels in a 
population-based study: Relation to age and ethnicity. J. Gerontol. A Biol. Sci. Med. Sci. 2009,  
6. Dobrenis, K. Microglia in cell culture and in transplantation therapy for central nervous 
system disease. Methods 1998, 16, 320-344. 
7. Mrak, R.E.; Griffin, W.S.T. Glia and their cytokines in progression of neurodegeneration. 
Neurobiol. Aging 2005, 26, 349-354. 
8. Lau, F.C.; Bielinski, D.F.; Joseph, J.A. Inhibitory effects of blueberry extract on the 
production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J. 
Neurosci. Res. 2007, 85, 1010-1017. 
9. Luchsinger, J.A.; Reitz, C.; Honig, L.S.; Tang, M.X.; Shea, S.; Mayeux, R. Aggregation of 
vascular risk factors and risk of incident Alzheimer disease. Neurology 2005, 65, 545-551. 
10. Arvanitakis, Z.; Wilson, R.S.; Bienias, J.L.; Evans, D.A.; Bennett, D.A. Diabetes mellitus 
and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 2004, 61, 661-
666. 
 115
11. Watson, G.S.; Craft, S. Modulation of memory by insulin and glucose: Neuropsychological 
observations in Alzheimer's disease. Eur. J. Pharmacol. 2004, 490, 97-113. 
12. Zhao, W.Q.; Chen, H.; Quon, M.J.; Alkon, D.L. Insulin and the insulin receptor in 
experimental models of learning and memory. Eur. J. Pharmacol. 2004, 490, 71-81. 
13. Li, M.H.; Jang, J.H.; Sun, B.; Surh, Y.J. Protective effects of oligomers of grape seed 
polyphenols against beta-amyloid-induced oxidative cell death. Ann. N. Y. Acad. Sci. 2004, 1030, 
317-329. 
14. Joseph, J.A.; Shukitt-Hale, B.; Casadesus, G. Reversing the deleterious effects of aging on 
neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. 
Am. J. Clin. Nutr. 2005, 81, 313S-316S. 
15. Ramirez, M.R.; Izquierdo, I.; do Carmo Bassols Raseira, M.; Zuanazzi, J.A.; Barros, D.; 
Henriques, A.T. Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in 
adult rats. Pharmacol. Res. 2005, 52, 457-462. 
16. Cavin, A.L.; Hay, A.E.; Marston, A.; Stoeckli-Evans, H.; Scopelliti, R.; Diallo, D.; 
Hostettmann, K. Bioactive diterpenes from the fruits of Detarium microcarpum  . J. Nat. Prod. 
2006, 69, 768-773. 
17. Dai, Q.; Borenstein, A.R.; Wu, Y.; Jackson, J.C.; Larson, E.B. Fruit and vegetable juices and 
Alzheimer's disease: the Kame Project. Am. J. Med. 2006, 119, 751-759. 
18. Egashira, N.; Kurauchi, K.; Iwasaki, K.; Mishima, K.; Orito, K.; Oishi, R.; Fujiwara, M. 
Schizandrin reverses memory impairment in rats. Phytother. Res. 2008, 22, 49-52. 
19. Deshane, J.; Chaves, L.; Sarikonda, K.V.; Isbell, S.; Wilson, L.; Kirk, M.; Grubbs, C.; 
Barnes, S.; Meleth, S.; Kim, H. Proteomics analysis of rat brain protein modulations by grape 
seed extract. J. Agric. Food Chem. 2004, 52, 7872-7883. 
 116
20. Tarozzi, A.; Morroni, F.; Hrelia, S.; Angeloni, C.; Marchesi, A.; Cantelli-Forti, G.; Hrelia, P. 
Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. 
Neurosci. Lett. 2007, 424, 36-40. 
21. Yao, Y.; Vieira, A. Protective activities of Vaccinium antioxidants with potential relevance to 
mitochondrial dysfunction and neurotoxicity. Neurotoxicology 2007, 28, 93-100. 
22. Lila, M.A.; Raskin, I. Health-related interactions of phytochemicals. J. Food Sci. 2005, 70, 
20-27. 
23. Campbell, J.K.; King, J.L.; Harmston, M.; Lila, M.A.; Erdman, J.W. Synergistic effects of 
flavonoids on cell proliferation in Hepa-1c1c7 and LNCaP cancer cell lines. J. Food Sci. 2006, 
71, 358-363. 
24. Jo, J.Y.; de Mejia, E.G.; Lila, M.A. Catalytic inhibition of human DNA topoisomerase II by 
interactions of grape cell culture polyphenols. J. Agric. Food Chem. 2006, 54, 2083-2087. 
25. Joseph, J.A.; Shukitt-Hale, B.; Denisova, N.A.; Bielinski, D.; Martin, A.; McEwen, J.J.; 
Bickford, P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and 
motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. 
Journal of Neuroscience 1999, 19, 8114-8121. 
26. Shukitt-Hale, B.; Carey, A.N.; Jenkins, D.; Rabin, B.M.; Joseph, J.A. Beneficial effects of 
fruit extracts on neuronal function and behavior in a rodent model of accelerated aging. 
Neurobiol. Aging 2007, 28, 1187-1194. 
27. Duffy, K.B.; Spangler, E.L.; Devan, B.D.; Guo, Z.; Bowker, J.L.; Janas, A.M.; Hagepanos, 
A.; Minor, R.K.; DeCabo, R.; Mouton, P.R. A blueberry-enriched diet provides cellular 
protection against oxidative stress and reduces a kainate-induced learning impairment in rats. 
Neurobiol. Aging 2008, 29, 1680-1689. 
 117
28. Galli, R.L.; Bielinski, D.F.; Szprengiel, A.; Shukitt-Hale, B.; Joseph, J.A. Blueberry 
supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection. 
Neurobiol. Aging 2006, 27, 344-350. 
29. Grace, M.H.; Ribnicky, D.M.; Kuhn, P.; Poulev, A.; Logendra, S.; Yousef, G.G.; Raskin, I.; 
Lila, M.A. Hypoglycemic activity of a novel anthocyanin-rich formulation from lowbush 
blueberry, Vaccinium angustifolium Aiton. Phytomedicine 2009, 16, 406-415. 
30. Kalt, W.; McDonald, J.E.; Donner, H. Anthocyanins, phenolics, and antioxidant capacity of 
processed lowbush blueberry products. J. Food Sci. 2000, 65, 390-393. 
31. Smith, M.A.; Marley, K.A.; Seigler, D.; Singletary, K.W.; Meline, B. Bioactive properties of 
wild blueberry fruits. J. Food Sci. 2000, 65, 352-356. 
32. Schmidt, B.M.; Howell, A.B.; McEniry, B.; Knight, C.T.; Seigler, D.; Erdman, J.W., Jr; Lila, 
M.A. Effective separation of potent antiproliferation and antiadhesion components from wild 
blueberry (Vaccinium angustifolium Ait.) fruits. J. Agric. Food Chem. 2004, 52, 6433-6442. 
33. Kraft, T.F.B.; Schmidt, B.M.; Knight, C.T.G.; Cuendet, M.; Gills, J.J.; Kang, Y.H.; Pezzuto, 
J.M.; Seigler, D.S.; Lila, M.A. Chemopreventive potential of wild, lowbush blueberry fruits in 
multiple stages of carcinogenesis. J. Food Sci. 2005, 70, S159-S166. 
34. Kraft, T.F.B.; Dey, M.; Rogers, R.B.; Ribnicky, D.M.; Gipp, D.M.; Cefalu, W.T.; Raskin, I.; 
Lila, M.A. Phytochemical composition and metabolic performance-enhancing activity of dietary 
berries traditionally used by Native North Americans. J. Agric. Food Chem. 2008, 56, 654-660. 
35. Chang, H.K.; Yang, H.Y.; Lee, T.H.; Shin, M.C.; Lee, M.H.; Shin, M.S.; Kim, C.J.; Kim, 
O.J.; Hong, S.P.; Cho, S. Armeniacae semen extract suppresses lipopolysaccharide-induced 
expressions of cyclooxygenase-2 and inducible nitric oxide synthase in mouse BV2 microglial 
cell. Biol. Pharm. Bull. 2005, 28, 449-454. 
 118
36. Shukitt-Hale, B.; Kalt, W.; Carey, A.N.; Vinqvist-Tymchuk, M.; McDonald, J.; Joseph, J.A. 
Plum juice, but not dried plum powder, is effective in mitigating cognitive deficits in aged rats. 
Nutrition 2009, 25, 567-573. 
37. Mouria, M.; Gukovskaya, A.S.; Jung, Y.; Buechler, P.; Hines, O.J.; Reber, H.A.; Pandol, S.J. 
Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C 
release and apoptosis. International Journal of Cancer 2002, 98, 761-769. 
38. Mertens-Talcott, S.U.; Percival, S.S. Ellagic acid and quercetin interact synergistically with 
resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia 
cells. Cancer Lett. 2005, 218, 141-151. 
39. Wu, X.; Gu, L.; Prior, R.L.; McKay, S. Characterization of anthocyanins and 
proanthocyanidins in some cultivars of Ribes, Aronia, and Sambucus and their antioxidant 
capacity. J. Agric. Food Chem. 2004, 52, 7846-7856. 
40. Ogawa, K.; Sakakibara, H.; Iwata, R.; Ishii, T.; Sato, T.; Goda, T.; Shimoi, K.; Kumazawa, 
S. Anthocyanin composition and antioxidant activity of the crowberry (Empetrum nigrum) and 
other berries. J. Agric. Food Chem. 2008, 56, 4457-4462. 
41. Prior, R.L.; Lazarus, S.A.; Cao, G.; Muccitelli, H.; Hammerstone, J.F. Identification of 
procyanidins and anthocyanins in blueberries and cranberries (Vaccinium spp.) using high-
performance liquid chromatography/mass spectrometry. J. Agric. Food Chem. 2001, 49, 1270-
1276. 
42. Kraft, T.; Rogers, R.; Grace, M.; Raskin, I.; Lila, M.A. Comparative phytochemical 
composition and aldose reductase inhibitory activity of Aristotelia chilensis (maqui) and Prunus 
virginiana (chokecherry) fruits. Food Chem. 2010, in review. 
 119
 120
43. Alwerdt, J.L.; Seigler, D.S.; Gonzalez de Mejia, E.; Yousef, G.G.; Lila, M.A. Influence of 
alternative liquid chromatography techniques on the chemical complexity and bioactivity of 
isolated proanthocyanidin mixtures. J. Agric. Food Chem. 2008, 56, 1896-1906. 
44. Rossi, L.; Mazzitelli, S.; Arciello, M.; Capo, C.R.; Rotilio, G. Benefits from dietary 
polyphenols for brain aging and Alzheimer’s disease. Neurochem. Res. 2008, 33, 2390-2400. 
45. Scapagnini, G.; Foresti, R.; Calabrese, V.; Stella, A.M.; Green, C.J.; Motterlini, R. Caffeic 
acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol. 
Pharmacol. 2002, 61, 554-561. 
46. Rahman, I.; Biswas, S.K.; Kirkham, P.A. Regulation of inflammation and redox signaling by 
dietary polyphenols. Biochem. Pharmacol. 2006, 72, 1439-1452. 
47. Andres-Lacueva, C.; Shukitt-Hale, B.; Galli, R.L.; Jauregui, O.; Lamuela-Raventos, R.M.; 
Joseph, J.A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance 
memory. Nutr. Neurosci. 2005, 8, 111-120. 
48. El Mohsen, A.; Manal, M.; Kuhnle, G.; Rechner, A.R.; Schroeter, H.; Rose, S.; Jenner, P.; 
Rice-Evans, C.A. Uptake and metabolism of epicatechin and its access to the brain after oral 
ingestion. Free Radic. Biol. Med. 2002, 33, 1693-1702. 
49. de Boer, V.C.J.; Dihal, A.A.; van der Woude, H.; Arts, I.C.W.; Wolffram, S.; Alink, G.M.; 
Rietjens, I.M.C.M.; Keijer, J.; Hollman, P.C.H. Tissue distribution of quercetin in rats and pigs. 
J. Nutr. 2005, 135, 1718-1725. 
50. Janle, E.M.; Lila, M.A.; Grannan, M.; Wood, L.; Higgins, A.; Yousef, G.G.; Rogers, R.B.; 
Kim, H.; Jackson, G.S.; Weaver, C.M. Method for evaluating the potential of 14C labeled plant 
polyphenols to cross the blood-brain barrier using accelerator mass spectrometry. NIMPR 2010, 
268, 1313-1316. 
Chapter 5 
Comparative Phytochemical Composition and Aldose Reductase Inhibitory Activity of 
Aristotelia chilensis (Maqui) and Prunus virginiana (Chokecherry) Fruits 
 
Abstract 
 Flavonoids are a natural source of aldose reductase inhibitors (ARIs), an enzyme whose 
increased activity in hyperglycemic conditions is associated with complications of diabetes.  In 
this study, flavonoids from Aristotelia chilensis and Prunus virginiana fruits were characterized 
and ARI activity of their crude extracts and fractions were quantified using a highly efficient 
microtiter-based aldose reductase inhibitory assay.  Flavonoid-rich fractions from A. chilensis 
had twice the ARI activity as those from P. virginiana.  A. chilensis extract was subfractionated 
into anthocyanin (up to 101 mg cyanidin-3 glucoside (C3G) equivalent / g sample), 
proanthocyanidin (up to 2220 mg epicatechin (EC) equivalent / g sample), and flavonol-enriched 
(up to 19.0 mg quercetin equivalent / g sample) fractions.  The anthocyanin content of the two 
active P. virginiana fractions was 2.30 and 274 mg C3G equivalent / g sample and the 
proanthocyanidin content was 26.6 and 1010 EC equivalent / g sample.  No flavonols were 
detected in P. virginiana fruit fractions.  Several anthocyanins and proanthocyanidins that have 
not been previously reported in these fruits were identified using LC-ESI-MS.  In addition, 
increased ARI activity was positively correlated with proanthocyanidin content (R-squared = 
0.74) but was not associated with total phenolic or anthocyanin content (R-squared = 0.04 and 
0.48, respectively). 
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Introduction 
 Aldose reductase (alditol : NADP+ 1-oxidoreductase, EC 1.1.1.21), an enzyme broadly 
distributed in mammalian tissues, catalyzes the first reaction in the polyol pathway, which 
reduces glucose to sorbitol (1-3).  This enzyme has been identified in seminal vesicles, Schwann 
cells of peripheral nerves, islets of Langerhans in the pancreas, lens epithelium, kidney papilla, 
and muscles (1).  Even though aldose reductase has a low affinity for hexoses, such as glucose, 
there is increased sorbitol production in a diabetic hyperglycemic state because the substrate 
level is so elevated.  This increased formation of sorbitol has been linked to diabetic 
microvascular complications such as retinopathy, neuropathy, and nephropathy (2-4).  
Hyperosmolarity results from the elevated sorbitol levels and leads to cellular swelling and 
altered membrane permeability (5, 6).  Additionally, aldose reductase competes with glutathione 
reductase for the cofactor NADPH, which reduces the oxidant scavenging action of glutathione, 
and hence leads to oxidative stress (7, 8).  Cellular swelling, changes in membrane permeability, 
and increased oxidative stress all contribute to the etiology of microvascular complications 
associated with diabetes.  Therefore aldose reductase inhibitors (ARIs) are clinically attractive 
and important targets for diabetic patients. 
  Aldose reductase inhibitors have demonstrated the ability to reduce oxidative stress and 
minimize the development of neuropathies, nephropathies, and retinopathies in diabetic patients.  
Ohmura et al. (9) gave epalrestat, an ARI, to type 2 diabetic patients for 3 months and found that 
it significantly reduced lipid hydroperoxide levels by 15%.  Cameron et al. (10) found that 
sorbinil, an ARI, improved nerve conduction velocity and restored axon growth in 
streptozotocin-diabetic rats.  In addition, streptozotocin-diabetic rats treated with zenarestat 
(another ARI) maintained morphologically normal dorsal root ganglia compared to their 
untreated counterparts (11), which may help ameliorate the somatosensory neuropathies 
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commonly associated with diabetes.  However, in another study patients with diabetic 
sensorimotor polyneuropathy were randomly assigned a placebo or ranirestat, another ARI, for 
52 weeks and found that ranirestat treatment improved motor nerve function but did not 
significantly improve sensory nerve function (12).  Tolrestat, yet another ARI, was found to 
prevent retinal basement thickening and reduce urinary albumin excretion in streptozotocin-
diabetic rats (13) showing the potential of ARIs to slow the development of renal and retinal 
complications in diabetics. 
Natural sources of ARIs are an attractive alternative to synthetic ARIs which, despite 
extensive testing, have not been deemed safe and effective enough for therapeutic use, except for 
epalrestat which is only available in Japan (14, 15).  De la Fuente and Manzanaro (16) 
extensively reviewed natural ARIs and grouped them into terrestrial, marine, and microorganism 
sources.  Du et al. (17) found that curcuminoids, phenolic compounds from Curcuma longa 
(tumeric), had potent inhibitory activity against aldose reductase; curcumin had the strongest 
activity with an IC50 value of 6.8 µM (2.5 µg/mL).  Polyphenols extracted from Eleusine 
coracana (finger millet) demonstrated ARI activity and quercetin had the greatest inhibitory 
activity (IC50 value of 14.8 nM, 25.23 µg/mL) (18).  In addition, hot water extract of Matricaria 
chamomilla (chamomile) flowers inhibited aldose reductase activity (IC50 value of 16.9 µg/mL) 
and components of the extract (umbelliferone, escultetin, luteolin, and quercetin) inhibited 
sorbitol accumulation in human erythrocytes (19). 
Fruits, already recognized for their anti-diabetic benefits, are rich in flavonoids, known to 
be potent ARIs, and are thus an under-explored potential source of natural ARIs (16, 20, 21).   
Aristotelia chilensis (maqui) is a shrub native to Chile that invades disturbed areas.  The fruits, 
technically berries, have been used in Chilean folk medicine to promote wound healing 
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(topically) and to combat diarrhea, inflammation, and dysentery.  Miranda-Rottmann et al. (22) 
found that the juice of the berries inhibited low-density lipoprotein (LDL) oxidation and 
protected human endothelial cells from oxidative stress indicating that it may have anti-
atherosclerosis capabilities.  In addition, Céspedes et al. (23) demonstrated the cardioprotective 
potential of the berry by showing that methanol extracts protected rat hearts from reperfusion 
dysrythmias via inhibiting lipid oxidation.  In an antioxidant screening of Chilean fruits, the 
maqui berry had the highest antioxidant score (12.32 millimoles of Fe / 100g) according to the 
ferric reducing antioxidant power (FRAP) assay (24).  A few studies have partially characterized 
the chemical constituents focusing mainly on alkaloids (from leaves and stems) and anthocyanins 
and phenolic acids (from berries) (25-27).  The dominant anthocyanin in the berries is 
delphinidin 3-sambubioside-5-glucoside (25).  
Prunus virginiana (chokecherry) is a shrub that is found throughout almost all of Canada 
and the United States.  It was used both as a food and medicinally by Native Americans (28, 29).  
The antioxidant capacity of several edible North American fruits was screened and the fruit of P. 
virginiana was found to have a moderate antioxidant capacity using the 1,1-diphenyl-2-
picrylhydrazyl (DPPH) assay (IC50 value of 54µg/mL) (30).   The ability of this fruit, technically 
a drupe, to ameliorate the development of diabetic complications was evaluated and fruit extract 
and fractions of the extract were found to decrease the expression of IL-1β and COX-2 in a 
stimulated macrophage cell model by 78% and 47%, respectively, and to also significantly 
inhibit aldose reductase activity (42% - 73% inhibition of aldose reductase activity) (31).  The 
drupe contains phenolic acids, anthocyanins, and carotenoids (31). 
This research was conducted to further evaluate these two fruits, A. chilensis and P. 
virginiana, as potential natural ARIs.  Assays for determining the potential of samples to inhibit 
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the activity of aldose reductase typically monitor the rate of NADPH conversion to NADP+ via 
measuring a decrease in absorbance at 340 nm over time (2).  Traditionally the assay has been 
conducted using cuvettes or microcuvettes, which are inefficient and time-intensive for routine 
screening of plant extracts and other samples for activity.  In this paper, we used an efficient, 
accurate, and economical method for testing the ability of samples to inhibit aldose reductase 
activity using microtiter plates, which we validated.  This updated protocol was used to test 
extracts and flavonoid-rich fractions of A. chilensis and P. virginiana for inhibition of aldose 
reductase activity.  It is hypothesized that fractions of A. chilensis berries will have greater 
aldose reductase inhibitory activity compared to fractions of P. virginiana drupes due to the 
unique array of flavonoids found in the berries of A. chilensis. 
 
Materials and Methods 
Reagents.  β-Nicotinamide adenine dinucleotide phosphate reduced form (β-NADPH), DL-
glyceraldehyde, DL-dithiothreitol (DTT), 3,3-tetramethyleneglutaric acid (TMG), and Sephadex 
LH-20 were all purchased from Sigma (St. Louis, MO).  Toyopearl HW-40F was obtained from 
Tosoh, Bioscience LLC (Montgomeryville, PA) and recombinant aldose reductase was bought 
from Wako Chemicals USA, Inc. (Richmond, VA).  Catechin, epicatechin (EC), and quercetin 
(Q) standards were purchased from Sigma and cyanidin-3-O-glucoside (C3G) was obtained 
bought from Chromadex (Santa Ana, CA). 
 
Fruit sources.  A. chilensis berries were harvested in 2005 in the wild in Chile (Patagonia 
Region) and were provided by Fundacion Chile.  P. virginiana drupes were collected in late 
summer and fall harvest seasons 2005 and 2006 on tribal lands in North Dakota by members of 
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five tribes coordinated under the leadership of United Tribes Technical College, Bismarck, ND.  
All fruits were frozen after harvest and stored at -80 °C. 
 
Fruit extraction and fractionation.  Fruits of A. chilensis and P. virginiana were extracted by 
mixing them several times in 70% aqueous acetone at room temperature (3.0 L solvent / kg 
frozen fruit), and the resulting crude extract was filtered through several layers of cheesecloth 
between extractions.  This crude extract was concentrated under vacuum in a 40 °C water bath to 
a thick aqueous slurry. 
 For each fruit, a portion of the crude extract (approximately 60 g) was fractionated by 
passing it over a Toyopearl HW-40F column (TP, 70 mm column diameter with a medium-
porosity fritted glass disc) for vacuum chromatography.  Six fractions were collected by elution 
with water (500 mL, TP1a), water (350 mL, TP1b), 50% aqueous methanol (MeOH, 1.0 L, TP2), 
100% MeOH (1.0 L, TP3), 100% acetone (1.0 L, TP4), and 50% aqueous acetone (1.0L, TP5).  
All fractions were concentrated as described above and dried via lyophilization. 
 Fraction TP2 (900 mg) from A. chilensis was significantly active in the aldose reductase 
inhibition assay, and therefore warranted further fractionation using a Sephadex LH-20 column 
(2.5 x 27 cm, w x l) to follow activity and determine active constituents.  The column was first 
equilibrated with water:MeOH (4:1, v/v with 0.1% trifluoroacetic acid), and 50  subfractions (50 
mL each) were collected.  All subfractions were eluted with the above mentioned solvent except 
an additional final subfraction which was eluted with 100% MeOH (1 L).  Subfractions were 
concentrated using a rotary evaporator with a 40 °C water bath and then lyophilized until dry.  
All subfractions were analyzed using thin-layer and paper chromatography (TLC and PC).  
Subfractions were then combined into 7 groups (TP2A-TP2G) based on chemical similarities. 
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Fractions TP3-TP5 (570 mg) from A. chilensis showed similar and significant activity in 
the aldose reductase assay and were therefore combined in order to obtain enough mass for 
further fractionation, which was accomplished using a Sephadex LH-20 column identical to the 
one described above.  Thirty-six subfractions (50 mL each) were eluted.  Three solvents (1 L 
each) were used in the following order: water:MeOH (4:1, v/v with 0.1% trifluoroacetic acid), 
MeOH:acetone:water (1:1:1, v/v/v), and 60% aqueous acetone.  The collected subfractions were 
concentrated as described above.  Subfractions were analyzed via TLC and similar subfractions 
were then combined together into 7 groups (TP3-5A through TP3-5G) based on chemical 
similarities. 
 
Folin-Ciocalteu assay for total phenolic determination.  The total phenolic content of all 
fractions was determined using the Folin-Ciocalteu assay as previously described by Slinkard 
and Singleton (32).  The standard (catechin) and samples (0.5 mL) were dissolved in distilled 
water at appropriate concentrations, added to 1 N Folin-Ciocalteu reagent (0.5 mL) and allowed 
to sit for 3 min.  Afterwards, 20% Na2CO3 (1 mL) was added to the mixture and the absorbance 
was read 10 min later at 725 nm using a Spectramax Plus384 microplate reader (Molecular 
Devices Corp.; Sunnyvale, CA).  An appropriate blank was used for each sample.  The total 
phenolic content of samples was determined using catechin standard curves and was expressed 
as catechin equivalent (CE) per g sample.  Samples and standards were all run in triplicate and 
expressed as mean +/- standard error. 
 
Thin-layer and paper chromatography.  TLC and PC were used to analyze A. chilensis TP 
subfractions to determine the best grouping of subfractions for further analysis and testing in the 
aldose reductase inhibition assay.  Anthocyanins were analyzed via two methods.  The first 
 127
method screened for the presence or absence of anthocyanins in fractions and used cellulose 
fibers on TLC PET foils (Sigma-Aldrich; Steinheim, Germany) with fluorescent indicator and a 
solvent mixture of n-butanol:hydrochloric acid (HCl):water (5:2:1, v/v/v) (33).  The second 
method provided good separation of anthocyanins and used descending PC (3 mm; Whatman; 
Maidstone, England) with 15% aqueous acetic acid (34).  Proanthocyanidins and polyphenols 
were analyzed using silica gel 60 F254 TLC sheets on aluminum backing (Merck; Darmstadt, 
Germany) with a solvent mixture of toluene:acetone:formic acid (3:3:1, v/v/v) and visualizing 
with vanillin-HCl acid (1 g vanillin / 20 mL; MeOH: HCl, 20:1, v/v) (35). 
 
Quantification of fruit components via HPLC.  An Agilent 1100 HPLC system (Agilent 
Technologies, Inc.; Wilmington, DE) with autosampler, photodiode array detector (PDA), and 
Supelcosil LC18 reverse-phase column (250 mm x 4.6 mm x 5 µm; Supelco; Bellefonte, PA) was 
used to quantify anthocyanins and proanthocyanidins in A. chilensis and P. virginiana fruit 
extracts and fractions.  All samples were prepared at 5 mg/mL in 100% MeOH and filtered 
through 0.2 µm nylon filters (Fisher Scientific; Hanover Park, IL) before injecting 15 µL onto 
the HPLC column kept at a constant temperature of 20 °C.  All anthocyanin and 
proanthocyanidin standards were prepared at three concentrations (0.25, 0.5, and 1.0 mg/mL) 
using 100% methanol and an injection volume of 15 µL.  For anthocyanin quantification, 
cyanidin-3-O-glucoside was used as the standard.  The mobile phase consisted of 5% formic acid 
in water (solvent A) and 100% MeOH (solvent B). The flow rate was constant during HPLC 
analysis at 1 ml/min with a step gradient of 10%, 15%, 20%, 25%, 30%, 60%, 10%, and 10% of 
solvent B at 0, 5, 15, 20, 25, 45, 47, and 60 min, respectively.  Quantification of anthocyanins 
was performed from the peak areas recorded at 520 nm with reference to the calibration curve 
obtained with cyanidin-3-O-glycoside.  For proanthocyanidin quantification, epicatechin was 
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used as the standard.  The mobile phase consisted of water:acetonitrile:formic acid (95:5:0.1 
v/v/v, solvent A) and acetonitrile:water:formic acid (95:5:0.1 v/v/v, solvent B).  The flow rate 
was constant during HPLC analysis at 1 ml/min with a step gradient of 0%, 5%, 30%, 60%, 90%, 
0%, and 0% of solvent B at 0, 5, 40, 45, 50, 55, and 60 min, respectively.  Quantification of 
proanthocyanidins was performed from the peak areas recorded at 280 nm with reference to the 
calibration curve obtained with epicatechin.  Flavonols were quantified using quercetin as the 
standard.  The HPLC system described for proanthocyanidin analysis was used with the 
exception that peak areas were recorded at 360 nm.  All data were processed using Chemstation 
Software for LC 3D systems (Rev. A.10.02; Agilent). 
 
LC-ESI-MS analysis of fruit components.  High performance liquid chromatography-electrospray 
ionization-mass spectrophotometer (HPLC-ESI-MS) data were obtained for identification of 
flavonoids.  The HPLC separations were carried out on Waters Alliance 2795 (Waters 
Corporation; Beverly, MA) on  a C18-reversed-phase column with 2.1 mm x 150 mm and particle 
size 5 µm, 90 A° (VYDAC; Western Analytical; Murrieta, CA) connected to a photodiode array 
(PDA) detector (UV: 262 mm; Thermo Scientific; San Jose, CA; 280, 340, and 520 nm).  A 15 
µL injection volume was used.  The mobile phase consisted of water:acetonitrile:formic acid 
(95:5:0.1 v/v/v, solvent A) and acetonitrile:water:formic acid (95:5:0.1 v/v/v, solvent B). The 
flow rate was constant during HPLC analysis (200 µl/min) with a step gradient of 0%, 5%, 30%, 
60%, 90%, 0%, and 0% of solvent B at 0, 5, 40, 45, 50, 55, and 60 min, respectively.  The 
HPLC-PDA was connected to a LCQ Deca XP mass spectrometer (Thermo Finnigan Corp., San 
Jose, CA) run in positive mode with a scan range of 100-2000 m/z.  Xcalibur software (Version 
1.4 SR1; Thermo Electron; San Jose, CA.) was used for data processing. 
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Aldose reductase preparation.  The aldose reductase enzyme was diluted with a solution 
containing 0.1 mM DTT in 25 mM sodium phosphate buffer (pH 6.2) 1:19, v/v, respectively, and 
adjusted to 1.0 units/mL.  These dilutions and adjustments were made immediately before 
assaying, and the diluted enzyme was kept on ice. 
 
Aldose reductase inhibition assay.  Aldose reductase activity was measured by monitoring 
NADPH absorbance at 340 nm over 5 min using a Spectramax Plus384 microplate reader 
(Molecular Devices Corp.).  Table 5.1 displays the composition of the reaction solutions used in 
the assay.  All compounds used were dissolved in water except samples and the positive control 
which were dissolved in DMSO.  After the diluted enzyme was added to the reaction mixture, 
the plate was shaken for 10 sec and absorbance was measured after 1 min and 5 min.  Percent 
inhibition of aldose reductase was determined by the following equation after the appropriate 
sample zero values had been subtracted from sample and sample blank absorbance values.   
Inhibitory Activity (%) = 1 - (Δ Sample abs - Δ Sample Blank abs)   x 100% 
                            (Δ Control abs - Δ Control Blank abs) 
 
All extracts and fractions were initially tested at 5 µg/mL and the % inhibition was calculated as 
an average of at least two replications.  TP fractions with inhibitory activity greater than 50% 
and TP subfractions with inhibitory activity greater than 60% were further tested to establish IC50 
(concentration that yields 50% inhibition) values. IC50 values were determined using at least 6 
different concentrations tested in duplicate or greater using a nonlinear least squares equation of 
best fit and GraphPad  Prism 5.00 (GraphPad Software; San Diego, CA); 95% confidence 
intervals were used to determine significance.  3,3-Tetramethyleneglutaric acid was used as a 
positive control (5 µg/mL yielded 80% inhibition).  Linear regression was used to compare the 
relationship of A. chilensis phytochemical content to ARI using SigmaStat 3.5 (Systat Software, 
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Inc.; San Jose, CA).  The validity of this updated method was demonstrated by calculating Km 
and Kcat values for aldose reductase using the methodology described above and various levels 
of DL-glyceraldehyde (0.001, 0.002, 0.004, 0.008, 0.012, 0.0175, and 0.025 mM; n = 4).  
Lineweaver-Burk plots were then constructed to calculate the above constants and these were 
compared to the literature (2). 
 
Results 
Phytochemical analysis.   Aqueous acetone extracts of frozen A. chilensis and P. virginiana 
fruits were concentrated and further separated using Toyopearl (TP).  TP binds most 
phytochemicals but allows sugars, which would otherwise complicate further fractioning and 
testing, to be efficiently removed from fruit samples by washing the TP with water.  
Subsequently, anthocyanins, phenolic acids, and simple proanthocyanidins can be easily 
recovered from the column using aqueous methanol while proanthocyanidin oligomers and 
polymers can be eluted with acetone and aqueous acetone (36-39). 
The total phenolic content for A. chilensis berry TP fractions ranged from 443 (TP2) to 
799 mg catechin equivalent (CE) / g (TP5).   The total phenolic content of TP2 subfractions of A. 
chilensis, which ranged from 226 (TP2A) to 1210 (TP2E) mg CE / g, was much higher than that 
of TP3-5 subfractions of A. chilensis, which ranged from 17.7 (TP3-5A) to 902 (TP3-5E) mg CE 
/ g (Table 5.2). The range of total phenolic content of P. virginiana drupe TP fractions was 
broader than TP fractions of A. chilensis; TP3 was the lowest (73.8 mg CE / g) and TP2 the 
highest (840 mg CE / g; Table 5.2). 
The total anthocyanin, proanthocyanidin, and flavonol content of A. chilensis and P. 
virginiana fruit TP fractions was determined using HPLC by comparing fruit fractions to a 
standard curve based on three concentrations of cyanidin-3-O-glycoside (C3G), epicatechin 
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(EC), and quercetin (Q) standards, respectively.  TP2 for both A. chilensis and P. virginiana had 
the highest anthocyanin content (101 and 274 mg C3G equivalent / g; Table 5.3).   Two of the 
subfractions of TP2 from A. chilensis (TP2B and TP2C) had anthocyanin contents (438 and 221 
mg C3G equivalent / g) that more than doubled the anthocyanin concentrations of their parent 
fraction (TP2; Table 5.3).  The remaining TP2 subfractions from A. chilensis all had an 
anthocyanin content less than 50 mg C3G equivalent / g.  The TP3-5 subfractions of A. chilensis 
berries had low levels of anthocyanins and only TP3-5B had an anthocyanin content greater than 
1.0 mg C3G equivalent / g (33.4 mg C3G equivalent / g; Table 5.3). 
The TP fractions of A. chilensis all contained proanthocyanidins which ranged from 646 
(TP5) to 1670 (TP4) mg EC equivalent / g (Table 5.3).  The TP fractions of P. virginiana drupes 
had a lower proanthocyanidin content that ranged from 17.0 (TP3) to 1010 (TP2) mg EC 
equivalent / g (Table 5.3).  Sephadex subfractions of TP2 from A. chilensis berries contained 
increasing levels of proanthocyanidins ranging from 15.3 (TP2A) to 1430 (TP2G) mg EC 
equivalents / g, with the level in TP2G being almost 1.5 times that found in its parent fraction 
TP2 (Table 5.3).  Two Sephadex subfractions of TP3-5 from A. chilensis berries (TP3-5E and 
TP3-5F) had much higher proanthocyanidin levels than their parent fractions (2220 and 1740 mg 
EC equivalent / g, respectively; Table 5.3). 
Few fractions contained measureable levels of flavonols.  TP3 was the only TP fraction 
of A. chilensis berries that contained flavonols (2.1 mg Q equivalents / g, Table 5.3), and none of 
the P. virginiana TP fractions contained detectable levels of flavonols.  Although no flavonols 
were detected in TP2 from A. chilensis berries, two of its subfractions (TP2A and TP2G) 
contained flavonols (1.0 and 3.7 mg Q equivalents / g, respectively; Table 5.3).  Two Sephadex 
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subfractions of TP3-5 from A. chilensis berries (TP3-5F and TP3-5G) contained measurable 
levels of flavonols (18.6 and 3.2 mg Q equivalents / g, respectively; Table 5.3). 
 
Compound identification using LC-ESI-MS.  Anthocyanins from fruit fractions were identified 
via analysis of ion fragments from LC-ESI-MS (positive mode), and compound assignments 
were verified by comparison to appropriate literature (40-42).  TP2 from both fruits contained 
the most diverse array of anthocyanins and in both fruits included cyanidin-3-
galactosides/glucosides (gal/glu; / indicates that either or both hexosides could be present), 
delphinidin-3-gal/glu, and cyanidin-3,5-diglucoside (Tables 5.4 and 5.5).  In addition, TP2 from 
A. chilensis contained delphinidin-3-arabinoside/xyloside, delphinidin-3,5-diglucoside, 
delphinidin-3-sambubioside-5-glucoside, and malvidin-3-gal/glu (Table 5.4), and TP2 from P. 
virginiana contained the 3-rutinoside of both cyanidin and delphinidin (Table 5.5).  No 
anthocyanins were identified from TP fractions 3-5 of A. chilensis but were indentified in TP 
fractions 3-5 of P. virginiana.  Cyanidin-3-gal/glu, cyanidin-3-rutinoside, cyanidin-3,5-
diglucoside, and delphinidin-3-gal/glu were identified in both TP3 and TP4 of P. virginiana, and 
cyanidin-3-gal/glu and cyanidin-3-rutinoside were identified in TP5 of P. virginiana (Table 5.5). 
Subfractions of TP2 from A. chilensis (TP2A-TP2G) all contained anthocyanins with the 
most diverse array in TP2A.  TP2A contained 3-sambubiosides and 3-sambubioside-5-glucosides 
of cyanidin and delphinidin as well as delphinidin-3,5-diglucoside (Table 5.4).  TP2B and TP2C 
both contained cyanidin-3-gal/glu, cyanidin-3-sambubioside, delphinidin-3-gal/glu, and 
delphidin-3,5-diglucoside.  TP2D and TP2E were the only two subfractions to contain malvidin 
anthocyanins (Table 5.4).  Only two anthocyanins were identified in TP2F (cyanidin-3,5-
diglucoside and delphinidin-3-rutinoside) and only one was found in TP2G (delphinidin-3-
gal/glu; Table 5.4).  TP3-5B of A. chilensis berries was the only subfraction from the TP3-5 
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series that contained identifiable anthocyanins, which included cyanidin-3-gal/glu, delphinidin-3-
gal/glu, delphinidin-3-sambubioside, delphinidin-3,5-digluocoside, and delphinidin-3-
sambubioside-5-glucoside (Table 5.4).  To our knowledge, this is the first time that cyanidin-3-
rutinoside, delphinidin-3-arabinoside/xyloside, and delphinidin-3-rutinoside have been reported 
in the berries of A. chilensis and the first time that cyanidin-3-rutinoside has been reported in the 
drupes of P. virginiana. 
Proanthocyanidin compounds were identified in A. chilensis and P. virginiana fruit TP 
fractions via analysis of ion fragments from LC-ESI-MS (positive mode), and, when possible, 
verified by comparison to relevant literature (43, 44).  Fragmentation analysis involved studying 
different routes of proanthocyanidin fission including heterocyclic ring fission (HRF), retro-
Diels-Alder (RDA) fission, benzofuran-forming (BFF) fission, and quinine methide (QM) 
fission.  Products of these fission reactions yield fragments whose size is characteristic of 
specific proanthocyanidin subunits.  For example, HRF results in 126 Da fragments from 
(epi)afzelechin, (epi)catechin, and (epi)gallocatechin; RDA fission results in 136 Da, 152 Da, 
and 168 Da fragments from (epi)afzelechin, (epi)catechin, and (epi)gallocatechin, respectively; 
and BFF fission results in 106 Da, 122 Da, and 138 Da fragments from (epi)afzelechin, 
(epi)catechin, and (epi)gallocatechin, respectively.  A water molecule is often lost before BFF 
fission, which increases the loss from the [M + H]+ parent ion by 18 Da.  In addition, Li and 
Deinzer (43, 44) have developed a set of rules for sequencing proanthocyanidins that facilitate 
identification.  Briefly, HRF of a proanthocyanidin subunit ring cannot subsequently undergo 
RDA fission and RDA fission of a proanthocyanidin subunit ring cannot subsequently undergo 
HRF.  Also, BFF fission of a proanthocyanidin subunit ring cannot subsequently undergo HRF 
(and visa versa) and the product of HRF cannot undergo BFF fission. 
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Figure 5.1 is an example of an ESI-MS spectra of a B-type procyanidin trimer ([M + H]+, 
m/z 867) from TP3 of P. virginiana, and the following description illustrates the typical 
identification process.  The fragment ion with m/z 577 (867 Da – 290 Da) is the product of QM 
fission of the parent ion and identifies (epi)catechin as the terminal unit of the trimer, and the 
fragment ion with m/z 579 (867 Da – 288 Da) is the product of another QM fission of the parent 
ion and identifies (epi)catechin as the upper unit of the trimer.  Hence by mass difference (867 
Da – 290 Da – 288 Da = 289 Da), the middle unit of the trimer must be (epi)catechin as well.  
Other fragments on the spectra further verify this assignment.  For example, the fragment ion 
with m/z 741 (867 Da – 126 Da) is the HRF product, the fragment ion with m/z 715 (867 Da – 
152 Da) is the RDA fission product, the fragment ion with m/z 697 (715 Da – 18 Da) is the loss 
of a water molecule from the RDA fission product, the fragment ion m/z 679 (715 Da – 36 Da) is 
the loss of two water molecules from the RDA fission product, the fragment ion m/z 589 (867 Da 
– 126 Da – 152 Da) is the product of HRF followed by RDA fission (or visa versa), the fragment 
ion m/z 559 (577 Da – 18 Da) is the loss of water from the QM fission of the terminal subunit, 
the fragment ions m/z 451and 453 (867 Da – 290 Da – 126 Da and 867 Da – 288 Da – 126 Da, 
respectively) are the HRF products from QM fission, the fragment ion m/z 409 (451 Da – 42 Da) 
is the loss of an ethynol molecule (HC≡C-OH) from the m/z 451 fragment described above, and 
the fragment ion m/z 289 is one of the (epi)catechin subunits.  Therefore, the structure of [M + 
H]+, m/z 867 from TP3 of P. virginiana drupes is assigned as (epi)catechin-(epi)catechin-
(epi)catechin with two B-type interflavan linkages (Table 5.6).  In some cases not all possible 
fragment ions were found, however, in each case, enough fragments were identified to 
definitively assign the structure. 
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Several proanthocyanidins were identified for the first time in the fruits of A. chilensis 
and P. virginiana.  TP2 was the only TP fraction from A. chilensis berries that contained an 
identifiable proanthocyanidin, which was the B-linked dimer (epi)catechin-(epi)catechin (Table 
5.6).   On the other hand, three of the TP fractions from P. virginiana drupes contained 
proanthocyanidins.  TP3 from P. virginiana contained the B-linked trimer (epi)catechin-
(epi)catechin-(epi)catechin (Table 5.6, Figure 5.1).  TP4 from P. virginiana contained 
(epi)catechin-A-(epi)catechin-A-(epi)catechin, a  proanthocyanidin trimer with two A-linkages, 
and a B-linked pentamer which contained (epi)afzelechin, (epi)catechin, and (epi)gallocatechin 
subunits.  TP5 from P. virginiana contained the same trimer found in TP3 as well as a B-linked 
proanthocyanidin hexamer composed entirely of (epi)catechin subunits (Table 5.6). 
TP subfractions of A. chilensis berries contained additional proanthocyanidins that were 
not discovered in the parent fractions.  Three TP2 subfractions (TP2E-TP2G) contained B-linked 
proanthocyanidins, and all three subfractions contained the proanthocyanidin dimer (epi)gal-
(epi)gal (Table 5.6).  In addition, TP2E contained the dimer (epi)gal-(epi)cat and the trimer 
(epi)cat-(epi)cat-(epi)cat.  TP2G also contained the dimer (epi)cat-(epi)cat, which was found in 
the parent fraction.  Although no proanthocyanidins were identified in TP3-5 of A. chilensis 
berries, proanthocyanidins were detected in the more purified subfractions.  TP3-5C contained 
one dimer and one trimer, each composed of only (epi)cat subunits and B-type interflavan 
linkages.  TP3-5E contained the A-linked dimer (epi)cat-A-(epi)cat (Table 5.6).  To the best of 
our knowledge, this is the first time that any of these proanthocyanidins have been identified in 
the fruits of either species. 
Flavonols were identified in TP2F, TP2G, TP3-5F, and TP3-5G from A. chilensis berries.  
All of these subfractions contained myricetin-3-gal/glu ([M + H]+ m/z 481, fragment m/z 319).  
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In addition, TP2G and TP3-5G contained isorhamnetin-3-gal/glu ([M + H]+ m/z 479, fragment 
m/z 317) and both TP3-5F and TP3-5G contained quercetin ([M + H]+ m/z 303). 
 
Aldose reductase inhibition.  The crude extract (CE) and Toyopearl (TP) fractions of A. chilensis 
and P. virginiana fruits were tested for their ability to inhibit aldose reductase using an improved 
assay method that utilizes microtiter plates.  This method was validated by determining Km and 
Kcat values of aldose reductase using the microtiter-based method (0.016 mM ± 0.001 and 0.825 
s-1 ± 0.012, respectively) and comparing them to those found in the literature (0.018 mM and 
0.673 s-1, respectively (2).  The microtiter based method was further validated by comparing the 
inhibitory activity of the positive control (3,3-tetramethyleneglutaric acid) using this method 
(80% ± 1.1 inhibition at 5 µg/mL) to that previously published (80% inhibition at 5 µg/mL) (45). 
The CE and TP fractions of both fruits were initially screened at 5 µg/mL, and fractions 
that inhibited aldose reductase activity by at least 50% were considered strongly active and tested 
further to establish their IC50 values (concentration needed to achieve 50% inhibition).  The CE, 
TP1a, and TP1b of both fruit species were not active (< 50% inhibition, data not shown).  TP 
fractions 2-5 (TP2-TP5) of A. chilensis berries demonstrated strong inhibitory activity against 
aldose reductase (86%, 89%, 78%, and 69%, respectively; Figure 5.2).  The IC50 value for A. 
chilensis TP2 was 1.1 µg/mL (Table 5.7).  A. chilensis fractions TP3-TP5 were combined due to 
their similar chemical composition and need for sufficient mass for further fractionation and 
testing.  The IC50 value of the combined fraction (TP3-5) was 0.8 µg/mL (Table 5.7).  TP 
fractions 2 and 5 were the only fractions of P. virginiana that had strong inhibitory activity 
against aldose reductase (49% and 72%, respectively; Figure 5.2) with IC50 values of 4.5 µg/mL 
for both (Table 5.7).  Both active P. virginiana TP fractions had significantly lower activity than 
the active TP fractions of A. chilensis. 
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 Since the fractions of A. chilensis demonstrated activity that was significantly greater 
than P. virginiana fractions, only A. chilensis fractions were further fractionated to examine the 
types of compounds responsible for aldose reductase inhibitory activity.  TP2 and TP3-5 of A. 
chilensis were each further fractionated into 7 subfractions (TP2A-G and TP3-5A-G, 
respectively).  Each subfraction was screened at 5 µg/mL and subfractions with greater than 60% 
inhibitory activity were further tested to establish IC50 values.  Four subfractions of TP2 from A. 
chilensis (TP2D-TP2G) demonstrated significant activity against aldose reductase (66, 78, 77, 
and 85% inhibition, respectively; Figure 5.2).  The aldose reductase inhibitory activity of TP2G 
(IC50 value of 0.7 µg/mL, Table 5.7) was significantly greater than the other subfractions but 
statistically the same as the parent fraction, TP2.  The inhibitory activity of TP2E and TP2F 
(respective IC50 values of 2.5 and 1.9 µg/mL, Table 5.7) was significantly less than that of TP2.  
The aldose reductase inhibitory activity of TP2D (IC50 value of 3.0 µg/mL, Table 5.7) was 
statistically the same as TP2. 
Five subfractions of TP3-5 from A. chilensis (TP3-5C-G) showed significant activity 
against aldose reductase (91%, 78%, 79%, 80%, and 84% inhibition, respectively; Figure 5.2) 
and had associated IC50 values of 1.1, 2.1, 1.2, 0.6, and 1.0 µg/mL, respectively (Table 5.7).  The 
aldose reductase inhibitory activities of these subfractions were all statistically the same as their 
parent fraction (TP3-5). 
 
Correlation of phytochemical content and ARI.  The association between the phytochemical 
content (total phenolic, anthocyanin, and proanthocyanidin content) of A. chilensis berries and 
ARI was evaluated using linear regression.  There was a moderate statistical association between 
proanthocyanidin content and ARI (R-squared = 0.74) and no significant association with 
anthocyanin content (R-squared = 0.48) or with total phenolic content (R-squared = 0.04).  An 
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association between flavonol content and ARI was not statistically evaluated due to the small 
number of fractions containing detectable amounts of flavonols.   
 
Discussion 
Aldose reductase is an important clinical target for reducing diabetic microvascular 
complications, and thus methods to quickly screen potential inhibitors for efficacy are necessary.  
The protocol described in this study using microtiter plates is an efficient, cost-effective, and 
accurate way to rapidly determine if samples have inhibitory activity against aldose reductase.  
This microtiter-based method has been validated by comparing kinetic constants and activity of a 
known ARI with published values.  Such a method is ideal for screening large numbers of plant 
extracts and samples of other biological sources. 
A. chilensis and P. virginiana fruits both have activity against aldose reductase and thus 
have potential to lessen the degree and onset of neuropathies, nephropathies, and retinopathies 
that are often associated with diabetes.  The TP berry fractions of A. chilensis had twice the 
inhibitory capacity against aldose reductase than the TP drupe fractions of P. virginiana.  Total 
phenolic content and anthocyanin content did not significantly correlate with aldose reductase 
inhibitory activity (R-squared = 0.04 and 0.48, respectively).  All active fractions had a total 
phenolic content greater than 100 mg catechin equivalent / g sample.   However, several 
fractions (TP2B-C from A. chilensis) had total phenolic contents greater than 400 mg catechin 
equivalent / g sample but were not active in the aldose reductase inhibitory assay.  The range of 
anthocyanin content from active A. chilensis fractions and subfractions was 0.5 – 101 mg C3G 
equivalent / g sample, and fractions containing low levels of anthocyanins (TP2-4, TP2E-G, and 
TP3-5C-D from A. chilensis) were actually strong inhibitors of aldose reductase.  However, 
several fractions containing low levels of anthocyanins (TP3-5A from A. chilensis) were not 
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active against aldose reductase.  Overall, total phenolic and anthocyanin content were not 
reliable indicators of aldose reductase inhibitory activity. 
Proanthocyanidins, however, were significantly correlated with aldose reductase 
inhibitory activity (R-squared = 0.74), and the presence of proanthocyanidins in A. chilensis and 
P. virginiana fractions may partially explain their activity.  Other studies have suggested that 
proanthocyanidins and flavan-3-ols may have aldose reductase inhibitory activity.  For example, 
streptozotocin-induced diabetic rats given green or black tea, both rich in flavan-3-ols, showed 
significant reduction in lens sorbitol accumulation compared to rats given only water, suggesting 
aldose reductase inhibitory activity (46).  
In addition, although flavonol compounds, such as quercetin, myricetin, and 
isorhamnetin, were not present in enough fractions to allow statistical analysis, their presence 
appeared to be positively associated with strong aldose reductase inhibitory activity as well.  
Fractions containing flavonols (TP2F, TP2G, TP3-5F, TP3-5G from A. chilensis) had aldose 
inhibitory activity.  This is consistent with other reports documenting the strong activity of 
flavonols against aldose reductase activity (14, 19, 47).  In a rat lens model of aldose reductase 
inhibition, an isorhamnetin derivative had an IC50 of 0.75 µg/mL (48), which is consistent with 
the level of activity found in flavonol-containing A. chilensis fruit fractions.  In another rat lens 
model, a Nelumbo nucifera fraction rich in quercetin had an IC50 values of 2.4 µg/mL, which is 
also consistent with flavonol-rich compounds from A. chilensis fruit (47).  None of the fractions 
from P. virginiana contained identifiable flavonols, which may partially explain their lower level 
of aldose reductase inhibitory activity.  Overall, proanthocyanidins and flavonols were associated 
with more robust aldose reductase inhibitory activity than total phenolic content and anthocyanin 
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content.  Therefore, the presence of proanthocyanidins and flavonols in A. chilensis berries may 
explain their increased ARI activity compared to the drupes of P. virginiana. 
A. chilensis berries have been increasingly studied.  Initial studies that focused on the 
berry’s anthocyanin compounds and antioxidant activity have since led to subsequent exploration 
of the berry’s cardioprotective properties and a more in-depth characterization of its phenolic 
acid content.  In this study, we provide a first-time examination of A. chilensis berry 
proanthocyanidins and also demonstrate their positive correlation with its aldose reductase 
inhibitory activity using an updated protocol that lends efficiency to this assay. 
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Tables and Figures 
 
 
 
 
Table 5.1 Composition of reaction solutions used for the aldose reductase assay. 
 
                                    Reaction Solutions        
   Reagents              Sample Zeroa         Sampleb      Sample Blankc 
0.2 M Sodium Phosphate Buffer (pH 6.2)       100 μL         100 μL         100 μL 
1.5 mM β-NADPH                  ---            20 μL           20 μL 
100 mM DL-Glyceraldehyde               20 μL           20 μL  --- 
Distilled Water                40 μL           20 μL           40 μL 
Sample, Positive Control, or DMSO              20 μL           20 μL           20 μL 
                          Incubate at 25 °C for 3 min 
Diluted Aldose Reductase Solution                20 μL           20 μL           20 μL  
Total Volume               200 μL         200 μL         200 μL 
aSample zero solution is used to account for background noise. 
bSample solution is used to account for aldose reductase activity when both a sample and  
glyceraldehyde are present. 
cSample blank is used to account for aldose reductase activity when sample is present but 
glyceraldehyde is not present. 
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Table 5.2  Total phenolic content of Aristotelia chilensis and 
Prunus virginiana fruit fractions using the Folin-Ciocalteu assay
Fractions Total Phenolic Content 
(mg catechin equivalent / g 
sample)a 
Standard Error 
A. chilensis   
TP2 443 5.1 
TP3 447 1.8 
TP4 793 10.5 
TP5 799 2.5 
   
TP2A 226 3.8 
TP2B 839 21.5 
TP2C 805 4.0 
TP2D 719 2.4 
TP2E 1210 7.6 
TP2F 675 1.5 
TP2G 980 18.9 
   
TP3-5A 17.7 1.4 
TP3-5B 161 0.7 
TP3-5C 631 2.6 
TP3-5D 467 2.7 
TP3-5E 902 0.5 
TP3-5F 898 8.5 
TP3-5G 262 2.0 
P. virginiana   
TP2 840 3.9 
TP3 73.8 1.0 
TP4 400 2.0 
TP5 611 3.6 
a Values are presented as mean +/- standard error. n = 3 
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Table 5.3  Anthocyanin, proanthocyanidin, and flavonol content of Aristotelia chilensis and  
Prunus virginiana fruit fractions 
Fractions Anthocyanin Content 
(mg C3G equivalent / g 
sample) a 
PAC Content 
(mg EC equivalent / g 
sample) b 
Flavonol Content 
 (mg Q equivalent / g 
sample) c 
A. chilensis    
TP2 101 943 0.0 
TP3 3.2 1470 2.1 
TP4 0.3 1670 0.0 
TP5 0.4 646 0.0 
    
TP2A 41.4 15.3 1.0 
TP2B 438 191 0.0 
TP2C 221 528 0.0 
TP2D 45.7 547 0.0 
TP2E 7.3 844 0.0 
TP2F 8.5 1050 0.0 
TP2G 5.5 1430 3.7 
    
TP3-5A 0.0 2.9 0.0 
TP3-5B 33.4 82.6 0.0 
TP3-5C 0.6 1290 0.0 
TP3-5D 0.8 189 0.0 
TP3-5E 0.5 2220 0.0 
TP3-5F 0.5 1740 18.6 
TP3-5G 0.8 1060 3.2 
P. virginiana    
TP2 274 1010 0.0 
TP3 13.5 17.0 0.0 
TP4 8.7 246 0.0 
TP5 2.3 26.6 0.0 
a,b,c Values are expressed as cyanidin-3-O-glycoside (C3G), epicatechin (EC), and quercetin (Q) 
equivalents by mass. PAC = proanthocyanidin 
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Table 5.4  Identification of anthocyanins from Aristotelia chilensis berry fractions by LC-ESI-MS 
Fractions Compound [M + H]+ (m/z) Fragment ions (m/z) 
TP2 Cyanidin-3-galactoside/glucoside 449 287 
 Cyanidin-3,5-diglucoside 611 449, 287 
 Delphinidin-3-galactoside/glucoside 465 303 
 Delphinidin-3-arabinoside/xyloside * 435 303 
 Delphinidin-3,5-diglucoside 627 465, 303 
 Delphinidin-3-sambubioside-5-glucoside 759 597, 465, 303 
 Malvidin-3-glatactoside/glucoside 493 331 
    
TP2A Cyanidin-3-sambubioside 581 287 
 Cyanidin-3-sambubioside-5-glucoside 743 581, 449, 287 
 Delphinidin-3-sambubioside 597 303 
 Delphinidin-3,5-diglucoside 627 465, 303 
 Delphinidin-3-sambubioside-5-glucoside 759 597, 465, 303 
    
TP2B Cyanidin-3-galactoside/glucoside 449 287 
 Cyanidin-3-sambubioside 581 287 
 Delphinidin-3-galactoside/glucoside 465 303 
 Delphinidin-3,5-diglucoside 627 465, 303 
    
TP2C Cyanidin-3-galactoside/glucoside 449 287 
 Cyanidin-3-sambubioside 581 287 
 Delphinidin-3-galactoside/glucoside 465 303 
 Delphinidin-3,5-diglucoside 627 465, 303 
    
TP2D Delphinidin-3-galactoside/glucoside 465 303 
 Delphinidin-3,5-diglucoside 627 465, 303 
 Delphinidin-3-sambubioside-5-glucoside 759 597, 465, 303 
 Malvidin-3-galactoside/glucoside 493 331 
    
TP2E Cyanidin-3,5-diglucoside 611 449, 287 
 Cyanidin-3-rutinoside * 595 287 
 Delphinidin-3-galactoside/glucoside 465 303 
 Malvidin-3-galactoside/glucoside 493 331 
    
TP2F Cyanidin-3,5-digluoside 611 449, 287 
 Delphinidin-3-rutinoside * 611 465, 303 
    
TP2G Delphinidin-3-galactoside/glucoside 465 303 
    
TP3-5B Cyanidin-3-galactoside/glucoside 449 287 
 Delphinidin-3-galactoside/glucoside 465 303 
 Delphinidin-3-sambubioside 597 303 
 Delphinidin-3,5-diglucoside 627 465, 303 
 Delphindin-3-sambubioside-5-glucoside 759 597, 465, 303 
* indicates first time indentified in the berries of A. chilensis. 
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Table 5.5  Identification of anthocyanins from Prunus virginiana drupe fractions by LC-ESI-
MS 
Fraction Compound [M + H]+ (m/z) Fragment ions (m/z) 
TP2 Cyanidin-3-galactoside/glucoside 449 287 
 Cyanidin-3-rutinoside * 595 449, 287 
 Cyanidin-3,5-digluoside 611 449, 287 
 Delphinidin-3-galactoside/glucoside 465 303 
 Delphinidin-3-rutinoside * 611 465, 303 
    
TP3 Cyanidin-3-galactoside/glucoside 449 287 
 Cyanidin-3-rutinoside * 595 449, 287 
 Cyanidin-3,5-digluoside 611 449, 287 
 Delphinidin-3-galactoside/glucoside 465 303 
    
TP4 Cyanidin-3-galactoside/glucoside 449 287 
 Cyanidin-3-rutinoside * 595 449, 287 
 Cyanidin-3,5-digluoside 611 449, 287 
 Delphinidin-3-galactoside/glucoside 465 303 
    
TP5 Cyanidin-3-galactoside/glucoside 449 287 
 Cyanidin-3-rutinoside * 595 449, 287 
* indicates first time indentified in the drupes of P. virginiana. 
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Table 5.6  Identification of proanthocyanidins from Aristotelia chilensis and Prunus virginiana 
fruit fractions by LC-ESI-MS 
Fraction Compound a [M+H]+ 
(m/z) 
Fragment ions 
(m/z) 
A. chilensis    
TP2 (epi)cat-(epi)cat * 579 427, 291 
    
TP2E (epi)cat-(epi)cat-(epi)cat * 867 741, 601, 589, 579, 
577, 451, 427, 301, 
291 
 (epi)gal-(epi)cat * 595 469, 443, 427, 329, 
317, 291 
 (epi)gal-(epi)gal * 611 443, 317, 307, 305 
    
TP2F (epi)gal-(epi)gal * 611 443, 317, 329, 307 
    
TP2G (epi)cat-(epi)cat * 579 427, 301, 289 
 (epi)gal-(epi)gal * 611 485, 443, 329 
    
TP3-5C (epi)cat-(epi)cat * 579 453, 427, 313, 301, 
291, 289 
 (epi)cat-(epi)cat-(epi)cat * 867 741, 601, 589, 579, 
577, 451, 427, 425, 
301, 291 
    
TP3-5E (epi)cat-A-(epi)cat * 577 425, 299, 287 
    
P. virginiana    
TP3 (epi)cat-(epi)cat-(epi)cat * 867 741, 601, 589, 579, 
577, 451, 427, 301, 
291 
    
TP4 (epi)cat-A-(epi)cat-A-(epi)cat * 863 737, 723 , 711, 577, 
573, 451, 447, 287  
 (epi)cat-(epi)afz-(epi)gal-(epi)cat-(epi)cat  *, # 1443 1291, 1155, 1553, 
863, 707 
    
TP5 (epi)cat-(epi)cat-(epi)cat * 867 741, 589, 579, 577, 
451, 427, 301, 291, 
288 
 (epi)cat-(epi)cat-(epi)cat-(epi)cat-(epi)cat-(epi)cat * 1731 1604, 1577, 1441, 
1153, 865, 577 
a-A- indicates an A-type interflavan linkage. * indicates first time indentified in the particular 
fruit.  # indicates order of flavan units is tentatively assigned.  (epi)cat, (epi)gal, and (epi)afz are 
abbreviations for (epi)catechin, (epi)gallocatechin, and (epi)afzelechin, respectively. 
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Table 5.7  IC50 values of Aristotelia chilensis and Prunus virginiana fruit fractions 
against aldose reductase 
Fractions IC50 (µg/mL) a 95% C.I. 
A. chilensis   
TP2 1.1 0.8 – 1.5 
TP2D 3.0 1.4 – 6.4 
TP2E 2.5 2.0 – 3.3 
TP2F 1.9 1.6 – 2.2 
TP2G 0.7 0.4 – 1.1 
   
TP3-5 0.8 0.5 – 1.3 
TP3-5C 1.1 0.8 – 1.3 
TP3-5D 2.1 1.1 – 4.0 
TP3-5E 1.2 0.8 – 1.6 
TP3-5F 0.6 0.2 – 1.8 
TP3-5G 1.0 0.4 – 2.4 
P. virginiana   
TP2 4.5 3.3 – 6.0 
TP5 4.5 3.8 – 5.3 
a The concentration needed to inhibit aldose reductase by 50% (IC50) by Toyopearl (TP) fractions 
of Aristotelia chilensis and Prunus virginiana fruits was calculated by testing at least 6 
concentrations in duplicate or greater and using a nonlinear least squares equation of best fit.  
Activity of fractions is relative to a DMSO control. 
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Figure 5.1 Positive ion ESI-MS fragmentation of m/z 867 from Prunus virginiana drupes TP3 
 
HRF & 
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fission 
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after QM fission 
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Example ESI-MS spectra of P. virginiana TP3 showing the fragmentation of [M + H]+ m/z 867, 
a B-type proanthocyanidin trimer composed solely of (epi)catechin subunits.  ESI-MS was run in 
positive mode. RDA, HRF, and QM are abbreviations for retro-Diels-Alder, heterocyclic ring 
fission, and quinine methide, respectively.
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 Figure 5.2  Inhibition of  aldose reductase by fractions of Aristoteila chilensis 
and Prunus virginiana fruits
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The percent inhibition of aldose reductase activity by Aristotelia chilensis (AC) and Prunus 
virginiana (PV) fruit Toyopearl (TP) fractions as mean +/- standard error relative to a DMSO 
control.  Fractions were tested at 5 µg/mL in triplicate. 
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Chapter 6 
 
Conclusion 
 
 The goal of this dissertation research was to study the roles and potential of fruit 
compounds in the reduction of diabetes.  It was hypothesized that fruits contain 
phytochemical constituents that contribute to protection against diabetes and its 
complications.  In Chapter 2 (“Phytochemical Composition and Metabolic Performance 
Enhancing Activity of Dietary Berries Traditionally Used by Native North Americans”), this 
hypothesis was addressed by studying four fruits (Amelanchier alnifolia, Viburnum trilobum, 
Prunus virginiana, and Shepherdia argentea) and screening them for properties related to 
metabolic performance enhancing activity.  Nonpolar and polar constituents from these fruits 
were assessed for potential to affect diabetic microvascular complications, hyperglycemia, pro-
inflammatory gene expression, and properties of metabolic syndrome.  In general, non-polar 
compounds (especially from P. virginiana and V. trilobum) showed the greatest degree of 
activity against aldose reductase and polar compounds (especially from P. virginiana) 
demonstrated strong inhibition of IL-1β and COX-2 gene expression.  In addition, compounds 
from V. trilobum improved glucose utilization, modulated lipid metabolism, and enhanced 
energy expenditure in vitro.  On the basis of these findings, three secondary hypotheses were 
proposed: 
(1) It is hypothesized that the ability of V. trilobum fruit compounds to enhance 
glucose utilization is due to their ability to activate and/or inhibit the expression 
of specific genes involved in glucose metabolism. 
(2) P. virginiana fruit compounds demonstrated ability to inhibit production of pro-
inflammatory cytokines.  The heavily researched and broadly bioactive Vaccinium 
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angustifolium fruit has also demonstrated anti-inflammatory ability (1).  Both P. 
virginiana and V. angustifolium fruits are rich in anthocyanins, however only the 
latter contains prominent amounts of proanthocyanidins.  Both anthocyanins and 
proanthocyanidins have individually demonstrated anti-inflammatory activity via 
decreasing expression of pro-inflammatory cytokines.  It is hypothesized that the 
anti-inflammatory capacity of P. virginiana fruits will be less than the anti-
inflammatory capacity of V. angustifolium fruits due to interactions between 
anthocyanins and proanthocyanidins in V. angustifolium fruit. 
(3) P. virginiana fruit compounds have demonstrated the ability to inhibit aldose 
reductase.  Fruits constituents from A. chilensis have demonstrated greater aldose 
reductase inhibitory activity than compounds from P. virginiana fruits. Fruits of A. 
chilensis also contain a unique array of anthocyanins not found in P. virginiana.  It is 
hypothesized that the greater aldose reductase inhibitory activity of A. chilensis 
is due to the unique anthocyanins found in this fruit. 
 
 “Effects of Viburnum trilobum Fruit Extract on Expression of Genes Important in 
Glucose Regulation” (Chapter 3) explores the manner in which components of V. trilobum fruit 
effect the expression of genes involved in glucose homeostasis.  In this study, the crude extract 
of V. trilobum fruit was tested for ability to overcome changes in gene expression associated with 
insulin resistance of 155 genes.  Of these, the expression of glucose-6-phosphatase (G6P) was 
affected in a dose-dependent manner and much of this activity was due to high molecular weight 
proanthocyanidins found in the fruit.  Although anthocyanins from this fruit did not affect G6P 
activity, they showed a tendency to promote the activity of the proanthocyanidins, although this 
was not statistically significant. 
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 Chapter 4 (“Interactions of Compounds from Prunus virginiana and Vaccinium 
angustifolium Fruits on In Vitro IL-6, TNFα, and Nitric Oxide Production”) further explores the 
anti-inflammatory potential of P. virginiana and compares it to the intensely studied and 
commercially important V. angustifolium berry.  A flavonoid-rich fraction, an anthocyanin-rich 
fraction, and a proanthocyanidin-rich fraction of these two fruits were studied for their ability to 
reverse the LPS-induced production of inflammatory markers in BV-2 cells, a murine microglial 
cell line.  Fractions from both berries demonstrated anti-inflammatory properties, although the 
fractions of V. angustifolium were generally more potent.  In addition, the flavonoid-rich fraction 
and the proanthocyanidin-rich fraction from V. angustifolium interacted in a more than additive 
manner to inhibit NO production whereas the anthocyanins and proanthocyanidins from the same 
fruit interfered with each other to inhibit NO production.  No interactions were identified among 
P. virginiana fruit fractions. 
 Lastly, in Chapter 5 (“Comparative Phytochemical Composition and Aldose Reductase 
Inhibitory Activity of Aristotelia chilensis (Maqui) and Prunus virginiana (Chokecherry) 
Fruits”) the ability of compounds of P. virginiana to inhibit aldose reductase activity was 
compared to the activity of compounds from Aristotelia chilensis (maqui), a Chilean berry which 
contains high concentrations of anthocyanin pigments.  In this study the anthocyanins and 
proanthocyanidins of both species were characterized, and it was found that compounds from A. 
chilensis, mainly flavonols and proanthocyanidins, had the highest levels of aldose reductase 
inhibitory activity. 
 The results from these four research projects demonstrate that fruits contain compounds 
that can potentially modify the progression of diabetes by inhibiting changes in gene expression 
associated with diabetes.  In addition, fruit compounds could mitigate complications associated 
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with diabetes by decreasing the production of inflammatory mediators that are typically 
increased in diabetic patients.  Different fruit compounds were responsible for these various 
types of activity.  Proanthocyanidin compounds, for example, demonstrated significant ability to 
modify the expression of genes associated with glucose metabolism, inhibit the production of 
inflammatory mediators, and inhibit the enzyme aldose reductase.  Anthocyanins, on the other 
hand, only showed significant ability to inhibit production of inflammatory mediators.  
Interestingly, the dynamics of compound interaction was explored and found to be an important 
factor in overall activity of fruits often resulting in more than additive interactions.  These results 
and conclusions support and validate the primary hypothesis. 
 Although this work has demonstrated the ability of fruit compounds to significantly effect 
markers of diabetes and diabetic complications, there are several studies still warranted to further 
describe these abilities.  This work clearly showed that fruit compounds can modulate gene 
expression and alter production of inflammatory compounds in cell culture, but the mechanism 
by which these actions occur is not understood.  Gene expression and protein quantification 
studies (ELISA, Western blots, and radioimmunoassay) can be used to explore pathways from 
gene expression to the production of end product proteins and intermediates in-between to 
determine how fruit compounds have their effect.  In addition, this work focused mainly on 
proanthocyanidin and anthocyanin compounds, but other compounds from fruits, such as 
carotenoids and phenolic acids, can be evaluated for potential activity as well.  Eventually, these 
types of studies will use pure compounds either directly separated from all other fruit compounds 
or available as standards for purchase.  At this point, however, the means of separating individual 
proanthocyanidins and anthocyanins from each other are inefficient and laborious, and all but of 
handful of these compounds are unavailable for purchase.  All studies such as these with 
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significant findings should be pursued and tested using primary cell cultures and eventually in 
animal models.  Important considerations regarding bioavailabilty, digestion effects, and 
interactions with gut microorganisms need to be explored to fully understand how fruit 
compounds effect the health and disease states, such as diabetes, in humans. 
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